nct_id,dropout_percentage_all,Clinical Title,Overall Status,Trial Phase,Allocation,Start Date,Completion Date,Primary Purpose,City,State,Zipcode,Gender,Minimum Age,New Completion Date,New Start Date,length_of_trial,RUCA2.0,Cleaned_Zipcodes
NCT00001596,17.39130435,Oral Pirfenidone for the Pulmonary Fibrosis of Hermansky-Pudlak Syndrome,Completed,Phase 2,Randomized,September 2005,"May 9, 2016",Treatment,Bethesda,Maryland,20892,All,18.0,2016-05-01,2005-09-01,3895.0,1.0,20892
NCT00001723,8.0,Safety and Efficacy of Xenical in Children and Adolescents With Obesity-Related Diseases,Completed,Phase 2,Randomized,May 1998,October 2011,Treatment,Bethesda,Maryland,20892,All,12.0,2011-10-01,1998-05-01,4901.0,1.0,20892
NCT00003869,21.87789084,Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer,Completed,Phase 3,Randomized,April 1999,May 2008,Treatment,Rochester,Minnesota,55905,All,18.0,2008-05-01,1999-04-01,3318.0,1.0,55905
NCT00003901,0.8595988539,"Prognostic Study of Metastases in Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Can Be Removed by Surgery",Completed,Phase 3,,July 1999,October 2011,Diagnostic,Mobile,Alabama,36608,All,18.0,2011-10-01,1999-07-01,4475.0,1.0,36608
NCT00045162,24.43651603,S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer,Completed,Phase 3,Randomized,November 2002,December 2009,Treatment,Anniston,Alabama,36202,All,18.0,2009-12-01,2002-11-01,2587.0,1.0,36202
NCT00047385,1.406735931,National Lung Screening Trial (NLST) Screening,Completed,Phase 3,Randomized,August 2002,October 2010,Screening,Birmingham,Alabama,35233,All,55.0,2010-10-01,2002-08-01,2983.0,1.0,35233
NCT00047463,13.63636364,Effects of Treating Obstructive Sleep Apnea in Epilepsy,Completed,Phase 2,Randomized,September 2002,July 2008,Treatment,Ann Arbor,Michigan,48109,All,18.0,2008-07-01,2002-09-01,2130.0,1.0,48109
NCT00048997,7.975460123,Radiation Therapy in Preventing Central Nervous System (CNS) Metastases in Patients With Non-Small Cell Lung Cancer,Completed,Phase 3,Randomized,September 2002,December 2016,Treatment,Phoenix,Arizona,85013,All,18.0,2016-12-01,2002-09-01,5205.0,1.0,85013
NCT00050960,40.19607843,"Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer",Completed,Phase 3,Randomized,May 2002,March 2005,Treatment,Montgomery,Alabama,36106,All,18.0,2005-03-01,2002-05-01,1035.0,1.0,36106
NCT00051363,22.62039077,Apnea Positive Pressure Long-Term Efficacy Study,Completed,Phase 3,Randomized,September 2002,September 2008,Treatment,Tucson,Arizona,85724,All,18.0,2008-09-01,2002-09-01,2192.0,1.0,85724
NCT00053846,12.92056595,Buspirone in Reducing Shortness of Breath in Patients With Cancer,Completed,Phase 2/Phase 3,Randomized,November 2002,January 2011,Supportive Care,Chicago,Illinois,60612-7323,All,18.0,2011-01-01,2002-11-01,2983.0,1.0,60612
NCT00057746,0.5050505051,Brain Irradiation in Treating Patients With Limited-Stage Small Cell Lung Cancer,Completed,Phase 2,Randomized,February 2003,November 2013,Treatment,Birmingham,Alabama,35294,All,18.0,2013-11-01,2003-02-01,3926.0,1.0,35294
NCT00057837,20.45454545,Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer,Completed,Phase 2,Randomized,"July 14, 2004",August 2012,Treatment,Lewes,Delaware,19958,All,18.0,2012-08-01,2004-07-01,2953.0,4.0,19958
NCT00062010,0.0,"Interferon Alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer",Completed,Phase 2,,"May 26, 2004",August 2012,Treatment,Decatur,Georgia,30033,All,18.0,2012-08-01,2004-05-01,3014.0,1.0,30033
NCT00063154,25.58139535,"Safety and Effect of Pertuzumab in Patients With Advanced Non-Small Cell Lung Cancer, Which Has Progressed After Prior Chemotherapy",Completed,Phase 2,,July 2003,April 2005,Treatment,Scottsdale,Arizona,85258,All,18.0,2005-04-01,2003-07-01,640.0,1.0,85258
NCT00065429,4.87804878,Safety Study Using Weekly Infusions of BB-10901 in Patients With Small Cell Lung Cancer,Completed,Phase 1/Phase 2,Non-Randomized,April 2003,December 2008,Treatment,Denver,Colorado,80218,All,18.0,2008-12-01,2003-04-01,2071.0,1.0,80218
NCT00066222,1.408450704,"Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer",Completed,Phase 2,,June 2003,November 2013,Treatment,Birmingham,Alabama,35294,All,18.0,2013-11-01,2003-06-01,3806.0,1.0,35294
NCT00069823,2.246453945,Study of Acid Reflux in Asthma,Completed,Phase 3,Randomized,September 2003,May 2008,Treatment,Birmingham,Alabama,35294,All,18.0,2008-05-01,2003-09-01,1704.0,1.0,35294
NCT00071032,0.8433040077,Safety and Effectiveness of Two Blood Transfusion Strategies in Surgical Patients With Cardiovascular Disease,Completed,Phase 3,Randomized,July 2003,May 2009,Treatment,New Brunswick,New Jersey,08903,All,50.0,2009-05-01,2003-07-01,2131.0,1.0,08903
NCT00078312,46.64634146,"Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder",Completed,Phase 3,Non-Randomized,January 2004,July 2006,Treatment,Peoria,Arizona,85381,All,18.0,2006-07-01,2004-01-01,912.0,1.0,85381
NCT00079040,1.587301587,"Cisplatin, Etoposide, and Bevacizumab in Treating Patients With Previously Untreated Extensive Stage Small Cell Lung Cancer",Completed,Phase 2,,January 2006,January 2009,Treatment,Boston,Massachusetts,02215,All,18.0,2009-01-01,2006-01-01,1096.0,1.0,02215
NCT00079937,14.96609178,"Efficacy and Safety of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Inadequately Controlled Allergic Asthma",Completed,Phase 3,Randomized,April 2004,March 2008,Treatment,Birmingham,Alabama,35209,All,6.0,2008-03-01,2004-04-01,1430.0,1.0,35209
NCT00080223,54.21686747,Safety Study of Oral Pirfenidone in Patients With Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis,Completed,Phase 2,,"August 31, 2003","April 30, 2015",Other,Phoenix,Arizona,85006,All,40.0,2015-04-01,2003-08-01,4261.0,1.0,85006
NCT00087438,0.0,Stereotactic Body Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer,Completed,Phase 2,,May 2004,December 2016,Treatment,Rochester,New York,14642,All,18.0,2016-12-01,2004-05-01,4597.0,1.0,14642
NCT00087698,18.18181818,Phase II Trial of Neo-Adjuvant Pemetrexed Plus Cisplatin Followed by Surgery and Radiation for Pleural Mesothelioma,Completed,Phase 2,Non-Randomized,September 2003,February 2008,Treatment,San Francisco,California,,All,18.0,2008-02-01,2003-09-01,1614.0,1.0,94101
NCT00094094,21.875,Anti-angiogenesis Agent AG-013736 in Patients With Advanced Non-Small Cell Lung Cancer,Completed,Phase 2,,February 2005,July 2007,Treatment,Irvine,California,92612,All,18.0,2007-07-01,2005-02-01,880.0,1.0,92612
NCT00095199,18.6503884,Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer,Completed,Phase 3,Randomized,January 2005,July 2011,Treatment,Birmingham,Alabama,35294,All,18.0,2011-07-01,2005-01-01,2372.0,1.0,35294
NCT00096226,26.31578947,"Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung Cancer",Completed,Phase 2,,September 2004,"May 16, 2016",Treatment,Phoenix,Arizona,85013,All,18.0,2016-05-01,2004-09-01,4260.0,1.0,85013
NCT00096486,6.477732794,Gefitinib and Everolimus in Treating Patients With Stage IIIB or Stage IV or Recurrent Non-Small Cell Lung Cancer,Completed,Phase 1/Phase 2,,May 2004,July 2010,Treatment,New York,New York,10021,All,18.0,2010-07-01,2004-05-01,2252.0,1.0,10021
NCT00097773,6.25,Comparison of Two Treatment Regimens to Reduce PA Infection in Children With Cystic Fibrosis,Completed,Phase 2,Randomized,September 2004,August 2009,Prevention,Birmingham,Alabama,35233,All,18.0,2009-08-01,2004-09-01,1795.0,1.0,35233
NCT00098254,5.405405405,BAY 43-9006 (Sorafenib) to Treat Relapsed Non-Small Cell Lung Cancer,Completed,Phase 2,Non-Randomized,December 2004,January 2011,Treatment,Bethesda,Maryland,20892,All,18.0,2011-01-01,2004-12-01,2222.0,1.0,20892
NCT00100932,21.97802198,"Phase II Study Of E7389, Halichondrin B Analogue, In Patients With Advanced Non-Small Cell Lung Cancer, NSCLC, Who Progressed During Or After Platinum-Based Doublet Chemotherapy",Completed,Phase 2,Non-Randomized,December 2004,,Treatment,Gilroy,California,,All,18.0,,2004-12-01,731.0,1.0,95020
NCT00102804,12.79340565,Pemetrexed and Best Supportive Care Versus Placebo and Best Supportive Care in Non-Small Cell Lung Cancer (NSCLC),Completed,Phase 3,Randomized,March 2005,December 2013,Treatment,Minneapolis,Minnesota,55455,All,18.0,2013-12-01,2005-03-01,3197.0,1.0,55455
NCT00103259,13.95881007,Bortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck,Completed,Phase 2,Randomized,July 2005,November 2011,Treatment,Boston,Massachusetts,02215,All,18.0,2011-11-01,2005-07-01,2314.0,1.0,02215
NCT00104520,52.59259259,Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa,Completed,Phase 3,Randomized,February 2005,September 2006,Treatment,Phoenix,Arizona,,All,6.0,2006-09-01,2005-02-01,577.0,1.0,13135
NCT00105183,5.188943886,EZ-2053 in the Prophylaxis of Acute Pulmonary Allograft Rejection,Completed,Phase 3,Randomized,January 2005,January 2011,Prevention,Los Angeles,California,90048,All,18.0,2011-01-01,2005-01-01,2191.0,1.0,90048
NCT00107952,5.361968834,Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus,Completed,Phase 3,Randomized,February 2005,July 2007,Treatment,Springfield,Massachusetts,01199,All,18.0,2007-07-01,2005-02-01,880.0,1.0,01199
NCT00111839,26.26866917,Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer,Completed,Phase 2,Randomized,"May 31, 2005","March 31, 2009",Treatment,Tucson,Arizona,85715,All,18.0,2009-03-01,2005-05-01,1400.0,1.0,85715
NCT00112294,0.0,Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer,Completed,Phase 3,Randomized,December 2004,August 2008,Treatment,Birmingham,Alabama,,All,18.0,2008-08-01,2004-12-01,1339.0,1.0,35203
NCT00112359,24.19642857,International Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa,Completed,Phase 3,Randomized,May 2005,April 2007,Treatment,Birmingham,Alabama,,All,6.0,2007-04-01,2005-05-01,700.0,1.0,35203
NCT00113516,26.19047619,A Study Of SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer,Completed,Phase 2,Non-Randomized,September 2005,March 2009,Treatment,Los Angeles,California,90048,All,18.0,2009-03-01,2005-09-01,1277.0,1.0,90048
NCT00117325,6.25181645,Study Of Adults And Adolescents With Vasomotor Rhinitis,Completed,Phase 3,Randomized,"July 11, 2005","February 9, 2006",Treatment,Beverly Hills,California,90212,All,12.0,2006-02-01,2005-07-01,215.0,1.0,90212
NCT00117572,4.396135266,Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE),Completed,Phase 3,Randomized,November 2004,December 2016,Treatment,Los Angeles,California,90033,All,18.0,2016-12-01,2004-11-01,4413.0,1.0,90033
NCT00118703,4.031293602,Once-Daily Investigational Nasal Spray In Adults And Adolescents With Vasomotor Rhinitis,Completed,Phase 3,Randomized,"July 1, 2005","February 9, 2006",Treatment,Birmingham,Alabama,35209,All,12.0,2006-02-01,2005-07-01,215.0,1.0,35209
NCT00124618,0.0,Cetuximab and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer,Completed,Phase 2,,January 2006,March 2015,Treatment,Scottsdale,Arizona,85259-5499,All,18.0,2015-03-01,2006-01-01,3346.0,1.0,85259
NCT00125359,11.9047619,Study of Tarceva and Targretin Oral Capsules in Patients With Advanced Lung Cancer,Completed,Phase 2,,August 2005,March 2014,Treatment,Lebanon,New Hampshire,03756,All,18.0,2014-03-01,2005-08-01,3134.0,1.0,03756
NCT00128492,25.13849984,Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis (CF) Patients With Pseudomonas Aeruginosa (PA),Completed,Phase 3,Non-Randomized,August 2005,January 2009,Treatment,Birmingham,Alabama,,All,6.0,2009-01-01,2005-08-01,1249.0,1.0,35203
NCT00129766,1.62806476,Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children,Completed,Phase 3,Randomized,November 2004,May 2006,Prevention,Birmingham,Alabama,35233,All,18.0,2006-05-01,2004-11-01,546.0,1.0,35233
NCT00138658,34.56790123,A Study of OGX-011/Gemcitabine/Platinum-Based Regimen in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC),Completed,Phase 1/Phase 2,,November 2004,March 2010,Treatment,Los Angeles,California,90033,All,18.0,2010-03-01,2004-11-01,1946.0,1.0,90033
NCT00139659,19.38453318,A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With Asthma,Completed,Phase 3,Randomized,January 2003,October 2008,Treatment,Glendale,Arizona,85306,All,18.0,2008-10-01,2003-01-01,2100.0,1.0,85306
NCT00144339,40.99070223,Evaluation of the Long- Term Effects of Spiriva on Lung Function in COPD Patients,Completed,Phase 3,,December 2002,,Treatment,Anniston,Alabama,,All,40.0,,2002-12-01,731.0,1.0,36201
NCT00147537,41.98247536,"Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung Cancer",Completed,Phase 1/Phase 2,Randomized,February 2005,August 2011,Treatment,Tucson,Arizona,85719,All,18.0,2011-08-01,2005-02-01,2372.0,1.0,85719
NCT00159913,2.673160173,"A Randomized, Double-Blind, Placebo-Controlled Study of Sildenafil in Children With Pulmonary Arterial Hypertension.",Completed,Phase 3,Randomized,August 2003,June 2008,Treatment,Palo Alto,California,94304,All,18.0,2008-06-01,2003-08-01,1766.0,1.0,94304
NCT00168831,25.35410676,Tiotropium / Respimat One-Year Study,Completed,Phase 3,Randomized,February 2003,,Treatment,Birmingham,Alabama,,All,40.0,,2003-02-01,731.0,1.0,35203
NCT00168844,20.55305863,Tiotropium / Respimat One-Year Study,Completed,Phase 3,Randomized,January 2003,,Treatment,Los Angeles,California,,All,40.0,,2003-01-01,731.0,1.0,90001
NCT00171834,45.71428571,"Dose Escalating Study of the Safety and Efficacy of Patupilone, q3w, in Patients With Non-small Cell Lung Cancer",Completed,Phase 1/Phase 2,Non-Randomized,August 2003,September 2008,Treatment,Louisville,Kentucky,40232-5070,All,18.0,2008-09-01,2003-08-01,1858.0,1.0,40232
NCT00182689,32.25146199,Sorafenib in Treating Patients With Extensive Stage Small Cell Lung Cancer,Completed,Phase 2,,July 2005,October 2008,Treatment,Portland,Oregon,97239,All,18.0,2008-10-01,2005-07-01,1188.0,1.0,97239
NCT00191139,21.875,"Gemcitabine or Gemcitabine Plus Docetaxel After Cisplatin, Etoposide and Radiation in Non Small Cell Lung Cancer (NSCLC)",Completed,Phase 2,Randomized,March 2003,February 2009,Treatment,Denver,Colorado,80218,All,18.0,2009-02-01,2003-03-01,2164.0,1.0,80218
NCT00200967,13.96825397,Asthma Clinical Research Network (ACRN) Trial - Long-Acting Beta Agonist Response by Genotype (LARGE),Completed,Phase 3,Randomized,December 2004,February 2008,Treatment,San Diego,California,92103,All,18.0,2008-02-01,2004-12-01,1157.0,1.0,92103
NCT00207740,23.05019542,A Study of Safety and Efficacy of CNTO 148 in Patients With Severe Persistent Asthma,Completed,Phase 2,Randomized,August 2004,July 2007,Treatment,Los Angeles,California,,All,18.0,2007-07-01,2004-08-01,1064.0,1.0,90001
NCT00216203,6.060606061,Pemetrexed Plus Cetuximab in Patients With Recurrent Non Small Cell Lung Cancer,Completed,Phase 1/Phase 2,,May 2005,December 2008,Treatment,Galesburg,Illinois,61401,All,18.0,2008-12-01,2005-05-01,1310.0,4.0,61401
NCT00227539,4.0,"Positron Emission Tomography in Predicting Response in Patients Who Are Undergoing Treatment With Pemetrexed Disodium and Cisplatin With or Without Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer",Completed,Phase 2,,July 2005,November 2013,Treatment,Seattle,Washington,98109-1023,All,18.0,2013-11-01,2005-07-01,3045.0,1.0,98109
NCT00228553,47.60601915,Extension Study of the Safety and Efficacy of Armodafinil in the Treatment of Patients With Excessive Sleepiness,Completed,Phase 3,Non-Randomized,May 2004,July 2006,Treatment,Birmingham,Alabama,35213,All,18.0,2006-07-01,2004-05-01,791.0,1.0,35213
NCT00228566,21.05263158,Study to Assess Patient Reported Outcomes With Armodafinil Treatment for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome,Completed,Phase 3,Non-Randomized,October 2005,July 2006,Treatment,Birmingham,Alabama,35213,All,18.0,2006-07-01,2005-10-01,273.0,1.0,35213
NCT00231465,4.545454545,Phase II Study of Docetaxel + ZD1839 in Elderly Patients With Non-Small Cell Lung Cancer,Completed,Phase 2,,July 2003,August 2012,Treatment,Tampa,Florida,33612,All,70.0,2012-08-01,2003-07-01,3319.0,1.0,33612
NCT00232557,5.958829902,Telecommunications System in Asthma,Completed,Phase 3,Randomized,August 2004,December 2009,Treatment,Boston,Massachusetts,02130,All,18.0,2009-12-01,2004-08-01,1948.0,1.0,02130
NCT00243074,21.27659574,S0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery,Completed,Phase 2,,November 2005,December 2011,Treatment,San Antonio,Texas,78245,All,18.0,2011-12-01,2005-11-01,2221.0,1.0,78245
NCT00244725,7.650205539,Odiparcil For The Prevention Of Venous Thromboembolism,Completed,Phase 2,Randomized,September 2005,September 2006,Prevention,Birmingham,Alabama,35209,All,35.0,2006-09-01,2005-09-01,365.0,1.0,35209
NCT00247416,5.225806452,Effects of Carboplatin and Gemcitabine on Stage IIIB Pleural Effusion and Stage IV Lung Cancer,Completed,Phase 2,Randomized,August 2005,July 2009,Treatment,Danville,Kentucky,40422,All,18.0,2009-07-01,2005-08-01,1430.0,4.0,40422
NCT00248495,2.631578947,"Pemetrexed Disodium and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer",Completed,Phase 2,,"June 8, 2005","April 5, 2017",Treatment,Buffalo,New York,14263-0001,All,18.0,2017-04-01,2005-06-01,4322.0,1.0,14263
NCT00250679,27.30371791,Safety and Efficacy of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease,Completed,Phase 3,Randomized,October 2005,October 2007,Treatment,Birmingham,Alabama,33744,All,35.0,2007-10-01,2005-10-01,730.0,1.0,33744
NCT00255047,8.861391361,Safety and Immune Response of Different Pediatric Combination Vaccines.,Completed,Phase 3,Randomized,November 2005,February 2009,Prevention,Tuscaloosa,Alabama,35401,All,18.0,2009-02-01,2005-11-01,1188.0,1.0,35401
NCT00257608,14.27432795,A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS),Completed,Phase 3,Randomized,January 2006,November 2014,Treatment,Mobile,Alabama,36608,All,18.0,2014-11-01,2006-01-01,3226.0,1.0,36608
NCT00258895,1.952619971,Safety and Immunogenicity of DAPTACEL® as 5th Dose in Children 4 to 6 Years Old After 4 Doses of Pentacel™ or DAPTACEL®,Completed,Phase 3,Non-Randomized,March 2005,April 2007,Prevention,Fayetteville,Arkansas,15213,All,4.0,2007-04-01,2005-03-01,761.0,1.0,15213
NCT00261833,11.80941787,Zemaira in Subjects With Emphysema Due to Alpha1-Proteinase Inhibitor Deficiency,Completed,Phase 4,Randomized,March 2006,September 2012,Treatment,Denver,Colorado,80206,All,18.0,2012-09-01,2006-03-01,2376.0,1.0,80206
NCT00264576,0.3262720886,Study of the Safety and Immunogenicity of an Influenza Vaccine Administered to Healthy Adults,Completed,Phase 2,Randomized,October 2005,May 2006,Prevention,Bardstown,Kentucky,40004,All,18.0,2006-05-01,2005-10-01,212.0,4.2,40004
NCT00265317,19.72445465,A Study In Patients With Non-Small Cell Lung Cancer Testing If Erlotinib Plus SU011248 (Sunitinib) Is Better Than Erlotinib Alone,Completed,Phase 2,Randomized,June 2006,January 2012,Treatment,Birmingham,Alabama,35233,All,18.0,2012-01-01,2006-06-01,2040.0,1.0,35233
NCT00266877,14.98778999,Study Evaluating the Safety Of HKI-272 (Neratinib) In Subjects With Advanced Non-Small Cell Lung Cancer,Completed,Phase 2,Non-Randomized,December 2005,January 2009,Treatment,Los Angeles,California,90033,All,18.0,2009-01-01,2005-12-01,1127.0,1.0,90033
NCT00267202,21.11722387,Study to Evaluate the Effect of Omalizumab on Improving the Tolerability of Specific Immunotherapy in Patients With Persistent Allergic Asthma,Completed,Phase 4,Randomized,December 2005,April 2008,Treatment,East Hanover,New Jersey,,All,18.0,2008-04-01,2005-12-01,852.0,1.0,07936
NCT00279916,13.21256039,Short Term Relief of Eustachian Tube Dysfunction and Serous Otitis Media Using Intranasal Steroid Sprays,Completed,Phase 3,Randomized,"September 1, 2005",March 2009,Treatment,Rochester,Minnesota,55905,All,6.0,2009-03-01,2005-09-01,1277.0,1.0,55905
NCT00280735,20.83333333,Ph II Adjuvant Carboplatin/Docetaxel in Curatively Resected Stage I-IIIA NSCLC,Completed,Phase 2,,May 2004,July 2011,Treatment,Chapel Hill,North Carolina,27599,All,18.0,2011-07-01,2004-05-01,2617.0,1.0,27599
NCT00282295,2.088680709,"US-licensed Combined Vaccine Against Tetanus & Diphtheria, Given With US-licensed Vaccine Against Meningococcal Disease",Completed,Phase 4,Randomized,"January 25, 2006","August 8, 2006",Prevention,Chandler,Arizona,85224,All,11.0,2006-08-01,2006-01-01,212.0,1.0,85224
NCT00283244,24.70291147,"Ph II Gemcitabine, Erlotinib, and Gemcitabine With Erlotinib/Elderly Patients W/ IIIB/IV NSCLC",Completed,Phase 2,Randomized,March 2006,October 2014,Treatment,Fayetteville,Arkansas,72703,All,70.0,2014-10-01,2006-03-01,3136.0,1.0,72703
NCT00284141,32.65306122,Study of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-small-cell-lung Adenocarcinoma,Completed,Phase 2,Non-Randomized,January 2006,July 2008,Treatment,Bridgewater,New Jersey,08807,All,18.0,2008-07-01,2006-01-01,912.0,1.0,08807
NCT00285012,33.04202545,Smoking Cessation in Subjects With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD).,Completed,Phase 3,Randomized,May 2006,April 2009,Treatment,Birmingham,Alabama,35249-2181,All,35.0,2009-04-01,2006-05-01,1066.0,1.0,35249
NCT00289198,19.20529801,Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR),Completed,Phase 3,Randomized,"February 7, 2006","July 4, 2006",Treatment,San Diego,California,92123,All,12.0,2006-07-01,2006-02-01,150.0,1.0,92123
NCT00289783,10.46572005,Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine,Completed,Phase 3,Randomized,"February 22, 2006","February 26, 2008",Prevention,Birmingham,Alabama,35216,All,18.0,2008-02-01,2006-02-01,730.0,1.0,35216
NCT00294762,4.19600939,Erlotinib (Tarceva) as a Single Agent or Intercalated With Combination Chemotherapy in Patients With EGFR Positive NSCLC,Completed,Phase 2,Randomized,January 2006,March 2009,Treatment,Alhambra,California,91801,All,18.0,2009-03-01,2006-01-01,1155.0,1.0,91801
NCT00296491,13.23477627,Study Of Allergic Rhinitis In Patients Who Also Have Asthma,Completed,Phase 4,Randomized,September 2005,October 2007,Treatment,Birmingham,Alabama,35209,All,15.0,2007-10-01,2005-09-01,760.0,1.0,35209
NCT00298896,7.272727273,Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung Cancer,Completed,Phase 2,,February 2006,June 2008,Treatment,Sacramento,California,95817,All,18.0,2008-06-01,2006-02-01,851.0,1.0,95817
NCT00301366,2.631578947,The Safety and Tolerability of Alpha-1 Modified Process (MP) In Subjects With Alpha-1-antitrypsin (AAT) Deficiency,Completed,Phase 3,Non-Randomized,June 2006,March 2007,Treatment,Denver,Colorado,80206,All,18.0,2007-03-01,2006-06-01,273.0,1.0,80206
NCT00301808,17.24137931,"Cisplatin, Pemetrexed Disodium, and Radiation Therapy Followed by Docetaxel in Treating Patients With Stage III Non-Small Cell Lung Cancer",Completed,Phase 2,,November 2005,October 2012,Treatment,Detroit,Michigan,48201-1379,All,18.0,2012-10-01,2005-11-01,2526.0,1.0,48201
NCT00303459,24.40790656,Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH),Completed,Phase 4,Randomized,May 2006,December 2013,Treatment,La Jolla,California,92037-7381,All,12.0,2013-12-01,2006-05-01,2771.0,1.0,92037
NCT00309907,10.25641026,Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant,Completed,Phase 2,,April 2006,September 2011,Treatment,Birmingham,Alabama,35294,All,18.0,2011-09-01,2006-04-01,1979.0,1.0,35294
NCT00309946,1.960784314,Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery,Completed,Phase 2,,December 2005,September 2010,Treatment,Chicago,Illinois,60637-1470,All,18.0,2010-09-01,2005-12-01,1735.0,1.0,60637
NCT00312377,6.396598845,ZACTIMA (an Anti-EGFR / Anti-VEGF Agent) Combined With Docetaxel Compared to Docetaxel in Non-small Cell Lung Cancer,Completed,Phase 3,Randomized,May 2006,March 2014,Treatment,Fullerton,California,,All,18.0,2014-03-01,2006-05-01,2861.0,1.0,58441
NCT00316186,24.24242424,First-line Treatment Of Subjects With Extensive Disease Small Cell Lung Cancer With Weekly Hycamtin And Paraplatin,Completed,Phase 2,Non-Randomized,June 2005,May 2009,Treatment,Tucson,Arizona,85712,All,18.0,2009-05-01,2005-06-01,1430.0,1.0,85712
NCT00317044,13.84869562,Safety and Efficacy Study to Determine Anti-Asthmatic Effect of Esomeprazole Magnesium; Nexium Reflux Asthma,Completed,Phase 2,Randomized,April 2006,July 2008,Treatment,Birmingham,Alabama,,All,18.0,2008-07-01,2006-04-01,822.0,1.0,35203
NCT00319020,38.0952381,Bosentan in Children With Pulmonary Arterial Hypertension Extension Study,Completed,Phase 3,,"August 23, 2005","October 28, 2011",Treatment,Denver,Colorado,80218,All,2.0,2011-10-01,2005-08-01,2252.0,1.0,80218
NCT00319111,21.85430464,Bosentan in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH),Completed,Phase 3,Non-Randomized,January 2006,April 2009,Treatment,La Jolla,California,92037-1300,All,18.0,2009-04-01,2006-01-01,1186.0,1.0,92037
NCT00319553,1.242248006,"Post-licensure, Modified Double-blind, Multi-center Study Evaluating Safety and Immunogenicity of ADACEL® and BOOSTRIX®",Completed,Phase 4,Randomized,May 2006,December 2008,Prevention,Annapolis,Maryland,21401,All,11.0,2008-12-01,2006-05-01,945.0,1.0,21401
NCT00320255,24.10511364,A Phase 2 Pilot Study of Apixaban for the Prevention of Thromboembolic Events in Patients With Advanced (Metastatic) Cancer,Completed,Phase 2,Randomized,June 2006,January 2009,Prevention,Tucson,Arizona,85724,All,18.0,2009-01-01,2006-06-01,945.0,1.0,85724
NCT00323297,26.37735849,Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension,Completed,Phase 4,Randomized,September 2006,August 2013,Treatment,Los Angeles,California,90073,All,18.0,2013-08-01,2006-09-01,2526.0,1.0,90073
NCT00323869,0.0,"Phase II Bevacizumab, Gemcitabine and Carboplatin in Newly Diagnosed Non-Small Cell Lung Cancer",Completed,Phase 2,,June 2006,October 2013,Treatment,Palo Alto,California,94304-1290,All,18.0,2013-10-01,2006-06-01,2679.0,1.0,94304
NCT00326599,20.68965517,Gemcitabine and Carboplatin With or Without AZD2171 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer,Completed,Phase 2,Randomized,June 2007,February 2010,Treatment,Scottsdale,Arizona,85259-5499,All,18.0,2010-02-01,2007-06-01,976.0,1.0,85259
NCT00336505,8.934707904,Study Comparing the Safety and Efficacy of Cethromycin to Clarithromycin for the Treatment of Community-Acquired Pneumonia (CAP),Completed,Phase 3,Randomized,December 2005,October 2007,Treatment,Woodridge,Illinois,60517,All,18.0,2007-10-01,2005-12-01,669.0,1.0,60517
NCT00336544,5.376510463,Study Comparing the Safety and Efficacy of Cethromycin to Clarithromycin for the Treatment of Community-Acquired Pneumonia,Completed,Phase 3,Randomized,June 2006,May 2007,Treatment,Woodridge,Illinois,60517,All,18.0,2007-05-01,2006-06-01,334.0,1.0,60517
NCT00343291,33.89344262,A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC,Completed,Phase 2,Randomized,December 2006,December 2010,Treatment,Decatur,Alabama,35601,All,18.0,2010-12-01,2006-12-01,1461.0,1.0,35601
NCT00345579,5.421561259,"Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 2, 4, 6 and 12 to 15 Months of Age",Completed,Phase 3,Randomized,September 2006,March 2008,Prevention,Birmingham,Alabama,35235,All,18.0,2008-03-01,2006-09-01,547.0,1.0,35235
NCT00346073,2.921715108,Safety and Immunogenicity of GSK's Tdap Vaccine (Boostrix) in Adults Aged 19 to 64 Years,Completed,Phase 3,Randomized,"July 13, 2006","March 7, 2007",Prevention,Huntsville,Alabama,35802,All,19.0,2007-03-01,2006-07-01,243.0,1.0,35802
NCT00346398,9.846153846,Promoting Tolerance to Common Allergens in High-Risk Children: Global Prevention of Asthma in Children (GPAC) Study,Completed,Phase 2,Randomized,May 2006,July 2011,Prevention,New York,New York,10029,All,1.0,2011-07-01,2006-05-01,1887.0,1.0,10029
NCT00346775,3.608247423,Validation Of Preference Module Of Experience With Allergic Rhinitis Nasal Sprays Questionnaire (EARNS-Q),Completed,Phase 3,Randomized,"May 1, 2006","June 29, 2006",Treatment,Fresno,California,93720,All,18.0,2006-06-01,2006-05-01,31.0,1.0,93720
NCT00347958,0.7352941176,"Descriptive, Open-label, Multicenter Study of the Safety of Redosing With ADACEL® Vaccine",Completed,Phase 4,Non-Randomized,August 2006,October 2008,Prevention,Jonesboro,Arkansas,72401,All,15.0,2008-10-01,2006-08-01,792.0,1.0,72401
NCT00355121,5.673816269,Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL®,Completed,Phase 2,Randomized,October 2006,July 2009,Prevention,Little Rock,Arkansas,72205,All,4.0,2009-07-01,2006-10-01,1004.0,1.0,72205
NCT00355342,37.62719704,Bone Mineral Density Study In Patients With Chronic Obstructive Pulmonary Disease. DISKUS® Inhaler is a Trademark of the GSK Group of Companies.,Completed,Phase 4,Randomized,"April 28, 2004","September 6, 2007",Treatment,Berkeley,California,94705,All,40.0,2007-09-01,2004-04-01,1248.0,1.0,94705
NCT00356122,43.39622642,Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC),Completed,Phase 2,Non-Randomized,July 2006,August 2010,Treatment,Bridgewater,New Jersey,08807,All,18.0,2010-08-01,2006-07-01,1492.0,1.0,08807
NCT00358436,21.92156863,Efficacy and Safety of LAS 34273 in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease(COPD),Completed,Phase 3,Randomized,August 2006,June 2008,Treatment,Jasper,Alabama,35501,All,40.0,2008-06-01,2006-08-01,670.0,4.2,35501
NCT00359788,10.61974514,A Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent Inhalation Aerosol in COPD Patients.,Completed,Phase 4,,July 2006,,Treatment,Birmingham,Alabama,,All,40.0,,2006-07-01,731.0,1.0,35203
NCT00363415,8.149819276,Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung Cancer,Completed,Phase 3,Randomized,August 2006,June 2008,Treatment,Huntsville,Alabama,35805,All,18.0,2008-06-01,2006-08-01,670.0,1.0,35805
NCT00364351,16.59846354,Efficacy Trial Comparing ZD6474 With Erlotinib in NSCLC After Failure of at Least One Prior Chemotherapy,Completed,Phase 3,Randomized,August 2006,November 2016,Treatment,Berkeley,California,,All,18.0,2016-11-01,2006-08-01,3745.0,1.0,60163
NCT00365105,3.969742436,"Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer",Completed,Phase 3,Randomized,"July 11, 2006","February 27, 2017",Supportive Care,Mobile,Alabama,36608,All,18.0,2017-02-01,2006-07-01,3868.0,1.0,36608
NCT00365547,4.347826087,Topotecan and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Did Not Respond to Previous Systemic Chemotherapy,Completed,Phase 2,,September 2006,September 2011,Treatment,Minneapolis,Minnesota,55455,All,18.0,2011-09-01,2006-09-01,1826.0,1.0,55455
NCT00367770,5.405405405,BREATHE 5-OL: Tracleer (Bosentan) in Patients With Pulmonary Arterial Hypertension Related to Eisenmenger Physiology,Completed,Phase 4,Non-Randomized,January 2004,December 2005,Treatment,Boston,Massachusetts,02115,All,12.0,2005-12-01,2004-01-01,700.0,1.0,02115
NCT00368927,11.4516129,Sulindac in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia,Completed,Phase 2,Randomized,August 2006,December 2010,Prevention,Scottsdale,Arizona,85259,All,40.0,2010-12-01,2006-08-01,1583.0,1.0,85259
NCT00368992,37.25490196,"S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer",Completed,Phase 2,,August 2006,October 2010,Treatment,San Antonio,Texas,78245,All,18.0,2010-10-01,2006-08-01,1522.0,1.0,78245
NCT00371683,10.07902025,Study of Apixaban for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery,Completed,Phase 3,Randomized,November 2006,May 2008,Prevention,Birmingham,Alabama,35205,All,18.0,2008-05-01,2006-11-01,547.0,1.0,35205
NCT00372775,28.125,Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain Metastases,Completed,Phase 2,Non-Randomized,March 2007,December 2009,Treatment,Norwalk,Connecticut,06856,All,18.0,2009-12-01,2007-03-01,1006.0,1.0,06856
NCT00373425,29.49845161,A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors,Completed,Phase 3,Randomized,September 2006,June 2014,Treatment,Birmingham,Alabama,35294,All,18.0,2014-06-01,2006-09-01,2830.0,1.0,35294
NCT00374140,5.0,Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer,Completed,Phase 2,,October 2006,June 2012,Treatment,Steubenville,Ohio,43952,All,18.0,2012-06-01,2006-10-01,2070.0,1.0,43952
NCT00377403,6.673928831,Treatment of Acute Sinusitis,Completed,Phase 4,Randomized,October 2006,August 2010,Treatment,St. Louis,Missouri,63110,All,18.0,2010-08-01,2006-10-01,1400.0,1.0,63110
NCT00377611,1.872743392,"Study on the Incidence of Influenza and Its Complications, in Subjects Aged 50 Years and Over Vaccinated With Fluarix™",Completed,Phase 4,Non-Randomized,"October 5, 2006","June 20, 2007",Prevention,Mobile,Alabama,36608,All,50.0,2007-06-01,2006-10-01,243.0,1.0,36608
NCT00380068,25.89285714,Safety and Efficacy Study of Ambrisentan in Subjects With Pulmonary Hypertension,Completed,Phase 3,Non-Randomized,August 2006,May 2009,Treatment,Birmingham,Alabama,35294,All,18.0,2009-05-01,2006-08-01,1004.0,1.0,35294
NCT00383123,6.177832483,Study Comparing the Immune Response and Safety of Fluarix and Fluzone Influenza Vaccines in Children,Completed,Phase 3,Randomized,"November 2, 2006","October 19, 2007",Prevention,Antioch,California,94509,All,0.5,2007-10-01,2006-11-01,334.0,1.1,94509
NCT00387088,15.21453823,Tiotropium / Respimat One Year Study in COPD.,Completed,Phase 3,,September 2006,,Treatment,Birmingham,Alabama,,All,40.0,,2006-09-01,731.0,1.0,35203
NCT00388505,11.51742994,Safety of Tobramycin Inhalation Powder (TIP) vs Tobramycin Solution for Inhalation in Patients With Cystic Fibrosis,Completed,Phase 3,Randomized,February 2006,March 2009,Treatment,Hartford,Connecticut,06102,All,6.0,2009-03-01,2006-02-01,1124.0,1.0,06102
NCT00388583,0.6195786865,"Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Elderly Subjects",Completed,Phase 2,Randomized,September 2006,September 2008,Prevention,Alabaster,Alabama,,All,65.0,2008-09-01,2006-09-01,731.0,1.0,35007
NCT00390806,9.322033898,Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer,Completed,Phase 3,Randomized,December 2006,September 2013,Treatment,Birmingham,Alabama,35294,All,18.0,2013-09-01,2006-12-01,2466.0,1.0,35294
NCT00390884,2.61645493,Safety and Immunogenicity of Fluzone® Vaccine in Children Who Received 2 Doses of the 2005-2006 Fluzone Formulation.,Completed,Phase 4,Non-Randomized,October 2006,September 2008,Prevention,Layton,Utah,84041,All,0.9166666666666666,2008-09-01,2006-10-01,701.0,1.0,84041
NCT00391053,0.5485229896,"Immunogenicity of High-dose Inactivated, Split-virion Influenza Vaccine Versus Standard Fluzone Vaccine in the Elderly",Completed,Phase 3,Randomized,October 2006,February 2008,Prevention,Mesa,Arizona,,All,65.0,2008-02-01,2006-10-01,488.0,1.0,83643
NCT00391391,11.40476765,"Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Infants and Children",Completed,Phase 2,Randomized,October 2006,October 2007,Prevention,Harrisburg,Arkansas,72432,All,0.5,2007-10-01,2006-10-01,365.0,2.0,72432
NCT00391768,12.86231884,Oseltamivir Treatment for Children Less Than 24 Months of Age With Influenza,Completed,Phase 1/Phase 2,Non-Randomized,January 2007,April 2010,Treatment,Birmingham,Alabama,35117,All,18.0,2010-04-01,2007-01-01,1186.0,1.0,35117
NCT00392288,11.03480837,Efficacy and Safety of Ciclesonide (CIC) Administered Twice Daily in Pediatric Patients With Asthma.,Completed,Phase 3,Randomized,September 2006,February 2008,Treatment,Bridgewater,New Jersey,08807,All,4.0,2008-02-01,2006-09-01,518.0,1.0,08807
NCT00393367,5.076173826,Budesonide Inhalation Suspension for Acute Asthma in Children,Completed,Phase 4,Randomized,December 2006,November 2007,Treatment,Philadelphia,Pennsylvania,19104,All,2.0,2007-11-01,2006-12-01,335.0,1.0,19104
NCT00400153,7.400428183,Respimat® Combivent Trial in Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,November 2006,,Treatment,Birmingham,Alabama,,All,40.0,,2006-11-01,731.0,1.0,35203
NCT00402649,5.714285714,Open-Label Study of H5 Vaccine in Participants of Protocol 04-077,Completed,Phase 1/Phase 2,Non-Randomized,February 2007,December 2007,Prevention,Torrance,California,90502,All,2.0,2007-12-01,2007-02-01,303.0,1.0,90502
NCT00404924,17.21316235,ZD6474 (ZACTIMA™) Phase III Study in EGFR Failures,Completed,Phase 3,Randomized,November 2006,November 2014,Treatment,Tucson,Arizona,,All,18.0,2014-11-01,2006-11-01,2922.0,1.0,85701
NCT00408317,8.064516129,Safety and Efficacy Study of ULTRASE® MT20 in Participants With Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (PI),Completed,Phase 3,Randomized,November 2006,April 2007,Treatment,Grand Rapids,Michigan,49503,All,7.0,2007-04-01,2006-11-01,151.0,1.0,49503
NCT00409188,0.0,Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START),Completed,Phase 3,Randomized,January 2007,April 2015,Treatment,Fort Smith,Arkansas,72901,All,18.0,2015-04-01,2007-01-01,3012.0,1.0,72901
NCT00411671,17.14285714,BATTLE Program: Sorafenib in Patients With NSCLC,Completed,Phase 2,,November 2006,November 2012,Treatment,Houston,Texas,77030,All,18.0,2012-11-01,2006-11-01,2192.0,1.0,77030
NCT00412737,4.425061164,A Study of Oseltamivir (Tamiflu) for the Seasonal Prophylaxis of Influenza in Immunocompromised Participants,Completed,Phase 4,Randomized,January 2007,May 2008,Prevention,Birmingham,Alabama,35233,All,18.0,2008-05-01,2007-01-01,486.0,1.0,35233
NCT00416455,3.08326229,"Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer",Completed,Phase 1/Phase 2,,September 2007,"July 16, 2016",Diagnostic,Los Angeles,California,90095,Female,18.0,2016-07-01,2007-09-01,3226.0,1.0,90095
NCT00419263,2.336728701,Evaluation of the Efficacy and Safety of Peramivir in Subjects With Uncomplicated Acute Influenza.,Completed,Phase 2,Randomized,January 2007,September 2007,Treatment,Birmingham,Alabama,35209,All,18.0,2007-09-01,2007-01-01,243.0,1.0,35209
NCT00419744,28.49988412,A Comparison of SYMBICORT® pMDI With Formoterol Turbuhaler® in Subjects With COPD,Completed,Phase 3,Randomized,January 2007,August 2009,Treatment,Jasper,Alabama,,All,40.0,2009-08-01,2007-01-01,943.0,1.0,14855
NCT00419757,10.79636387,"An Efficacy Study Comparing SYMBICORT® Pressurised Metered Dose Inhaler (pMDI) With Budesonide Hydrofluoroalkanes (HFA) pMDI, in Hispanic Subjects With ICS Dependent Asthma",Completed,Phase 3,Randomized,January 2007,June 2008,Treatment,Anaheim,California,,All,12.0,2008-06-01,2007-01-01,517.0,1.0,92801
NCT00419952,36.20834999,A Comparison of SYMBICORT® pMDI With Budesonide HFA pMDI in African American Subjects With Asthma.,Completed,Phase 3,Randomized,February 2007,November 2009,Treatment,Birmingham,Alabama,,All,12.0,2009-11-01,2007-02-01,1004.0,1.0,35203
NCT00423319,8.212523868,Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3),Completed,Phase 3,Randomized,March 2007,September 2009,Prevention,Birmingham,Alabama,35209,All,18.0,2009-09-01,2007-03-01,915.0,1.0,35209
NCT00424528,5.569050832,Efficacy Safety Study of Arformoterol/Tiotropium Combination Versus Either Therapy Alone in Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 4,Randomized,December 2006,October 2007,Treatment,Jasper,Alabama,35501,All,45.0,2007-10-01,2006-12-01,304.0,4.2,35501
NCT00425061,11.11111111,Study Evaluating the Effect of IMA-638 in Subjects With Persistent Asthma,Completed,Phase 2,Randomized,February 2007,August 2008,Treatment,Birmingham,Alabama,35209,All,18.0,2008-08-01,2007-02-01,547.0,1.0,35209
NCT00431964,3.852298953,Effect of Azithromycin on Lung Function in 6-18 Year-olds With Cystic Fibrosis (CF) Not Infected With P. Aeruginosa,Completed,Phase 4,Randomized,February 2007,November 2009,Treatment,Phoenix,Arizona,85016,All,6.0,2009-11-01,2007-02-01,1004.0,1.0,85016
NCT00433329,16.0,Combination Therapy in Pulmonary Arterial Hypertension,Completed,Phase 4,Non-Randomized,March 2007,August 2010,Treatment,Birmingham,Alabama,35294,All,12.0,2010-08-01,2007-03-01,1249.0,1.0,35294
NCT00435461,6.091161608,Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine,Completed,Phase 4,Randomized,"December 20, 2006","February 28, 2007",Treatment,Austin,Texas,78731,All,12.0,2007-02-01,2006-12-01,62.0,1.0,78731
NCT00439725,10.26963992,Once - Daily Oral Direct Factor Xa Inhibitor Rivaroxaban In The Long-Term Prevention Of Recurrent Symptomatic Venous Thromboembolism In Patients With Symptomatic Deep-Vein Thrombosis Or Pulmonary Embolism. The Einstein-Extension Study,Completed,Phase 3,Randomized,February 2007,September 2009,Prevention,Little Rock,Arkansas,72205,All,18.0,2009-09-01,2007-02-01,943.0,1.0,72205
NCT00439777,10.90768157,Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Pulmonary Embolism - The EINSTEIN PE Study,Completed,Phase 3,Randomized,March 2007,December 2011,Treatment,Little Rock,Arkansas,72205,All,18.0,2011-12-01,2007-03-01,1736.0,1.0,72205
NCT00441441,6.280003919,A 12-Week Study To Assess The Safety Of Fluticasone Propionate/Salmeterol 100/50 Hydrofluoroalkane (HFA) Versus Fluticasone Propionate 100 HFA In Children With Asthma,Completed,Phase 3,Randomized,February 2007,January 2008,Treatment,Huntington Beach,California,92647,All,4.0,2008-01-01,2007-02-01,334.0,1.0,92647
NCT00445848,27.05882353,S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Cancer,Completed,Phase 2,,July 2007,January 2014,Treatment,Antioch,California,94531,All,18.0,2014-01-01,2007-07-01,2376.0,1.1,94531
NCT00449072,25.42061929,"Study of Triamcinolone Acetonide on the Growth Velocity of Children, Ages 3 to 9, With Perennial Allergic Rhinitis (PAR)",Completed,Phase 4,Randomized,March 2007,October 2011,Treatment,Bridgewater,New Jersey,08807,All,3.0,2011-10-01,2007-03-01,1675.0,1.0,08807
NCT00452348,22.92148509,A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg Twice Daily To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg Twice Daily In Symptomatic Patients With Asthma,Completed,Phase 4,Randomized,May 2007,April 2009,Treatment,Birmingham,Alabama,35209,All,12.0,2009-04-01,2007-05-01,701.0,1.0,35209
NCT00452400,3.748459062,Efficacy and Safety of 4 Weeks Treatment With Inhaled BI 1744 CL in Patients With COPD.,Completed,Phase 2,,March 2007,,Treatment,Birmingham,Alabama,,All,40.0,,2007-03-01,731.0,1.0,35203
NCT00452699,23.20728291,A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg BID To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg BID In Symptomatic Subjects With Asthma,Completed,Phase 4,Randomized,May 2007,May 2009,Treatment,Scottsdale,Arizona,85251,All,12.0,2009-05-01,2007-05-01,731.0,1.0,85251
NCT00453999,9.500805153,Evaluation of Efficacy and Safety of Peramivir in Adults With Acute Serious or Potentially Life-threatening Influenza,Completed,Phase 2,Randomized,July 2007,August 2009,Treatment,Mobile,Alabama,36608,All,18.0,2009-08-01,2007-07-01,762.0,1.0,36608
NCT00454194,37.12974552,Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer,Completed,Phase 2,Randomized,September 2007,May 2013,Treatment,Scottsdale,Arizona,85259-5499,All,18.0,2013-05-01,2007-09-01,2069.0,1.0,85259
NCT00457002,10.75367647,Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness,Completed,Phase 3,Randomized,June 2007,May 2011,Prevention,Birmingham,Alabama,35294,All,40.0,2011-05-01,2007-06-01,1430.0,1.0,35294
NCT00457249,0.7685749885,A Trial to Evaluate the Safety and Immunogenicity of ADACEL® Vaccine in Persons 65 Years of Age and Older,Completed,Phase 4,Randomized,March 2007,November 2008,Prevention,Chandler,Arizona,85224,All,65.0,2008-11-01,2007-03-01,611.0,1.0,85224
NCT00457392,22.70833333,A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib Alone,Completed,Phase 3,Randomized,July 2007,December 2012,Treatment,Florence,Alabama,35630,All,18.0,2012-12-01,2007-07-01,1980.0,1.0,35630
NCT00459342,0.0,"Dasatinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer",Completed,Phase 2,,March 2007,April 2012,Treatment,Houston,Texas,77030,All,18.0,2012-04-01,2007-03-01,1858.0,1.0,77030
NCT00461981,19.82352941,A Phase 2 Study to Evaluate Immune Responses of FluMist®,Completed,Phase 2,Randomized,May 2007,February 2008,Treatment,Jonesboro,Arkansas,73401,All,1.0,2008-02-01,2007-05-01,276.0,4.0,73401
NCT00463567,15.17252815,"26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)",Completed,Phase 2/Phase 3,Randomized,April 2007,August 2008,Treatment,Anniston,Alabama,36207,All,40.0,2008-08-01,2007-04-01,488.0,1.0,36207
NCT00467519,3.568756657,Safety and Immunogenicity of Tdap Vaccine Compared to DTaP Vaccine in Children 4 to 6 Years of Age,Completed,Phase 3,Randomized,April 2007,December 2009,Prevention,Birmingham,Alabama,35205,All,4.0,2009-12-01,2007-04-01,975.0,1.0,35205
NCT00467740,2.026108075,Efficacy and Safety of 4 Weeks of Treatment With Inhaled BI 1744 CL in Patients With Asthma,Completed,Phase 2,,May 2007,,Treatment,Lakewood,California,,All,18.0,,2007-05-01,731.0,1.0,08701
NCT00468052,12.29508197,Decrease Emergence Agitation and Provide Pain Relief for Children Undergoing Tonsillectomy & Adenoidectomy,Completed,Phase 3,Randomized,March 2007,May 2008,Prevention,Newark,New Jersey,07103,All,2.0,2008-05-01,2007-03-01,427.0,1.0,07103
NCT00469898,22.0,Irinotecan and Carboplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer,Completed,Phase 2,,December 2003,July 2010,Treatment,Owensboro,Kentucky,42303,All,18.0,2010-07-01,2003-12-01,2404.0,1.0,42303
NCT00470054,0.0,Dasatinib in Treating Patients With Relapsed Small Cell Lung Cancer,Completed,Phase 2,,April 2007,April 2013,Treatment,Chicago,Illinois,60606,All,18.0,2013-04-01,2007-04-01,2192.0,1.0,60606
NCT00477269,18.77880184,Safety and Efficacy of Imatinib Mesylate in Patients With Pulmonary Arterial Hypertension,Completed,Phase 2/Phase 3,Randomized,April 2006,January 2014,Treatment,Los Angeles,California,90073,All,18.0,2014-01-01,2006-04-01,2832.0,1.0,90073
NCT00481078,14.89361702,"Vorinostat, Carboplatin, and Paclitaxel in Treating Patients With Advanced or Metastatic Non-Small Cell Lung Cancer",Completed,Phase 2,Randomized,May 2007,July 2009,Treatment,Duarte,California,91010,All,18.0,2009-07-01,2007-05-01,792.0,1.0,91010
NCT00482014,16.97324415,"A Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin With Radiation Therapy Followed by Pemetrexed in Patients With Inoperable Non-Small-Cell Lung Cancer",Completed,Phase 1/Phase 2,Randomized,May 2007,October 2011,Treatment,Los Angeles,California,90095,All,18.0,2011-10-01,2007-05-01,1614.0,1.0,90095
NCT00488345,19.04761905,"Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age",Completed,Phase 2,,December 2007,September 2009,Treatment,Long Beach,California,90806,All,8.0,2009-09-01,2007-12-01,640.0,1.0,90806
NCT00492024,3.01234088,BAY12-8039: 5 Days for Sinusitis vs Placebo,Completed,Phase 3,Randomized,January 2005,March 2008,Treatment,Birmingham,Alabama,35209,All,18.0,2008-03-01,2005-01-01,1155.0,1.0,35209
NCT00500318,10.2753978,A Study of Exercise Endurance and Lung Hyperinflation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,July 2007,September 2010,Treatment,Jasper,Alabama,35501,All,40.0,2010-09-01,2007-07-01,1158.0,4.2,35501
NCT00502775,5.008648661,Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine,Completed,Phase 4,Randomized,August 2007,November 2007,Treatment,Little Rock,Arkansas,72205,All,12.0,2007-11-01,2007-08-01,92.0,1.0,72205
NCT00502801,24.59016393,"An Effectiveness, Safety, and Microbiology Study of Doripenem in Patients With Nosocomial (Hospital-acquired) Pneumonia",Completed,Phase 2,,August 2007,November 2008,Treatment,Palm Springs,California,,All,18.0,2008-11-01,2007-08-01,458.0,1.0,92262
NCT00508144,0.0,Single Agent Alimta in Poor Performance Status in Non-small Cell Lung Cancer,Completed,Phase 2,,September 2005,December 2015,Treatment,Houston,Texas,77030,All,18.0,2015-12-01,2005-09-01,3743.0,1.0,77030
NCT00509106,7.229719249,Comparative Study of Ceftaroline vs. Ceftriaxone in Adults With Community-Acquired Pneumonia,Completed,Phase 3,Randomized,July 2007,June 2009,Treatment,Durham,North Carolina,27710,All,18.0,2009-06-01,2007-07-01,701.0,1.0,27710
NCT00510510,9.660887766,Safety and Tolerability of 28 Days Treatment With Glycopyrronium Bromide (NVA237) (100 or 200 µg Once a Day) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease,Completed,Phase 2,Randomized,August 2007,January 2008,Treatment,Glendale,Arizona,85306,All,40.0,2008-01-01,2007-08-01,153.0,1.0,85306
NCT00517933,12.74848747,Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosis,Completed,Phase 3,Randomized,August 2007,October 2009,Treatment,Birmingham,Alabama,35294,All,18.0,2009-10-01,2007-08-01,792.0,1.0,35294
NCT00518986,18.86774194,Efficacy and Safety of Armodafinil for Adults With Excessive Sleepiness Obstructive Sleep Apnea/Hypopnea and Depression,Completed,Phase 4,Randomized,October 2007,March 2009,Treatment,Jasper,Alabama,35501,All,18.0,2009-03-01,2007-10-01,517.0,4.2,35501
NCT00519636,5.53710543,Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNS,Completed,Phase 4,Randomized,August 2007,November 2007,Treatment,Birmingham,Alabama,35209,All,18.0,2007-11-01,2007-08-01,92.0,1.0,35209
NCT00523991,10.46678946,Trial Comparing Tiotropium Inhalation Capsules vs Placebo in Chronic Obstructive Pulmonary Disease (COPD).,Completed,Phase 4,Randomized,April 2007,,Treatment,Birmingham,Alabama,,All,40.0,,2007-04-01,731.0,1.0,35203
NCT00525512,27.75393525,Tiotropium In Exercise,Completed,Phase 4,Randomized,August 2007,,Treatment,Jasper,Alabama,,All,40.0,,2007-08-01,731.0,1.0,14855
NCT00528645,13.04347826,AZD0530 in Treating Patients With Extensive Stage Small Cell Lung Cancer,Completed,Phase 2,,November 2007,May 2013,Treatment,Rochester,Minnesota,55905,All,18.0,2013-05-01,2007-11-01,2008.0,1.0,55905
NCT00529516,0.4624785914,Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults,Completed,Phase 3,Non-Randomized,"October 15, 2007","June 4, 2008",Prevention,Clearwater,Florida,33761,All,18.0,2008-06-01,2007-10-01,244.0,1.0,33761
NCT00529529,10.31228615,Safety of Indacaterol in Patients (≥ 12 Years) With Moderate to Severe Persistent Asthma,Completed,Phase 3,Randomized,September 2007,August 2008,Treatment,Glendale,Arizona,85306,All,12.0,2008-08-01,2007-09-01,335.0,1.0,85306
NCT00531284,36.98717949,"Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma",Completed,Phase 1/Phase 2,Non-Randomized,September 2007,"May 22, 2017",Treatment,Scottsdale,Arizona,85258,All,18.0,2017-05-01,2007-09-01,3530.0,1.0,85258
NCT00532155,31.55447426,A Study of Aflibercept Versus Placebo in Patients With Second-Line Docetaxel for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer,Completed,Phase 3,Randomized,September 2007,October 2011,Treatment,Bridgewater,New Jersey,08807,All,18.0,2011-10-01,2007-09-01,1491.0,1.0,08807
NCT00539006,5.020996,Comparator Study Evaluating Patient Preference Of FFNS vs. FPNS,Completed,Phase 4,Randomized,August 2007,November 2007,Treatment,Scottsdale,Arizona,85251,All,18.0,2007-11-01,2007-08-01,92.0,1.0,85251
NCT00539864,0.4977924945,"Safety and Reactogenicity of FluBlok and Comparison of Immunogenicity, Efficacy and Effectiveness Against TIV",Completed,Phase 3,Randomized,September 2007,April 2008,Prevention,Fresno,California,93726,All,50.0,2008-04-01,2007-09-01,213.0,1.0,93726
NCT00540514,28.79675114,Albumin-bound Paclitaxel (ABI-007) for Patients With Advanced Non-Small Cell Lung Cancer,Completed,Phase 3,Randomized,"November 1, 2007","February 1, 2013",Treatment,Huntsville,Alabama,35805,All,18.0,2013-02-01,2007-11-01,1919.0,1.0,35805
NCT00545532,6.948051948,A Study of Oseltamivir (Tamiflu) for Treatment of Influenza in Immunocompromised Participants.,Completed,Phase 3,Randomized,"February 4, 2008","May 2, 2017",Treatment,Birmingham,Alabama,35233,All,18.0,2017-05-01,2008-02-01,3377.0,1.0,35233
NCT00550537,29.31034483,"Proteomic Profiling in Predicting Response in Patients Receiving Erlotinib for Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer",Completed,Phase 2,,October 2007,December 2013,Treatment,Gainesville,Florida,32610-0232,All,18.0,2013-12-01,2007-10-01,2253.0,1.0,32610
NCT00551031,0.8298675501,"Study of Inactivated, Split-Virion Influenza Vaccine and Standard Fluzone® Vaccine in Adult and Elderly Subjects",Completed,Phase 2,Randomized,October 2007,November 2008,Prevention,Alabaster,Alabama,,All,18.0,2008-11-01,2007-10-01,397.0,1.0,35007
NCT00553462,12.0,Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery,Completed,Phase 2,,March 2008,"June 15, 2017",Treatment,Castro Valley,California,94546,All,18.0,2017-06-01,2008-03-01,3379.0,1.0,94546
NCT00564733,8.695652174,FDG-Labeled PET Scan in Planning Chemotherapy in Treating Patients With Stage IIIB or IV Non-Small Cell Lung Cancer,Completed,Phase 2,,October 2007,March 2012,Treatment,Seattle,Washington,98104,All,18.0,2012-03-01,2007-10-01,1613.0,1.0,98104
NCT00570401,9.523809524,Dasatinib in Treating Patients With Advanced Lung Cancer That Is No Longer Responding to Erlotinib or Gefitinib,Completed,Phase 2,,June 2006,September 2011,Treatment,New York,New York,10065,All,18.0,2011-09-01,2006-06-01,1918.0,1.0,10065
NCT00570778,1.470588235,Efficacy and Safety of QVA149 in Patients With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 2,Randomized,December 2007,September 2008,Treatment,Saint Louis,Missouri,,All,40.0,2008-09-01,2007-12-01,275.0,1.0,48880
NCT00577655,4.883107089,Albuterol HFA MDI in Pediatric Participants With Asthma,Completed,Phase 3,Randomized,August 2007,July 2008,Treatment,Huntington Beach,California,92647,All,4.0,2008-07-01,2007-08-01,335.0,1.0,92647
NCT00581945,10.90336912,Safety and Efficacy of Multiple Doses of Canakinumab (ACZ885) in Chronic Obstructive Pulmonary Disease (COPD) Patients,Completed,Phase 1/Phase 2,Randomized,January 2007,May 2010,Basic Science,Anaheim,California,92801,All,40.0,2010-05-01,2007-01-01,1216.0,1.0,92801
NCT00585039,1.754385965,Albuterol Versus Xopenex in Treatment of Acute Asthma in the Emergency Department (ED),Completed,Phase 4,Randomized,September 2005,March 2009,Treatment,Phoenix,Arizona,85016,All,6.0,2009-03-01,2005-09-01,1277.0,1.0,85016
NCT00585533,0.0,"A Phase 2 Study of Tarceva for Untreated, Good Prognosis Patients With Advanced Non-Small Cell Lung Cancer",Completed,Phase 2,,June 2004,March 2012,Treatment,Salt Lake City,Utah,84112,All,18.0,2012-03-01,2004-06-01,2830.0,1.0,84112
NCT00587288,1.886792453,Efficacy and Safety Study of Reslizumab to Treat Poorly Controlled Asthma,Completed,Phase 2,Randomized,April 2008,March 2010,Treatment,Orange,California,92868,All,18.0,2010-03-01,2008-04-01,699.0,1.0,92868
NCT00588445,21.53846154,Phase II Trial to Correlate Radiographic Response Induced By Gefitinib With Mutations in the Protein-Tyrosine Kinase Domain of the EGF Receptor Gene,Completed,Phase 2,,June 2004,September 2010,Treatment,New York,New York,10065,All,18.0,2010-09-01,2004-06-01,2283.0,1.0,10065
NCT00589121,8.860759494,"Image-Guided Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Shoulder, Arm, Hip, or Leg",Completed,Phase 2,Non-Randomized,March 2008,"May 21, 2018",Treatment,Newark,Delaware,19713,All,18.0,2018-05-01,2008-03-01,3713.0,1.0,19713
NCT00590902,0.0,"Ph II OSI-774 (Erlotinib,Tarceva) In Advanced Bronchioloalveolar Cell Lung Cancer",Completed,Phase 2,,March 2002,February 2013,Treatment,New York,New York,10065,All,18.0,2013-02-01,2002-03-01,3990.0,1.0,10065
NCT00591591,14.19386535,Brain Oxygenation and Hemodynamics During Sleep in Obstructive Sleep Apnea Sufferers,Completed,Phase 3,Non-Randomized,August 2007,June 2010,Diagnostic,Orange,California,92868,All,21.0,2010-06-01,2007-08-01,1035.0,1.0,92868
NCT00600171,2.142075972,Efficacy And Safety Of GW642444M Comparing Placebo In Adolescent And Adult Subjects With Persistent Asthma.,Completed,Phase 2,Randomized,December 2007,September 2008,Treatment,Phoenix,Arizona,85006,All,12.0,2008-09-01,2007-12-01,275.0,1.0,85006
NCT00600821,10.14367816,A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer.,Completed,Phase 2,Randomized,April 2008,October 2012,Treatment,Baton Rouge,Louisiana,70809,All,18.0,2012-10-01,2008-04-01,1644.0,1.0,70809
NCT00603278,4.20751413,A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Low-Dose ICS Therapy.,Completed,Phase 2,Randomized,December 2007,November 2008,Treatment,Phoenix,Arizona,85028,All,12.0,2008-11-01,2007-12-01,336.0,1.0,85028
NCT00603382,4.148555927,A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Non-steroidal Therapy.,Completed,Phase 2,Randomized,"December 1, 2007","October 2, 2008",Treatment,Phoenix,Arizona,85028,All,12.0,2008-10-01,2007-12-01,305.0,1.0,85028
NCT00603746,3.716618084,A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Moderate-Dose ICS Therapy.,Completed,Phase 2,Randomized,"December 1, 2007","September 20, 2008",Treatment,Phoenix,Arizona,85028,All,12.0,2008-09-01,2007-12-01,275.0,1.0,85028
NCT00606502,1.5,Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based Treatment,Completed,Phase 2,Randomized,January 2008,"June 24, 2010",Treatment,Bakersfield,California,93309,All,18.0,2010-06-01,2008-01-01,882.0,1.0,93309
NCT00606684,8.910891089,A Study To Assess Efficacy And Safety Of Different Doses Of GW642444 In Subjects With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 2,Randomized,February 2008,October 2008,Treatment,Florence,Alabama,35630,All,40.0,2008-10-01,2008-02-01,243.0,1.0,35630
NCT00609674,4.445564516,A Clinical Study To Test A Nasal Spray (Fluticasone Furoate Nasal Spray) For The Treatment Of Perennial (Year-round) Allergic Rhinitis,Completed,Phase 4,Randomized,January 2008,June 2008,Treatment,Baltimore,Maryland,21236,All,12.0,2008-06-01,2008-01-01,152.0,1.0,21236
NCT00613626,0.0,Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer,Completed,Phase 2,Randomized,January 2008,August 2015,Treatment,Newark,Delaware,19713,All,18.0,2015-08-01,2008-01-01,2769.0,1.0,19713
NCT00616928,2.110521781,Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years,Completed,Phase 3,Randomized,"January 23, 2008","March 19, 2009",Prevention,Huntsville,Alabama,35802,All,18.0,2009-03-01,2008-01-01,425.0,1.0,35802
NCT00617305,18.18181818,Study of Add-on Ambrisentan Therapy to Background Phosphodiesterase Type-5 Inhibitor (PDE5i) Therapy in Pulmonary Arterial Hypertension (ATHENA-1),Completed,Phase 4,Randomized,April 2008,July 2011,Treatment,Mobile,Alabama,36617,All,16.0,2011-07-01,2008-04-01,1186.0,1.0,36617
NCT00619801,1.286054118,Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 1 to Less Than 6 Years Suffering From Allergic Rhinitis or Chronic Urticaria of Unknown Origin,Completed,Phase 3,Randomized,March 2008,July 2008,Treatment,Birmingham,Alabama,,All,2.0,2008-07-01,2008-03-01,122.0,1.0,35203
NCT00620022,8.426966292,The Effect of Indacaterol on Exercise Endurance in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease,Completed,Phase 3,Randomized,April 2008,January 2009,Treatment,Torrance,California,,All,40.0,2009-01-01,2008-04-01,275.0,1.0,90501
NCT00621504,6.271720066,Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia,Completed,Phase 3,Randomized,January 2008,June 2009,Treatment,Los Angeles,California,90015,All,18.0,2009-06-01,2008-01-01,517.0,1.0,90015
NCT00621959,2.345852807,A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis,Completed,Phase 4,Randomized,March 2008,June 2008,Treatment,Scottsdale,Arizona,,All,18.0,2008-06-01,2008-03-01,92.0,1.0,85250
NCT00624286,6.467460409,Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,February 2008,July 2008,Treatment,Anniston,Alabama,36207-5710,All,40.0,2008-07-01,2008-02-01,151.0,1.0,36207
NCT00626028,2.205882353,Comparison of Inhaled Nitric Oxide and Oxygen in Participants Reactivity During Acute Pulmonary Vasodilator Testing,Completed,Phase 3,Randomized,September 2004,February 2010,Diagnostic,Stanford,California,94304,All,18.0,2010-02-01,2004-09-01,1979.0,1.0,94304
NCT00628108,5.416666667,Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months,Completed,Phase 3,Randomized,March 2008,September 2008,Treatment,Birmingham,Alabama,,All,0.5,2008-09-01,2008-03-01,184.0,1.0,35203
NCT00630331,4.870866646,Efficacy Study of Two Influenza Vaccines and Placebo in Healthy Adult Subjects,Completed,Phase 3,Randomized,October 2007,July 2008,Prevention,Denver,Colorado,80212,All,18.0,2008-07-01,2007-10-01,274.0,1.0,80212
NCT00631475,21.09375,Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443,Completed,Phase 3,Non-Randomized,April 2008,May 2010,Treatment,Birmingham,Alabama,35294,All,18.0,2010-05-01,2008-04-01,760.0,1.0,35294
NCT00633217,13.70523416,Advair HFA For Chronic Obstructive Pulmonary Disease(COPD),Completed,Phase 4,Randomized,March 2008,February 2009,Treatment,Jasper,Alabama,35501,All,40.0,2009-02-01,2008-03-01,337.0,4.2,35501
NCT00633893,16.2820363,Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism,Completed,Phase 3,Randomized,May 2008,August 2012,Treatment,Birmingham,Alabama,35235,All,18.0,2012-08-01,2008-05-01,1553.0,1.0,35235
NCT00640926,11.99806483,Safety and Efficacy Study of Oxazolidinone to Treat Pneumonia,Completed,Phase 2,Randomized,October 2007,April 2009,Treatment,San Diego,California,,All,18.0,2009-04-01,2007-10-01,548.0,1.0,78384
NCT00642759,2.777777778,"Carboplatin, Abraxane, and Bevacizumab in Previously Untreated Patients With Advanced Non-Small Cell Lung Cancer",Completed,Phase 2,,April 2008,April 2015,Treatment,Boston,Massachusetts,02114,All,18.0,2015-04-01,2008-04-01,2556.0,1.0,02114
NCT00643201,14.99380056,Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism,Completed,Phase 3,Randomized,July 2008,March 2013,Treatment,Birmingham,Alabama,35235,All,18.0,2013-03-01,2008-07-01,1704.0,1.0,35235
NCT00645411,5.83433123,Pediatric Safety and Immunogenicity Study of Cell-Culture Derived and Egg-based Subunit Influenza Vaccines in Healthy Children and Adolescents,Completed,Phase 2/Phase 3,Randomized,October 2007,July 2008,Prevention,Fayetteville,Arkansas,72703,All,3.0,2008-07-01,2007-10-01,274.0,1.0,72703
NCT00645788,11.10244594,Study to Evaluate the Safety and Efficacy of Ciprofloxacin (Inhaled) in Patients With Cystic Fibrosis,Completed,Phase 2,Randomized,May 2008,January 2011,Treatment,Phoenix,Arizona,85016,All,12.0,2011-01-01,2008-05-01,975.0,1.0,85016
NCT00650091,12.1333869,"Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF",Completed,Phase 3,Randomized,October 2009,January 2014,Treatment,Birmingham,Alabama,35294,All,35.0,2014-01-01,2009-10-01,1553.0,1.0,35294
NCT00651118,4.087815868,A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies,Completed,Phase 3,Randomized,March 2008,July 2008,Treatment,Scottsdale,Arizona,85251,All,12.0,2008-07-01,2008-03-01,122.0,1.0,85251
NCT00652340,0.0,APRiCOT-L: Study to Evaluate Efficacy and Safety of Apricoxib With Erlotinib in Patients With Non-small Cell Lung Cancer,Completed,Phase 2,Randomized,April 2008,March 2012,Treatment,Tucson,Arizona,,All,18.0,2012-03-01,2008-04-01,1430.0,1.0,85701
NCT00653224,1.72432246,A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis,Completed,Phase 4,Randomized,April 2008,July 2008,Treatment,Tucson,Arizona,,All,18.0,2008-07-01,2008-04-01,91.0,1.0,85701
NCT00653939,29.6996663,"A Safety and Efficacy Study of Carboplatin, Paclitaxel, Bevacizumab and CA4P in Non-Small Cell Lung Cancer",Completed,Phase 2,Randomized,March 2008,October 2011,Treatment,Campbell,California,95008,All,18.0,2011-10-01,2008-03-01,1309.0,1.0,95008
NCT00655850,2.564102564,Lower Dose Chemotherapy Given More Frequent With Avastin to Treat Advanced Non-Squamous Non-Small Cell Lung Cancer,Completed,Phase 2,,March 2008,September 2016,Treatment,Birmingham,Alabama,35294 - 0104,All,19.0,2016-09-01,2008-03-01,3106.0,1.0,35294 
NCT00656136,13.33333333,BIBW 2992 and BSC Versus Placebo and BSC in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib (LUX-LUNG 1),Completed,Phase 3,Randomized,April 2008,October 2013,Treatment,Kingman,Arizona,,All,18.0,2013-10-01,2008-04-01,2009.0,1.0,04451
NCT00659529,25.92592593,Safety and Efficacy of Sildenafil in Cystic Fibrosis (CF) Lung Disease,Completed,Phase 1/Phase 2,,August 2008,December 2012,Treatment,Denver,Colorado,80206,All,14.0,2012-12-01,2008-08-01,1583.0,1.0,80206
NCT00660179,4.030853994,Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension,Completed,Phase 3,Randomized,May 2008,April 2012,Treatment,Birmingham,Alabama,35249-0001,All,12.0,2012-04-01,2008-05-01,1431.0,1.0,35249
NCT00660816,13.06818182,Pemetrexed or Docetaxel With or Without Erlotinib in Stage IIIB or Stage IV Non-Small Cell Lung Cancer,Completed,Phase 2,Randomized,January 2008,July 2015,Treatment,Detroit,Michigan,48202,All,18.0,2015-07-01,2008-01-01,2738.0,1.0,48202
NCT00660829,6.015037594,A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies,Completed,Phase 3,Randomized,December 2007,April 2008,Treatment,Austin,Texas,78731,All,12.0,2008-04-01,2007-12-01,122.0,1.0,78731
NCT00661193,12.93706294,S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer,Completed,Phase 2,Randomized,December 2008,December 2016,Treatment,Little Rock,Arkansas,72205,All,18.0,2016-12-01,2008-12-01,2922.0,1.0,72205
NCT00662038,44.13988658,Open-Label Study of the Long Term Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF),Completed,Phase 3,,August 2008,February 2016,Treatment,South San Francisco,California,94080-4990,All,40.0,2016-02-01,2008-08-01,2740.0,1.0,94080
NCT00669331,20.60274076,Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis,Completed,Phase 3,Randomized,November 2009,January 2014,Treatment,Denver,Colorado,80206,All,18.0,2014-01-01,2009-11-01,1522.0,1.0,80206
NCT00669617,0.4494382022,Study to Determine the Onset of Action of Indacaterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,April 2008,August 2008,Treatment,Tamarac,Florida,33321,All,40.0,2008-08-01,2008-04-01,122.0,1.0,33321
NCT00670930,4.347826087,"Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonists",Completed,Phase 4,Randomized,April 2008,November 2011,Treatment,Denver,Colorado,80206,All,18.0,2011-11-01,2008-04-01,1309.0,1.0,80206
NCT00676052,4.51419033,Dose-Ranging Study Of GSK233705B In Subjects With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 2,Randomized,"May 16, 2008","December 22, 2008",Treatment,Jasper,Alabama,35501,All,40.0,2008-12-01,2008-05-01,214.0,4.2,35501
NCT00677365,5.283674363,"Safety, Tolerability and Efficacy of MP-376 Given for 28 Days to Cystic Fibrosis (CF) Patients",Completed,Phase 2,Randomized,June 2008,June 2009,Treatment,Mobile,Alabama,36608,All,16.0,2009-06-01,2008-06-01,365.0,1.0,36608
NCT00677807,9.83443397,"Safety, Tolerability and Efficacy of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)",Completed,Phase 3,Randomized,May 2008,March 2009,Treatment,Homewood,Alabama,35209-6870,All,40.0,2009-03-01,2008-05-01,304.0,1.0,35209
NCT00677820,0.2083333333,A Prospective Study to Evaluate the Safety of a New Trivalent Intranasal Influenza Vaccine,Completed,Phase 4,Randomized,June 2008,December 2008,Prevention,Daytona Beach,Florida,32117,All,18.0,2008-12-01,2008-06-01,183.0,1.0,32117
NCT00682643,41.27538501,A Clinical Study With Fluticasone Furoate Nasal Spray And Vehicle Placebo For The Treatment Of Perennial (Year-round) Allergic Rhinitis,Completed,Phase 4,Randomized,June 2008,February 2011,Treatment,Oxford,Alabama,36203,All,12.0,2011-02-01,2008-06-01,975.0,1.0,36203
NCT00686959,0.0,Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer,Completed,Phase 3,Randomized,September 2008,November 2014,Treatment,Birmingham,Alabama,35249,All,18.0,2014-11-01,2008-09-01,2252.0,1.0,35249
NCT00696020,3.337946335,Combination of Orally Inhaled BI1744CL/Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease ( COPD),Completed,Phase 2,Randomized,June 2008,,Treatment,Riverside,California,,All,40.0,,2008-06-01,731.0,1.0,02915
NCT00698516,6.0,Study of Oral Topotecan With Bevacizumab for Recurrent Small Cell Lung Cancer,Completed,Phase 2,Non-Randomized,July 2008,May 2010,Treatment,Jonesboro,Arkansas,72401,All,18.0,2010-05-01,2008-07-01,669.0,1.0,72401
NCT00698815,12.35368737,Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer,Completed,Phase 2,Randomized,"April 15, 2008",,Treatment,Anaheim,California,92807,All,18.0,,2008-04-01,731.0,1.0,92807
NCT00702325,29.99690867,Phase4/Symbicort® Versus Pulmicort Flexhaler® in African Americans,Completed,Phase 4,Randomized,June 2008,September 2009,Treatment,Pell City,Alabama,,All,12.0,2009-09-01,2008-06-01,457.0,1.0,35125
NCT00705406,2.222845437,"A Phase II, Multicenter, Randomized, Placebo -Controlled, Study To Evaluate The Efficacy and Safety Of Intramuscular Peramivir 600 mg In Subjects With Uncomplicated Acute Influenza",Completed,Phase 2,Randomized,July 2008,October 2009,Treatment,Birmingham,Alabama,35209,All,18.0,2009-10-01,2008-07-01,457.0,1.0,35209
NCT00709098,24.58333333,Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension,Completed,Phase 3,Randomized,September 2008,June 2010,Treatment,La Jolla,California,92037,All,18.0,2010-06-01,2008-09-01,638.0,1.0,92037
NCT00709956,10.89931574,Iloprost Power 15 in Pulmonary Arterial Hypertension,Completed,Phase 3,Randomized,July 2008,August 2009,Treatment,La Jolla,California,92037,All,18.0,2009-08-01,2008-07-01,396.0,1.0,92037
NCT00712166,0.6578947368,"Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Patients With Cystic Fibrosis, Mild Lung Disease, and P. Aeruginosa",Completed,Phase 3,Randomized,May 2008,August 2009,Treatment,Phoenix,Arizona,,All,6.0,2009-08-01,2008-05-01,457.0,1.0,13135
NCT00712920,7.608462199,A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergies,Completed,Phase 3,Randomized,January 2007,,Treatment,Huntington Beach,California,92647,All,12.0,,2007-01-01,731.0,1.0,92647
NCT00719862,2.293562053,A Study to Evaluate the Safety & Effectiveness of a Nasal Spray to Treat Seasonal Allergies,Completed,Phase 3,Randomized,August 2007,November 2007,Treatment,Huntington Beach,California,92647,Female,12.0,2007-11-01,2007-08-01,92.0,1.0,92647
NCT00720226,10.32763533,Efficacy of Losartan in Preventing Progression of COPD,Completed,Phase 4,Randomized,July 2008,August 2016,Treatment,Baltimore,Maryland,21205,All,40.0,2016-08-01,2008-07-01,2953.0,1.0,21205
NCT00720278,3.237165558,A Study to Evaluate the Safety and Efficacy of Two Nasal Sprays to Treat Seasonal Allergies,Completed,Phase 3,Randomized,August 2007,November 2007,Treatment,Oxford,Alabama,36203,All,12.0,2007-11-01,2007-08-01,92.0,1.0,36203
NCT00720382,27.92325383,A Study to Evaluate the Safety and Tolerability of a Nasal Spray to Treat Perennial Allergic Rhinitis,Completed,Phase 3,Randomized,March 2007,July 2008,Treatment,Oxford,Alabama,36203,All,12.0,2008-07-01,2007-03-01,488.0,1.0,36203
NCT00720499,3.546099291,Efficacy and Safety of 4 Weeks of Treatment With Orally Inhaled BI1744/Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 2,Randomized,July 2008,,Treatment,Clearwater,Florida,,All,40.0,,2008-07-01,731.0,1.0,33755
NCT00723957,17.2541744,A Randomized Phase 2 Study of Ixabepilone Plus Carboplatin and Paclitaxel Plus Carboplatin in Advanced Nonsmall-Cell Lung Cancer,Completed,Phase 2,Randomized,December 2008,August 2011,Treatment,La Jolla,California,90237,All,18.0,2011-08-01,2008-12-01,973.0,1.0,90237
NCT00729612,15.87301587,"Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer",Completed,Phase 2,,"August 14, 2008","December 16, 2011",Treatment,Columbus,Ohio,43210,All,18.0,2011-12-01,2008-08-01,1217.0,1.0,43210
NCT00735475,1.263102725,A Study to Determine the Immunogenicity and Safety Profile of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Comparator Influenza Virus Vaccine,Completed,Phase 4,Randomized,October 2008,June 2009,Prevention,Mountain Home,Arkansas,72635,All,65.0,2009-06-01,2008-10-01,243.0,5.0,72635
NCT00735696,5.0,A Study of Ramucirumab (IMC-1121B) With Paclitaxel and Carboplatin in Non-small Cell Lung Cancer,Completed,Phase 2,,January 2009,January 2012,Treatment,Beverly Hills,California,90211,All,18.0,2012-01-01,2009-01-01,1095.0,1.0,90211
NCT00737100,4.120268955,Safety and Efficacy of 12-wk Treatment With Two Doses of Tiotropium Respimat in Cystic Fibrosis,Completed,Phase 2,Randomized,September 2008,,Treatment,Tucson,Arizona,,All,18.0,,2008-09-01,731.0,1.0,85701
NCT00739648,23.49428868,A Phase 2 Study of MP-376 to Prevent Acute Exacerbations in Chronic Obstructive Pulmonary Disease (COPD) Patients,Completed,Phase 2,Randomized,October 2008,April 2010,Treatment,Haleyville,Alabama,35565,All,40.0,2010-04-01,2008-10-01,547.0,7.0,35565
NCT00740636,2.23880597,Temozolomide for Relapsed Sensitive or Refractory Small Cell Lung Cancer,Completed,Phase 2,Non-Randomized,August 2008,February 2013,Treatment,Basking Ridge,New Jersey,11725,All,18.0,2013-02-01,2008-08-01,1645.0,1.0,11725
NCT00740792,4.133341155,A Study Evaluating the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies,Completed,Phase 3,Randomized,August 2008,November 2008,Treatment,Scottsdale,Arizona,85251,All,12.0,2008-11-01,2008-08-01,92.0,1.0,85251
NCT00741819,8.219178082,Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in Pulmonary Arterial Hypertension (PAH) Subjects,Completed,Phase 4,Non-Randomized,September 2008,December 2010,Treatment,Birmingham,Alabama,35294,All,18.0,2010-12-01,2008-09-01,821.0,1.0,35294
NCT00741988,7.380952381,Ixabepilone and Carboplatin +/- Bevacizumab in Advanced Non-Small-Cell Lung Cancer,Completed,Phase 2,Non-Randomized,September 2008,September 2012,Treatment,Fort Myers,Florida,33901,All,18.0,2012-09-01,2008-09-01,1461.0,1.0,33901
NCT00743275,0.8196721311,A Study to Evaluate the Safety and Immune Responses to Fluzone® Vaccination,Completed,Phase 4,,August 2008,November 2008,Prevention,Norfolk,Virginia,23507,All,18.0,2008-11-01,2008-08-01,92.0,1.0,23507
NCT00745251,11.16600791,A Study of VI-0521 for the Treatment of Obstructive Sleep Apnea / Hypopnea Syndrome in Obese Adults,Completed,Phase 1/Phase 2,Randomized,August 2008,December 2009,Treatment,Louisville,Kentucky,40217,All,30.0,2009-12-01,2008-08-01,487.0,1.0,40217
NCT00752895,3.748485696,American Ginseng Extract in Preventing Respiratory Infection and in Reducing Antibiotic Use in Patients With CLL,Completed,Phase 2,Randomized,"September 1, 2008","June 1, 2009",Prevention,Burbank,California,91505,All,18.0,2009-06-01,2008-09-01,273.0,1.0,91505
NCT00753272,22.63162077,Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older,Completed,Phase 3,Randomized,"September 15, 2008","January 5, 2011",Prevention,Alabaster,Alabama,35007,All,65.0,2011-01-01,2008-09-01,852.0,1.0,35007
NCT00757237,12.37745098,Aztreonam for Inhalation Solution vs Tobramycin Inhalation Solution in Patients With Cystic Fibrosis & Pseudomonas Aeruginosa,Completed,Phase 3,Randomized,August 2008,November 2010,Treatment,Anchorage,Alaska,99508,All,6.0,2010-11-01,2008-08-01,822.0,1.0,99508
NCT00762034,28.31746997,"A Study of Pemetrexed, Carboplatin and Bevacizumab in Participants With Nonsquamous Non-Small Cell Lung Cancer",Completed,Phase 3,Randomized,December 2008,December 2014,Treatment,Fayetteville,Arkansas,72703,All,18.0,2014-12-01,2008-12-01,2191.0,1.0,72703
NCT00762476,10.22022259,Efficacy Trial of 3804-250A in the Prevention of Cold Illnesses,Completed,Phase 2,Randomized,August 2008,November 2008,Prevention,Paramus,New Jersey,07652,All,18.0,2008-11-01,2008-08-01,92.0,1.0,07652
NCT00764790,3.285714913,Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine Versus a Licensed Comparator in Children,Completed,Phase 3,Randomized,"October 1, 2008","June 1, 2009",Prevention,Birmingham,Alabama,35205,All,0.5,2009-06-01,2008-10-01,243.0,1.0,35205
NCT00765076,1.149758454,Clinical Study of the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in People Aged 65 Years or Older,Completed,Phase 3,Randomized,"October 16, 2008","December 4, 2009",Prevention,Houston,Texas,77030,All,18.0,2009-12-01,2008-10-01,426.0,1.0,77030
NCT00768755,11.77198482,Evaluation Of The Efficacy Of The Combination Of Axitinib With Pemetrexed And Cisplatin In The Treatment Of Non-Squamous Non-Small Cell Lung Cancer,Completed,Phase 1/Phase 2,Randomized,January 2009,March 2012,Treatment,Huntsville,Alabama,35805,All,18.0,2012-03-01,2009-01-01,1155.0,1.0,35805
NCT00769067,4.787234043,A Randomized Trial Of PF-00299804 Taken Orally Versus Erlotinib Taken Orally For Treatment Of Advanced Non-Small Cell Lung Cancer That Has Progressed After One Or Two Prior Chemotherapy Regimen,Completed,Phase 2,Randomized,November 2008,August 2014,Treatment,Muscle Shoals,Alabama,35661,All,18.0,2014-08-01,2008-11-01,2099.0,1.0,35661
NCT00770120,44.06779661,S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery,Completed,Phase 2,,December 2008,April 2014,Treatment,Tucson,Arizona,85724-5024,All,18.0,2014-04-01,2008-12-01,1947.0,1.0,85724
NCT00771615,1.603606413,Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged 18-64 Years,Completed,Phase 2,Randomized,"October 16, 2008","December 4, 2009",Prevention,Huntsville,Alabama,35802,All,18.0,2009-12-01,2008-10-01,426.0,1.0,35802
NCT00771953,16.66666667,0822GCC: Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer,Completed,Phase 2,Randomized,November 2008,December 2014,Treatment,Los Angeles,California,90033,All,18.0,2014-12-01,2008-11-01,2221.0,1.0,90033
NCT00772109,2.087688489,Study of Fluzone Vaccine Administered by Intradermal Route in Comparison With Standard Fluzone® in Adults,Completed,Phase 3,Randomized,October 2008,July 2009,Prevention,Hoover,Alabama,35216,All,18.0,2009-07-01,2008-10-01,273.0,1.0,35216
NCT00772538,9.778766108,Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study I),Completed,Phase 3,Randomized,October 2008,,Treatment,Birmingham,Alabama,,All,18.0,,2008-10-01,731.0,1.0,35203
NCT00772889,6.109530912,Evaluation of the Safety and Immunogenicity of the Influenza Vaccine GSK2186877A in the Elderly,Completed,Phase 3,Non-Randomized,"October 9, 2008","December 15, 2009",Prevention,Clearwater,Florida,33761,All,19.0,2009-12-01,2008-10-01,426.0,1.0,33761
NCT00772928,7.288457747,Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™,Completed,Phase 3,Randomized,October 2003,November 2006,Prevention,Montgomery,Alabama,36106,All,18.0,2006-11-01,2003-10-01,1127.0,1.0,36106
NCT00775450,0.4023948056,Influenza Vaccine Revaccination in Ambulatory Elderly Subjects,Completed,Phase 2,Randomized,October 2008,July 2009,Prevention,Hoover,Alabama,35216,All,65.0,2009-07-01,2008-10-01,273.0,1.0,35216
NCT00776984,11.19014167,Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study II),Completed,Phase 3,Randomized,October 2008,,Treatment,Fountain Valley,California,,All,18.0,,2008-10-01,731.0,1.0,92708
NCT00777257,2.379903185,Study of Menactra® in US Adolescents When Administered Concomitantly With Tdap Vaccine,Completed,Phase 4,Randomized,April 2005,September 2007,Prevention,Jonesboro,Arkansas,72401,All,11.0,2007-09-01,2005-04-01,883.0,1.0,72401
NCT00782210,17.70334928,12 / 48 Week Pivotal PFT vs PBO in COPD I,Completed,Phase 3,Randomized,November 2008,,Treatment,Jasper,Alabama,,All,40.0,,2008-11-01,731.0,1.0,14855
NCT00782509,13.0369879,12 / 48 wk Pivotal PFT vs PBO in COPD II,Completed,Phase 3,Randomized,February 2009,,Treatment,Mobile,Alabama,,All,40.0,,2009-02-01,731.0,1.0,36602
NCT00783432,14.22136492,Study to Evaluate the Safety and Tolerability of a Nasal Spray in Patients With Chronic Allergic or Nonallergic Rhinitis,Completed,Phase 3,Randomized,July 2006,December 2007,Treatment,Somerset,New Jersey,08873,All,12.0,2007-12-01,2006-07-01,518.0,1.0,08873
NCT00783705,12.91574279,Inositol in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia,Completed,Phase 2,Randomized,November 2008,May 2014,Prevention,Scottsdale,Arizona,85259,All,45.0,2014-05-01,2008-11-01,2007.0,1.0,85259
NCT00784550,21.06919315,A 24-Week Study to Evaluate the Safety and Efficacy of ADVAIR DISKUS® Inhaler 250/50mcg Plus SPIRIVA HANDIHALER® Inhaler Versus SPIRIVA HANDIHALER® Inhaler Plus Placebo DISKUS® Inhaler in Subjects With Chronic Obstructive Pulmonary Disease (COPD).,Completed,Phase 4,Randomized,December 2008,December 2009,Treatment,Riverside,California,92506,All,40.0,2009-12-01,2008-12-01,365.0,1.0,92506
NCT00789555,15.23110136,Safety of PATANASE Nasal Spray in Patients With Perennial Allergic Rhinitis,Completed,Phase 4,Randomized,November 2008,January 2011,Treatment,Fort Worth,Texas,76134,All,12.0,2011-01-01,2008-11-01,791.0,1.0,76134
NCT00790023,5.944279858,Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis,Completed,Phase 3,Randomized,November 2008,February 2009,Treatment,Austin,Texas,78731,All,12.0,2009-02-01,2008-11-01,92.0,1.0,78731
NCT00791934,23.80952381,Clinical Study of Safety and Efficacy for the Relieva Stratus With Elution of Triamcinolone Acetonide,Completed,Phase 3,,August 2008,November 2011,Treatment,Burlington,Massachusetts,01805,All,17.0,2011-11-01,2008-08-01,1187.0,1.0,01805
NCT00798603,53.22580645,"Pemetrexed, Carboplatin, and Bevacizumab as First-Line Therapy in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer",Completed,Phase 2,,December 2008,May 2013,Treatment,Scottsdale,Arizona,85259-5499,All,70.0,2013-05-01,2008-12-01,1612.0,1.0,85259
NCT00802867,1.31445905,Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™,Completed,Phase 4,Non-Randomized,February 2004,September 2005,Prevention,Jonesboro,Arkansas,72401,All,4.0,2005-09-01,2004-02-01,578.0,1.0,72401
NCT00805025,53.93258427,Evaluation of the Quality of Life Questionnaire-Bronchiectasis (QOL-B) in Patients With Bronchiectasis,Completed,Phase 2,,December 2008,October 2009,Treatment,Birmingham,Alabama,35209,All,18.0,2009-10-01,2008-12-01,304.0,1.0,35209
NCT00806819,31.9723796,Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC,Completed,Phase 3,Randomized,December 2008,December 2015,Treatment,Downy,California,,All,18.0,2015-12-01,2008-12-01,2556.0,1.0,83234
NCT00807573,4.545454545,"Paclitaxel, Bevacizumab and Pemetrexed in Patients With Untreated, Advanced Non-Small Cell Lung Cancer Using Web-Based Data Collection, Patient Self-Reporting of Adverse Effects and Automated Response Assessment",Completed,Phase 2,,December 2008,April 2014,Treatment,Basking Ridge,New Jersey,07920,All,18.0,2014-04-01,2008-12-01,1947.0,1.0,07920
NCT00809094,1.470588235,"NAC Phase IIB: A Multi-Center, Phase IIB, Randomized, Placebo-controlled, Double-Blind Study Of The Effects Of N-Acetylcysteine On Redox Changes and Lung Inflammation In Cystic Fibrosis Patients",Completed,Phase 2,Randomized,November 2008,February 2011,Treatment,Birmingham,Alabama,35294,All,7.0,2011-02-01,2008-11-01,822.0,1.0,35294
NCT00809757,11.32538485,"A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma",Completed,Phase 3,Randomized,December 2008,June 2013,Treatment,Little Rock,Arkansas,72205,All,18.0,2013-06-01,2008-12-01,1643.0,1.0,72205
NCT00810693,12.0130817,A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH),Completed,Phase 3,Randomized,"December 17, 2008","May 14, 2012",Treatment,Tucson,Arizona,85724,All,18.0,2012-05-01,2008-12-01,1247.0,1.0,85724
NCT00818441,8.389513109,Dacomitinib (PF-00299804) As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung,Completed,Phase 2,Non-Randomized,"March 11, 2009","April 30, 2015",Treatment,Orange,California,92868-3298,All,18.0,2015-04-01,2009-03-01,2222.0,1.0,92868
NCT00818454,1.659292035,4 Week 2 Way Crossover Double Blind Treatment Phase With Combivent CFC Versus Albuterol Followed by a 4 Week Open Label Combivent Respimat When All Drugs Are Used for Symptom Relief as Needed in Pts With Moderate to Severe Asthma,Completed,Phase 2,,December 2008,,Treatment,Birmingham,Alabama,,All,18.0,,2008-12-01,731.0,1.0,35203
NCT00821093,6.157411239,Safety and Efficacy of Indacaterol Once Daily Versus Salmeterol Twice Daily in Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,January 2009,October 2009,Treatment,Anniston,Alabama,36207-5710,All,40.0,2009-10-01,2009-01-01,273.0,1.0,36207
NCT00824473,4.750290178,A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies,Completed,Phase 3,Randomized,December 2008,February 2009,Treatment,Austin,Texas,78731,All,12.0,2009-02-01,2008-12-01,62.0,1.0,78731
NCT00826449,2.127659574,Dasatinib and Erlotinib in Non-Small Cell Lung Cancer (NSCLC),Completed,Phase 1/Phase 2,,February 2009,June 2014,Treatment,Houston,Texas,77030,All,16.0,2014-06-01,2009-02-01,1946.0,1.0,77030
NCT00836953,6.060606061,Study to Collect Sera for Immunogenicity Testing in Children Vaccinated With Fluzone®,Completed,Phase 4,Non-Randomized,September 2003,July 2004,Prevention,Norfolk,Virginia,23510,All,0.5,2004-07-01,2003-09-01,304.0,1.0,23510
NCT00843193,8.080808081,Efficacy and Safety Study of GSK679586 in Patients With Severe Asthma,Completed,Phase 2,Randomized,"December 9, 2008","July 25, 2010",Treatment,Medford,Oregon,97504,All,18.0,2010-07-01,2008-12-01,577.0,1.0,97504
NCT00845429,6.71949754,"Immunogenicity of a Split, Cell-Based, Inactivated, Trivalent Influenza Vaccine in Healthy Adult Subjects",Completed,Phase 2,Randomized,October 2007,November 2008,Prevention,Hoover,Alabama,35216,All,18.0,2008-11-01,2007-10-01,397.0,1.0,35216
NCT00846586,5.477999812,Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease,Completed,Phase 3,Randomized,March 2009,March 2010,Treatment,Birmingham,Alabama,32509,All,40.0,2010-03-01,2009-03-01,365.0,1.0,32509
NCT00854360,2.848860456,Study to Assess the Efficacy and Safety of BDP HFA Nasal Aerosol in Patients 12 Years and Older With SAR,Completed,Phase 2,Randomized,March 2009,May 2009,Treatment,Mission Viejo,California,92691,All,12.0,2009-05-01,2009-03-01,61.0,1.1,92691
NCT00855465,6.906857593,A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH.,Completed,Phase 3,Randomized,"February 23, 2009","June 27, 2012",Treatment,La Jolla,California,92093,All,18.0,2012-06-01,2009-02-01,1216.0,1.0,92093
NCT00855894,2.43902439,A Study of the Combination of Erlotinib and Pertuzumab in Patients With Relapsed Non-small Cell Lung Cancer,Completed,Phase 2,Non-Randomized,March 2009,March 2012,Treatment,Los Angeles,California,90033,All,18.0,2012-03-01,2009-03-01,1096.0,1.0,90033
NCT00856193,1.515151515,A Study to Investigate the Bronchodilatory Effect of NVA237 in Patients With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 2,Randomized,February 2009,May 2009,Treatment,Spartanburg,South Carolina,29303,All,40.0,2009-05-01,2009-02-01,89.0,1.0,29303
NCT00857766,22.5029036,A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 4,Randomized,March 2009,March 2010,Treatment,Birmingham,Alabama,35294,All,50.0,2010-03-01,2009-03-01,365.0,1.0,35294
NCT00862641,0.9049629411,A Study of the Safety and Tolerance of Regadenoson in Subjects With Asthma or Chronic Obstructive Pulmonary Disease,Completed,Phase 4,Randomized,April 2009,October 2009,Diagnostic,Montgomery,Alabama,36117,All,18.0,2009-10-01,2009-04-01,183.0,1.0,36117
NCT00863746,17.66086605,A 3rd/4th Line Placebo-controlled Trial of Sorafenib in Patients With Predominantly Non Squamous Non-Small Cell Lung Cancer (NSCLC).,Completed,Phase 3,Randomized,April 2009,April 2013,Treatment,Fayetteville,Arkansas,72703,All,18.0,2013-04-01,2009-04-01,1461.0,1.0,72703
NCT00864721,53.96825397,Sunitinib Non Small Cell Lung Cancer Patients Over 70,Completed,Phase 2,,February 2009,July 2012,Treatment,Ocala,Florida,34471,All,70.0,2012-07-01,2009-02-01,1246.0,1.0,34471
NCT00870584,9.221132898,Evaluate the Effect of Omalizumab on Markers of Asthma Impairment in Patients With Persistent Allergic Asthma,Completed,Phase 4,Randomized,March 2009,March 2010,Treatment,Jasper,Alabama,35501,All,12.0,2010-03-01,2009-03-01,365.0,4.2,35501
NCT00870870,15.17241379,A Study of IMC-A12 (Cixutumumab) With and Without Other Standard Chemotherapies in Participants With Lung Cancer Who Have Not Received Chemotherapy Before,Completed,Phase 2,Randomized,March 2009,May 2012,Treatment,Anniston,Alabama,36207,All,18.0,2012-05-01,2009-03-01,1157.0,1.0,36207
NCT00873912,0.625,A Prospective Study to Evaluate the Safety of a New Monovalent Intranasal Influenza Vaccine,Completed,Phase 4,Randomized,May 2009,December 2009,Prevention,Daytona Beach,Florida,32117,All,18.0,2009-12-01,2009-05-01,214.0,1.0,32117
NCT00874848,31.58971362,Efficacy/Safety of Imprime PGG With Cetuximab & Paclitaxel/Carboplatin Therapy in Pts With Untreated Advanced Non-Small Cell Lung Cancer,Completed,Phase 2,Randomized,August 2009,August 2015,Treatment,Augusta,Georgia,30912,All,18.0,2015-08-01,2009-08-01,2191.0,1.0,30912
NCT00877383,4.55434916,Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease,Completed,Phase 3,Randomized,April 2009,February 2010,Treatment,Anniston,Alabama,36207-5710,All,40.0,2010-02-01,2009-04-01,306.0,1.0,36207
NCT00880100,8.333333333,Use of Ultrase® MT12 in Young Cystic Fibrosis Children (CF),Completed,Phase 3,,April 2009,November 2009,Treatment,Aurora,Colorado,80045,All,2.0,2009-11-01,2009-04-01,214.0,1.0,80045
NCT00887159,31.41025641,A Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive Stage,Completed,Phase 2,Randomized,"July 16, 2009","November 15, 2016",Treatment,Scottsdale,Arizona,85259,All,18.0,2016-11-01,2009-07-01,2680.0,1.0,85259
NCT00887978,8.665334499,Efficacy and Safety of Oral UT-15C Tablets to Treat Pulmonary Arterial Hypertension,Completed,Phase 3,Randomized,June 2009,July 2011,Treatment,Birmingham,Alabama,35294-0006,All,18.0,2011-07-01,2009-06-01,760.0,1.0,35294
NCT00890825,1.136363636,AZD6244 in Combination With Docetaxel Versus Docetaxel Alone in KRAS Mutation Positive NSCLC Patients,Completed,Phase 2,Randomized,"April 20, 2009","November 2, 2016",Treatment,Los Angeles,California,90095,All,18.0,2016-11-01,2009-04-01,2771.0,1.0,90095
NCT00891462,13.23306513,Efficacy and Safety of Aclidinium Bromide for Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-33),Completed,Phase 3,Randomized,April 2009,November 2009,Treatment,Birmingham,Alabama,35209,All,40.0,2009-11-01,2009-04-01,214.0,1.0,35209
NCT00893763,0.0,Strategies To Prevent Pneumonia 2 (SToPP2),Completed,Phase 2,Randomized,September 2008,June 2012,Prevention,Richmond,Virginia,23298-0567,All,18.0,2012-06-01,2008-09-01,1369.0,1.0,23298
NCT00896454,39.39393939,Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium,Completed,Phase 2,,"November 16, 2009","August 21, 2013",Treatment,Encinitas,California,92024,All,18.0,2013-08-01,2009-11-01,1369.0,1.0,92024
NCT00900731,5.462432575,A Study to Compare the Lung Effect of Indacaterol and Tiotropium in Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,June 2009,March 2010,Treatment,Birmingham,Alabama,35209,All,40.0,2010-03-01,2009-06-01,273.0,1.0,35209
NCT00902174,19.61361185,Imatinib (QTI571) in Pulmonary Arterial Hypertension,Completed,Phase 3,Randomized,September 2009,May 2011,Treatment,Birmingham,Alabama,35294,All,18.0,2011-05-01,2009-09-01,607.0,1.0,35294
NCT00903201,7.544255025,28 Day Repeat Dose in Cystic Fibrosis Patients,Completed,Phase 2,Randomized,"September 28, 2009","December 29, 2010",Treatment,Birmingham,Alabama,35233,All,18.0,2010-12-01,2009-09-01,456.0,1.0,35233
NCT00903331,4.208802165,Macitentan Use in an Idiopathic Pulmonary Fibrosis Clinical Study,Completed,Phase 2,Randomized,May 2009,August 2011,Treatment,Birmingham,Alabama,35294,All,18.0,2011-08-01,2009-05-01,822.0,1.0,35294
NCT00906282,6.52173913,"Preoperative Pemetrexed and Carboplatin for Select Stage IB, II, and III Non-Squamous Non-Small-Cell Lung Cancer",Completed,Phase 2,,June 2009,September 2015,Treatment,Fort Myers,Florida,33901,All,18.0,2015-09-01,2009-06-01,2283.0,1.0,33901
NCT00909532,8.74266296,Study of Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older With the G551D Mutation,Completed,Phase 3,Randomized,June 2009,November 2012,Treatment,Birmingham,Alabama,35233-1711,All,12.0,2012-11-01,2009-06-01,1249.0,1.0,35233
NCT00909727,5.769230769,Study of Ivacaftor in Cystic Fibrosis Subjects Aged 6 to 11 Years With the G551D Mutation,Completed,Phase 3,Randomized,August 2009,April 2011,Treatment,Birmingham,Alabama,35233-1711,All,6.0,2011-04-01,2009-08-01,608.0,1.0,35233
NCT00909779,41.96895148,Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects,Completed,Phase 3,Randomized,June 2009,June 2012,Treatment,Birmingham,Alabama,25233,All,40.0,2012-06-01,2009-06-01,1096.0,1.0,25233
NCT00918203,9.27005597,A Study of Paclitaxel/Carboplatin With or Without Olaratumab (IMC-3G3) in Previously Untreated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC),Completed,Phase 2,Randomized,January 2010,"November 17, 2017",Treatment,Birmingham,Alabama,35294,All,18.0,2017-11-01,2010-01-01,2861.0,1.0,35294
NCT00923273,22.22222222,Sirolimus and Pemetrexed to Treat Non-Small Cell Lung Cancer,Terminated,Phase 1/Phase 2,Randomized,"February 29, 2008","March 10, 2013",Treatment,Bethesda,Maryland,20892,All,18.0,2013-03-01,2008-02-01,1855.0,1.0,20892
NCT00928746,4.225352113,Actuation Indicator Trial in Patients With COPD,Completed,Phase 3,,June 2009,,Treatment,Lafayette,Louisiana,,All,40.0,,2009-06-01,731.0,1.0,07848
NCT00929110,19.48219576,"1-year Study to Assess the Efficacy, Safety, and Tolerability of Glycopyrronium Bromide (NVA237) in Chronic Obstructive Pulmonary Disease (COPD)",Completed,Phase 3,Randomized,June 2009,April 2011,Treatment,Birmingham,Alabama,35249,All,40.0,2011-04-01,2009-06-01,669.0,1.0,35249
NCT00930982,40.15625,Evaluation of Cipro Inhale in Patients With Non-cystic Fibrosis Bronchiectasis,Completed,Phase 2,Randomized,June 2009,September 2010,Treatment,Little Rock,Arkansas,72205,All,18.0,2010-09-01,2009-06-01,457.0,1.0,72205
NCT00931385,2.525252525,Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease,Completed,Phase 3,Randomized,June 2009,,Treatment,Tampa,Florida,,All,40.0,,2009-06-01,731.0,1.0,33602
NCT00932451,9.005628518,"An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene",Completed,Phase 2,Non-Randomized,January 2010,December 2015,Treatment,Birmingham,Alabama,35233,All,18.0,2015-12-01,2010-01-01,2160.0,1.0,35233
NCT00932646,3.25,Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease,Completed,Phase 3,Randomized,June 2009,,Treatment,Jasper,Alabama,,All,40.0,,2009-06-01,731.0,1.0,14855
NCT00932893,10.40462428,"An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene",Completed,Phase 3,Randomized,September 2009,January 2016,Treatment,Little Rock,Arkansas,72205,All,18.0,2016-01-01,2009-09-01,2313.0,1.0,72205
NCT00939627,45.37037037,Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab,Completed,Phase 2,Randomized,July 2009,January 2014,Treatment,Tampa,Florida,33612,All,18.0,2014-01-01,2009-07-01,1645.0,1.0,33612
NCT00941798,22.81971043,Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma,Completed,Phase 2,Randomized,July 2009,May 2011,Treatment,Birmingham,Alabama,35209,All,12.0,2011-05-01,2009-07-01,669.0,1.0,35209
NCT00949650,18.26086957,BIBW 2992 (Afatinib) Versus Chemotherapy as First Line Treatment in NSCLC With EGFR Mutation,Completed,Phase 3,Randomized,"August 14, 2009","March 16, 2017",Treatment,Fayetteville,Arkansas,72703,All,18.0,2017-03-01,2009-08-01,2769.0,1.0,72703
NCT00949975,12.02075246,A Dose Range Finding Study to Evaluate the Efficacy and Safety of AZD9668 Administered Orally at Three Dose Levels to Patients With Chronic Obstructive Pulmonary Disease (COPD) on Treatment With Tiotropium,Completed,Phase 2,Randomized,July 2009,August 2010,Basic Science,Fullerton,California,,All,40.0,2010-08-01,2009-07-01,396.0,1.0,58441
NCT00950807,1.363636364,GSK573719 Dose Ranging Study in Chronic Obstructive Pulmonary Disease,Completed,Phase 2,Randomized,"September 1, 2009","March 15, 2010",Treatment,Phoenix,Arizona,85013,All,40.0,2010-03-01,2009-09-01,181.0,1.0,85013
NCT00952276,0.3227695712,A Study of Different Formulations of an Adjuvanted A/H1N1 Pandemic Vaccine in Healthy Adults and the Elderly,Completed,Phase 2,Randomized,October 2009,March 2011,Prevention,Anaheim,California,92801,All,18.0,2011-03-01,2009-10-01,516.0,1.0,92801
NCT00952419,2.532796661,A Study of Different Formulations of an A/H1N1 Pandemic Vaccine in Healthy Children Aged 6 Months to 9 Years,Completed,Phase 2,Randomized,August 2009,June 2010,Prevention,Miami Beach,Florida,33141,All,0.5,2010-06-01,2009-08-01,304.0,1.0,33141
NCT00953147,12.04390594,A 6 Month Safety and Efficacy Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) in the Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older,Completed,Phase 3,Randomized,August 2009,May 2010,Treatment,Huntington Beach,California,92647,All,12.0,2010-05-01,2009-08-01,273.0,1.0,92647
NCT00953524,7.122419363,A Study of Different Formulations of an A/H1N1 Pandemic Vaccine in Healthy Adults and the Elderly,Completed,Phase 2,Randomized,August 2009,December 2010,Prevention,Hoover,Alabama,35216,All,18.0,2010-12-01,2009-08-01,487.0,1.0,35216
NCT00955825,9.918546366,Study of Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Adult Patients With Allergic Grass Pollen Rhinoconjunctivitis,Completed,Phase 3,Randomized,October 2008,August 2009,Treatment,Normal,Illinois,61761,All,18.0,2009-08-01,2008-10-01,304.0,1.0,61761
NCT00957996,5.769230769,Safety Study of IV Peramivir in Hospitalized Subjects With Confirmed or Suspected Influenza,Completed,Phase 3,Randomized,October 2009,August 2011,Treatment,Dothan,Alabama,,All,6.0,2011-08-01,2009-10-01,669.0,1.0,36301
NCT00958126,2.165612977,A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Adults in the USA,Completed,Phase 2,Randomized,August 2009,April 2010,Prevention,Huntsville,Alabama,35802,All,18.0,2010-04-01,2009-08-01,243.0,1.0,35802
NCT00958243,9.355900852,A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in a Healthy Pediatric Population in the USA,Completed,Phase 2,Randomized,August 2009,April 2010,Prevention,Chandler,Arizona,85224,All,0.5,2010-04-01,2009-08-01,243.0,1.0,85224
NCT00959049,3.278053503,A Study to Determine the Immunogenicity and Safety Profile of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Comparator Influenza Virus Vaccine in a Pediatric Population,Completed,Phase 3,Randomized,September 2009,May 2010,Prevention,Chandler,Arizona,85224,All,0.5,2010-05-01,2009-09-01,242.0,1.0,85224
NCT00968669,15.60991028,A Study to Evaluate the Effectiveness and Safety of MEDI-528 in Adults,Completed,Phase 2,Randomized,December 2009,January 2012,Treatment,Pell City,Alabama,35128,All,18.0,2012-01-01,2009-12-01,761.0,7.1,35128
NCT00972816,6.401922725,Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children (3 to < 9 Years),Completed,Phase 2/Phase 3,Randomized,September 2009,October 2010,Prevention,Downey,California,90241-4982,All,3.0,2010-10-01,2009-09-01,395.0,1.0,90241
NCT00973349,0.1157407407,Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Non-Elderly and Elderly Adults,Completed,Phase 2/Phase 3,Randomized,September 2009,December 2010,Prevention,Miami,Florida,33143,All,18.0,2010-12-01,2009-09-01,456.0,1.0,33143
NCT00975780,5.299539171,A Trial to Reduce Pneumonia in Nursing Home Residents,Completed,Phase 3,Randomized,October 2009,December 2012,Prevention,New Haven,Connecticut,06520,All,65.0,2012-12-01,2009-10-01,1157.0,1.0,06520
NCT00976820,11.2316024,Safety and Immunogenicity of H1N1 Vaccines in Children Aged 6 Months to Less Than 9 Years of Age,Completed,Phase 2,Randomized,"October 20, 2009","March 21, 2011",Prevention,Conway,Arkansas,72034,All,0.5,2011-03-01,2009-10-01,516.0,4.2,72034
NCT00978120,1.607312094,Safety and Efficacy of an H1N1 Influenza Vaccine in People With Asthma,Completed,Phase 2,Randomized,October 2009,September 2010,Prevention,Atlanta,Georgia,,All,12.0,2010-09-01,2009-10-01,335.0,1.0,14808
NCT00979602,6.867444145,"Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older",Completed,Phase 3,Randomized,"November 9, 2009","February 1, 2011",Prevention,Mesa,Arizona,85213,All,18.0,2011-02-01,2009-11-01,457.0,1.0,85213
NCT00980005,5.196385418,Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children,Completed,Phase 3,Randomized,"October 13, 2009","June 17, 2010",Prevention,Birmingham,Alabama,35205,All,3.0,2010-06-01,2009-10-01,243.0,1.0,35205
NCT00980200,0.2666666667,Efficacy and Safety Study in Subjects With Asthma,Completed,Phase 2,Randomized,September 2009,January 2010,Treatment,Cypress,California,90630,All,18.0,2010-01-01,2009-09-01,122.0,1.0,90630
NCT00984542,26.0,Bendamustine as Second-Line Therapy in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer,Completed,Phase 2,,September 2009,September 2012,Treatment,Elizabethtown,Kentucky,42701,All,18.0,2012-09-01,2009-09-01,1096.0,1.0,42701
NCT00985088,3.734665947,Safety and Immunogenicity of H1N1 Vaccines in Adults Aged 18 Years and Older,Completed,Phase 2,Randomized,"October 11, 2009","December 16, 2010",Prevention,Huntsville,Alabama,35802,All,18.0,2010-12-01,2009-10-01,426.0,1.0,35802
NCT00985673,9.167919846,Safety and Immunogenicity of H1N1 Vaccine With Trivalent Inactivated Seasonal Influenza Vaccine in Adults,Completed,Phase 2,Randomized,"October 1, 2009","December 29, 2010",Prevention,Stockbridge,Georgia,30281,All,19.0,2010-12-01,2009-10-01,426.0,1.0,30281
NCT00986154,1.553398424,Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).,Completed,Phase 3,Randomized,October 2009,April 2013,Treatment,Mobile,Alabama,36608,All,18.0,2013-04-01,2009-10-01,1278.0,1.0,36608
NCT00986674,42.41037173,Carboplatin and Paclitaxel Combined With Cetuximab and/or IMC-A12 in Patients With Advanced Non-Small Cell Lung Cancer,Completed,Phase 2,Randomized,September 2009,December 2013,Treatment,Stanford,California,94305,All,18.0,2013-12-01,2009-09-01,1552.0,1.0,94305
NCT00988247,21.02547211,Long Term Safety and Efficacy Trial of Beclomethasone Dipropionate - Hydrofluoroalkane (BDP-HFA) 320 mcg in Allergic Rhinitis,Completed,Phase 3,Randomized,"October 31, 2009","February 28, 2011",Treatment,Oxford,Alabama,36203,All,12.0,2011-02-01,2009-10-01,488.0,1.0,36203
NCT00988858,12.72727273,A Study of Advanced or Metastatic Non-small Cell Lung Cancer,Completed,Phase 2,,November 2009,November 2014,Treatment,Tucson,Arizona,85704,All,18.0,2014-11-01,2009-11-01,1826.0,1.0,85704
NCT00992017,7.8125,Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women,Completed,Phase 2,,October 2009,November 2010,Prevention,Alhambra,California,91803,Female,18.0,2010-11-01,2009-10-01,396.0,1.0,91803
NCT00992836,3.225806452,Safety of and Immune Response to an H1N1 Influenza Virus Vaccine in HIV Infected Children and Youth,Completed,Phase 2,,October 2009,August 2010,Prevention,Birmingham,Alabama,35233,All,4.0,2010-08-01,2009-10-01,304.0,1.0,35233
NCT00996307,10.99385625,"Pivotal, Multicenter, Observer-Blind, Randomized Study of Influenza A (H1N1)2009 Monovalent Subunit Vaccine With and Without Adjuvant in Children Ages 6 to <36 Months",Completed,Phase 2/Phase 3,Randomized,October 2009,December 2010,Prevention,Bentonville,Arkansas,72712,All,0.5,2010-12-01,2009-10-01,426.0,1.0,72712
NCT00997334,15.0,Erlotinib Therapy and Subsequent Development of Mechanisms of Secondary Resistance in Patients With NSCLC,Completed,Phase 2,,February 2010,January 2017,Treatment,Boston,Massachusetts,02115,All,18.0,2017-01-01,2010-02-01,2526.0,1.0,02115
NCT01000025,12.08333333,PF-00299804 in Stage IIIB or Stage IV Non-Small Cell Lung Cancer Not Responding to Standard Therapy for Advanced or Metastatic Cancer,Completed,Phase 3,Randomized,"December 23, 2009","November 27, 2015",Treatment,Arcadia,California,91007,All,18.0,2015-11-01,2009-12-01,2161.0,1.0,91007
NCT01000506,10.38223066,Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma,Completed,Phase 2,Randomized,"November 1, 2009","March 23, 2012",Treatment,Long Beach,California,90808,All,12.0,2012-03-01,2009-11-01,851.0,1.0,90808
NCT01005901,17.8123936,"A Study to Assess the Safety, Tolerability and Efficacy of NVA237 Versus Placebo",Completed,Phase 3,Randomized,October 2009,December 2010,Treatment,Birmingham,Alabama,,All,40.0,2010-12-01,2009-10-01,426.0,1.0,35203
NCT01007253,0.0,Effect of Veramyst and Olopatadine 0.2% Opthalmic Solution on Allergy Symptoms,Completed,Phase 4,Randomized,November 2009,August 2011,Treatment,Chicago,Illinois,60637,All,18.0,2011-08-01,2009-11-01,638.0,1.0,60637
NCT01009099,1.260504202,Reducing Dynamic Hyperinflation Through Breathing Retraining,Completed,Phase 2/Phase 3,Randomized,July 2009,January 2015,Treatment,Hines,Illinois,60141-5000,All,21.0,2015-01-01,2009-07-01,2010.0,1.0,60141
NCT01009463,15.84137206,A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,"September 25, 2009","October 31, 2011",Treatment,Birmingham,Alabama,35235,All,40.0,2011-10-01,2009-09-01,760.0,1.0,35235
NCT01010971,3.594082417,Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis (SAR) to Mountain Cedar in Subjects 12 Years and Older,Completed,Phase 3,Randomized,December 2009,February 2010,Treatment,Austin,Texas,78731,All,12.0,2010-02-01,2009-12-01,62.0,1.0,78731
NCT01011049,0.6592449969,Study of Influenza Vaccine Revaccination in Healthy Adults Previously Vaccinated With Fluzone ID or Fluzone IM,Completed,Phase 2,Randomized,September 2009,October 2010,Prevention,Hoover,Alabama,35216,All,18.0,2010-10-01,2009-09-01,395.0,1.0,35216
NCT01014988,10.31339031,Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital,Completed,Phase 2,,November 2009,February 2015,Treatment,Birmingham,Alabama,35233,All,0.5,2015-02-01,2009-11-01,1918.0,1.0,35233
NCT01017952,17.70079902,A Study to Evaluate Annual Rate of Exacerbations and Safety of 3 Dosage Strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,"September 25, 2009","October 17, 2011",Treatment,Birmingham,Alabama,35215,All,40.0,2011-10-01,2009-09-01,760.0,1.0,35215
NCT01018186,11.16816906,Fluticasone Furoate/GW642444 Inhalation Powder Long-Term Safety Study,Completed,Phase 3,Randomized,"October 19, 2009","May 12, 2011",Treatment,Oxford,Alabama,36203,All,12.0,2011-05-01,2009-10-01,577.0,1.0,36203
NCT01018862,7.373162614,A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis,Completed,Phase 3,Randomized,November 2009,April 2011,Treatment,Costa Mesa,California,92626,All,6.0,2011-04-01,2009-11-01,516.0,1.0,92626
NCT01019694,23.4938098,Combivent Respimat 1-year Safety Study in Patients With Chronic Obstructive Pulmonary Disease,Completed,Phase 3,Randomized,November 2009,,Treatment,Jasper,Alabama,,All,40.0,,2009-11-01,731.0,1.0,14855
NCT01024608,2.367195434,Study in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis (SAR),Completed,Phase 3,Randomized,"December 31, 2009","February 28, 2010",Treatment,Austin,Texas,78731,All,12.0,2010-02-01,2009-12-01,62.0,1.0,78731
NCT01025284,0.0,A Study for Participants With Small-Cell Lung Cancer,Completed,Phase 2,Non-Randomized,December 2009,July 2012,Treatment,Torrington,Connecticut,06790,All,18.0,2012-07-01,2009-12-01,943.0,1.0,06790
NCT01030965,3.858568075,28-day Repeat Dose Study of GSK573719,Completed,Phase 2,Randomized,"December 15, 2009","July 4, 2010",Treatment,Madisonville,Kentucky,42431,All,40.0,2010-07-01,2009-12-01,212.0,4.0,42431
NCT01033825,4.40121348,Study of the Effects of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol on Hypothalamic-Pituitary-Adrenal (HPA) Axis,Completed,Phase 3,Randomized,January 2010,May 2010,Treatment,Stockbridge,Georgia,30281,All,12.0,2010-05-01,2010-01-01,120.0,1.0,30281
NCT01039675,9.523809524,"Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the Combination of GSK573719 and GW642444 in Subjects With COPD",Completed,Phase 2,Randomized,"January 1, 2010","April 20, 2010",Treatment,Chester,South Carolina,29706,All,40.0,2010-04-01,2010-01-01,90.0,4.0,29706
NCT01040728,4.098360656,"A Randomized, Double-Blind, 4-way Crossover Study to Evaluate the Efficacy of of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease",Completed,Phase 3,Randomized,January 2010,,Treatment,Jasper,Alabama,,All,40.0,,2010-01-01,731.0,1.0,14855
NCT01042158,0.0,A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis,Completed,Phase 4,,January 2010,November 2014,Treatment,Baltimore,Maryland,21287,All,18.0,2014-11-01,2010-01-01,1765.0,1.0,21287
NCT01044459,30.98639794,"Long-term Safety, Tolerability and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-35)",Completed,Phase 3,Randomized,November 2009,April 2011,Treatment,Birmingham,Alabama,35209,All,40.0,2011-04-01,2009-11-01,516.0,1.0,35209
NCT01045421,1.424242424,"Alisertib in Adults With Nonhematological Malignancies, Followed by Alisertib in Lung, Breast, Head and Neck or Gastroesophageal Malignancies",Completed,Phase 1/Phase 2,Randomized,February 2010,April 2014,Treatment,Houston,Texas,,All,18.0,2014-04-01,2010-02-01,1520.0,1.0,15342
NCT01046136,2.639977604,Mucinex Exploratory Cold Study,Completed,Phase 2,Randomized,December 2009,,Treatment,Bellevue,Nebraska,68005,All,12.0,,2009-12-01,731.0,1.0,68005
NCT01048866,4.062468102,A Study of Flurbiprofen 8.75 mg Lozenge in Patients With Pharyngitis,Completed,Phase 3,Randomized,November 2009,March 2011,Treatment,New York,New York,10010,All,18.0,2011-03-01,2009-11-01,485.0,1.0,10010
NCT01049334,6.862745098,A Study of Flurbiprofen 8.75 mg Lozenge in Patient With Pharyngitis,Completed,Phase 3,Randomized,November 2009,March 2011,Treatment,Storrs,Connecticut,06268,All,18.0,2011-03-01,2009-11-01,485.0,1.0,06268
NCT01050257,23.26415094,A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza,Completed,Phase 3,Randomized,January 2010,September 2012,Treatment,Birmingham,Alabama,35233,All,13.0,2012-09-01,2010-01-01,974.0,1.0,35233
NCT01052038,11.66666667,Post Operative Sore Throat and Dexamethasone,Completed,Phase 4,Randomized,January 2010,September 2010,Prevention,Chicago,Illinois,60611,Female,18.0,2010-09-01,2010-01-01,243.0,1.0,60611
NCT01052116,10.62176166,The Study of Soy Isoflavones in Asthma,Completed,Phase 4,Randomized,March 2010,August 2012,Treatment,Tucson,Arizona,85724,All,12.0,2012-08-01,2010-03-01,884.0,1.0,85724
NCT01052480,17.34693878,Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza,Completed,Phase 2,Randomized,December 2010,November 2015,Treatment,Los Angeles,California,90095-1752,All,18.0,2015-11-01,2010-12-01,1796.0,1.0,90095
NCT01053988,15.82634091,A 6-month Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,"October 5, 2009","April 14, 2011",Treatment,Mobile,Alabama,36608,All,40.0,2011-04-01,2009-10-01,547.0,1.0,36608
NCT01054885,14.12738855,Efficacy and Safety Study of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and the Individual Components in Subjects With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,"October 19, 2009","February 8, 2011",Treatment,Birmingham,Alabama,35235,All,40.0,2011-02-01,2009-10-01,488.0,1.0,35235
NCT01055197,12.98701299,Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer,Completed,Phase 2,Randomized,March 2010,December 2016,Treatment,Tucson,Arizona,85704,All,18.0,2016-12-01,2010-03-01,2467.0,1.0,85704
NCT01059565,25.24038462,Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Patients With Cystic Fibrosis and Chronic Burkholderia Species Infection,Completed,Phase 3,Randomized,February 2010,January 2012,Treatment,Mobile,Alabama,36608,All,6.0,2012-01-01,2010-02-01,699.0,1.0,36608
NCT01059643,4.854368932,"A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck",Completed,Phase 2,,April 2011,December 2012,Treatment,Jonesboro,Arkansas,72401,All,18.0,2012-12-01,2011-04-01,610.0,1.0,72401
NCT01067105,16.38349515,A 6 Month Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol in The Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older,Completed,Phase 3,,February 2010,November 2010,Treatment,Huntington Beach,California,92647,All,12.0,2010-11-01,2010-02-01,273.0,1.0,92647
NCT01068600,6.603773585,Comparison of Efficacy of Indacaterol Versus Placebo Over 12 Weeks,Completed,Phase 3,Randomized,January 2010,,Treatment,Anniston,Alabama,36207-5710,All,40.0,,2010-01-01,731.0,1.0,36207
NCT01068912,8.597822557,Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza,Completed,Phase 2,Randomized,February 2010,May 2012,Treatment,Birmingham,Alabama,,All,20.0,2012-05-01,2010-02-01,820.0,1.0,35203
NCT01072396,9.523809524,Effects of Tiotropium on Breathing Capacity and Exercise Limitation in Early Stages of Chronic Obstructive Pulmonary Disease,Completed,Phase 4,Randomized,February 2010,November 2011,Treatment,Birmingham,Alabama,,All,40.0,2011-11-01,2010-02-01,638.0,1.0,35203
NCT01072448,10.54447853,12-week Efficacy of Indacaterol,Completed,Phase 3,Randomized,January 2010,July 2010,Treatment,Peoria,Arizona,85381,All,40.0,2010-07-01,2010-01-01,181.0,1.0,85381
NCT01079130,4.002662794,Efficacy and Safety of Different Doses of Indacaterol,Completed,Phase 3,Randomized,February 2010,,Treatment,Glendale,Arizona,85306,All,18.0,,2010-02-01,731.0,1.0,85306
NCT01086384,10.20272989,Asthma Exacerbation Study,Completed,Phase 3,Randomized,"February 22, 2010","September 15, 2011",Treatment,Birmingham,Alabama,35209,All,12.0,2011-09-01,2010-02-01,577.0,1.0,35209
NCT01089127,2.947521143,Efficacy and Safety of Different Doses of Indacaterol in Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,March 2010,July 2010,Treatment,Florence,Alabama,35630,All,40.0,2010-07-01,2010-03-01,122.0,1.0,35630
NCT01097694,19.16666667,Effects of cKit Inhibition by Imatinib in Patients With Severe Refractory Asthma (KIA),Completed,Phase 2,Randomized,November 2010,August 2016,Treatment,Birmingham,Alabama,35294,All,18.0,2016-08-01,2010-11-01,2100.0,1.0,35294
NCT01102374,12.13286713,Vitamin D Supplementation and Acute Respiratory Infection in Older Long-Term Care Residents,Completed,Phase 2,Randomized,May 2010,July 2016,Prevention,Aurora,Colorado,80045,All,60.0,2016-07-01,2010-05-01,2253.0,1.0,80045
NCT01104155,34.84126984,"Eribulin Mesylate in Combination With Intermittent Erlotinib in Patients With Previously Treated, Advanced Non-Small Cell Lung Cancer",Completed,Phase 2,Randomized,"February 22, 2010","January 18, 2017",Treatment,Bessemer,Alabama,,All,18.0,2017-01-01,2010-02-01,2526.0,1.0,16112
NCT01106014,18.88417927,Selexipag (ACT-293987) in Pulmonary Arterial Hypertension,Completed,Phase 3,Randomized,"December 1, 2009","October 1, 2014",Treatment,Mobile,Alabama,36617,All,18.0,2014-10-01,2009-12-01,1765.0,1.0,36617
NCT01109524,35.0,Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer,Completed,Phase 2,,July 2010,September 2012,Treatment,Casa Grande,Arizona,85122,All,18.0,2012-09-01,2010-07-01,793.0,1.0,85122
NCT01110200,24.41499265,Chronic Obstructive Pulmonary Disease (COPD) Post-hospitalization Study,Completed,Phase 4,Randomized,"April 30, 2010","May 8, 2012",Treatment,Birmingham,Alabama,35233,All,40.0,2012-05-01,2010-04-01,761.0,1.0,35233
NCT01118312,17.78867884,Study of Asthma and Nasal Steroids,Completed,Phase 4,Randomized,September 2010,June 2015,Treatment,Tucson,Arizona,85724,All,6.0,2015-06-01,2010-09-01,1734.0,1.0,85724
NCT01120691,15.90804467,Effect of QVA149 Versus NVA237 and Tiotropium on Chronic Obstructive Pulmonary Disorder (COPD) Exacerbations,Completed,Phase 3,Randomized,April 2010,July 2012,Treatment,Birmingham,Alabama,35233,All,40.0,2012-07-01,2010-04-01,822.0,1.0,35233
NCT01122680,1.904761905,Efficacy and Safety of 3 Doses of Tiotropium Compared to Placebo in Adolescents (12 to 17 Yrs) With Moderate Asthma,Completed,Phase 2,Randomized,May 2010,,Treatment,Denver,Colorado,,All,12.0,,2010-05-01,731.0,1.0,12421
NCT01124422,5.112656981,Fluticasone Propionate/Salmeterol Combination 250/50 DISKUS in the Exercise Endurance Time in Patients With Chronic Obstructive Pulmonary Disease,Completed,Phase 4,Randomized,"July 19, 2010","May 2, 2011",Treatment,Birmingham,Alabama,35294,All,40.0,2011-05-01,2010-07-01,304.0,1.0,35294
NCT01124864,10.3403731,A Study of AUY922 in Non-small-cell Lung Cancer Patients Who Have Received Previous Two Lines of Chemotherapy.,Completed,Phase 2,Non-Randomized,October 2010,August 2014,Treatment,Los Angeles,California,90095,All,18.0,2014-08-01,2010-10-01,1400.0,1.0,90095
NCT01126437,22.20118932,Comparison of Tiotropium in the HandiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease,Completed,Phase 3,Randomized,May 2010,May 2013,Treatment,Athens,Alabama,,All,40.0,2013-05-01,2010-05-01,1096.0,1.0,04912
NCT01133626,7.139227642,Hypothalamic-Pituitary-Adrenal (HPA) Axis Study in Adult and Adolescent Subjects With Perennial Allergic Rhinitis (PAR),Completed,Phase 3,Randomized,June 2010,September 2010,Treatment,North Dartmouth,Massachusetts,02747,All,12.0,2010-09-01,2010-06-01,92.0,1.0,02747
NCT01134042,8.884858927,Study HZA106829: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics,Completed,Phase 3,Randomized,June 2010,October 2011,Treatment,Bell Gardens,California,90201,All,12.0,2011-10-01,2010-06-01,487.0,1.0,90201
NCT01134705,7.933613322,Study in Adult and Adolescent Subjects With PAR (Perennial Allergic Rhinitis),Completed,Phase 3,Randomized,May 2010,October 2010,Treatment,Los Angeles,California,90025,All,12.0,2010-10-01,2010-05-01,153.0,1.0,90025
NCT01136382,5.921052632,A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo,Completed,Phase 2,Randomized,July 2010,April 2013,Treatment,Scottsdale,Arizona,,All,6.0,2013-04-01,2010-07-01,1005.0,1.0,85250
NCT01147068,4.09158924,Safety and Immunogenicity of PanBlok Influenza Vaccine in Healthy Adults,Completed,Phase 1/Phase 2,Randomized,June 2010,October 2011,Prevention,Overland Park,Kansas,66210,All,18.0,2011-10-01,2010-06-01,487.0,1.0,66210
NCT01147744,9.368932039,Dose Ranging Study Evaluating the Efficacy and Safety of GSK2190915 Administered Once Daily,Completed,Phase 2,Randomized,"June 28, 2010","October 6, 2011",Treatment,Birmingham,Alabama,35209,Female,12.0,2011-10-01,2010-06-01,487.0,1.0,35209
NCT01147848,7.320099256,HZA113091 Efficacy and Safety of Fluticasone Furoate/Vilanterol (GW642444) in Adults and Adolescents,Completed,Phase 3,Randomized,June 2010,July 2011,Treatment,Huntington Beach,California,92647,All,12.0,2011-07-01,2010-06-01,395.0,1.0,92647
NCT01154127,10.2058319,Effect of NVA237 on Exercise Endurance in Patients With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,June 2010,February 2011,Treatment,Spartanburg,South Carolina,29303,All,40.0,2011-02-01,2010-06-01,245.0,1.0,29303
NCT01154153,5.695039804,Nasacort AQ Hypothalamic-Pituitary-Adrenal (HPA) Axis Study in Children With Allergic Rhinitis,Completed,Phase 4,Randomized,June 2010,October 2010,Treatment,Cypress,California,90630,All,2.0,2010-10-01,2010-06-01,122.0,1.0,90630
NCT01156844,4.78916127,"Efficacy, Safety and Pharmacokinetics of Different Regimens of Indacaterol",Completed,Phase 2,Randomized,March 2010,,Treatment,Anniston,Alabama,36207,All,18.0,,2010-03-01,731.0,1.0,36207
NCT01159912,9.605898805,Evaluating the Efficacy and Safety of Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Adults and Adolescents,Completed,Phase 3,Randomized,"June 30, 2010","January 16, 2012",Treatment,Birmingham,Alabama,35209,All,12.0,2012-01-01,2010-06-01,579.0,1.0,35209
NCT01160744,15.74811186,A Study of Pemetrexed and Carboplatin/Cisplatin or Gemcitabine and Carboplatin/Cisplatin With or Without IMC-1121B in Participants Previously Untreated With Recurrent or Advanced Non-Small Cell Lung Cancer (NSCLC),Completed,Phase 2,Randomized,September 2010,April 2018,Treatment,Scottsdale,Arizona,85258,All,18.0,2018-04-01,2010-09-01,2769.0,1.0,85258
NCT01162122,4.095053181,Safety and Immunogenicity of MF59C.1 Adjuvanted Trivalent Subunit Influenza Vaccine in Elderly Subjects,Completed,Phase 3,Randomized,August 2010,November 2011,Prevention,Phoenix,Arizona,85253,All,65.0,2011-11-01,2010-08-01,457.0,1.0,85253
NCT01165138,4.92959927,Study HZA106827: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics,Completed,Phase 3,Randomized,"August 20, 2010","October 19, 2011",Treatment,Bell Gardens,California,90201,All,12.0,2011-10-01,2010-08-01,426.0,1.0,90201
NCT01168973,24.56700637,A Study of Chemotherapy and Ramucirumab Versus Chemotherapy Alone in Second Line Non-Small Cell Lung Cancer (NSCLC) Participants Who Received Prior First Line Platinum-based Chemotherapy,Completed,Phase 3,Randomized,December 2010,August 2016,Treatment,Phoenix,Arizona,85016,All,18.0,2016-08-01,2010-12-01,2070.0,1.0,85016
NCT01172808,6.640860741,Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 mcg Twice Daily) in Patient With Moderate Persistent Asthma I,Completed,Phase 3,Randomized,August 2010,November 2012,Treatment,Huntington Beach,California,,All,18.0,2012-11-01,2010-08-01,823.0,1.0,92646
NCT01172821,5.427597272,Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 mcg Twice Daily) in Patient With Moderate Persistent Asthma II,Completed,Phase 3,Randomized,August 2010,November 2012,Treatment,Los Angeles,California,,All,18.0,2012-11-01,2010-08-01,823.0,1.0,90001
NCT01178073,20.70117346,A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH),Completed,Phase 3,Randomized,"October 1, 2010","July 31, 2014",Treatment,Birmingham,Alabama,35294,All,18.0,2014-07-01,2010-10-01,1369.0,1.0,35294
NCT01181895,5.467266367,Study B2C112060: A Study of the Efficacy and Safety of Vilanterol Inhalation Powder in Adults and Adolescents With Persistent Asthma,Completed,Phase 3,Randomized,"September 1, 2010","August 26, 2011",Treatment,Huntington Beach,California,92647,All,12.0,2011-08-01,2010-09-01,334.0,1.0,92647
NCT01196975,3.12508311,A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Adults,Completed,Phase 3,Randomized,"October 1, 2010","June 24, 2011",Prevention,Mesa,Arizona,85213,All,18.0,2011-06-01,2010-10-01,243.0,1.0,85213
NCT01196988,2.30924267,Immunogenicity and Safety Study of GSK Biologicals' Influenza Vaccine When Administered in Children,Completed,Phase 3,Randomized,"October 4, 2010","June 15, 2011",Prevention,Sacramento,California,95816,All,0.5,2011-06-01,2010-10-01,243.0,1.0,95816
NCT01198756,5.059929038,A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Children,Completed,Phase 3,Randomized,"October 1, 2010","July 1, 2011",Prevention,Chandler,Arizona,85224,All,0.5,2011-07-01,2010-10-01,273.0,1.0,85224
NCT01202188,7.371642787,"A Study to Assess the Efficacy, Safety and Tolerability of Once-daily (q.d.) QVA149 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)",Completed,Phase 3,Randomized,September 2010,March 2012,Treatment,Fullerton,California,92835,All,40.0,2012-03-01,2010-09-01,547.0,1.0,92835
NCT01204671,1.198772312,Safety and Immunogenicity Study of GSK Biologicals' Seasonal Influenza Candidate Vaccine (GSK2321138A),Completed,Phase 3,Randomized,"October 4, 2010","June 6, 2011",Prevention,Chandler,Arizona,85224,All,18.0,2011-06-01,2010-10-01,243.0,1.0,85224
NCT01214187,18.96551724,Study of Inhaled Carbon Monoxide to Treat Idiopathic Pulmonary Fibrosis,Completed,Phase 2,Randomized,July 2011,April 2015,Treatment,San Francisco,California,94143,All,18.0,2015-04-01,2011-07-01,1370.0,1.0,94143
NCT01218126,12.81366318,"Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-centre, Dose Ranging Study to Evaluate the Efficacy and Safety of Losmapimod Tablets Administered Twice Daily Compared With Placebo for 24 Weeks in Adult Subjects With Chronic Obstructive Pulmonary Disease (COPD).",Completed,Phase 2,Randomized,"November 4, 2010","December 21, 2011",Treatment,Birmingham,Alabama,35294,All,40.0,2011-12-01,2010-11-01,395.0,1.0,35294
NCT01218646,0.7239583333,Study of Quadrivalent Influenza Vaccine Among Adults,Completed,Phase 3,Randomized,October 2010,April 2011,Prevention,Hoover,Alabama,35216,All,18.0,2011-04-01,2010-10-01,182.0,1.0,35216
NCT01225211,4.825908858,Study of VX-809 Alone and in Combination With VX-770 in Cystic Fibrosis (CF) Patients Homozygous or Heterozygous for the F508del-CFTR Mutation,Completed,Phase 2,Randomized,October 2010,April 2014,Treatment,Birmingham,Alabama,,All,18.0,2014-04-01,2010-10-01,1278.0,1.0,35203
NCT01227278,10.88235294,A Study to Evaluate the Effectiveness of MEDI-563 in Subjects With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 2,Randomized,November 2010,July 2013,Treatment,Los Angeles,California,,All,40.0,2013-07-01,2010-11-01,973.0,1.0,90001
NCT01227421,6.068342303,Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza,Completed,Phase 2/Phase 3,Randomized,December 2010,May 2011,Treatment,Elmira,New York,14901,All,12.0,2011-05-01,2010-12-01,151.0,1.0,14901
NCT01227967,4.310591213,"Comparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir) Versus Oseltamivir for the Treatment of Influenza in Adults at Risk for Complications",Completed,Phase 2,Randomized,September 2010,"March 30, 2017",Treatment,Birmingham,Alabama,35211,All,18.0,2017-03-01,2010-09-01,2373.0,1.0,35211
NCT01229150,6.666666667,Randomized Phase II Study of AZD6244 (Mitogen-activated Protein Kinase Inhibitor) MEK-Inhibitor With Erlotinib in KRAS Wild Type Advanced Non-Small Cell Lung Cancer (NSCLC) and a Randomized Phase II Study of AZD6244 With Erlotinib in Mutant KRAS Adva...,Completed,Phase 2,Randomized,"October 26, 2010","November 21, 2015",Treatment,Davis,California,95616,All,18.0,2015-11-01,2010-10-01,1857.0,1.0,95616
NCT01231620,6.664917138,A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza,Completed,Phase 3,Randomized,"January 15, 2011","March 18, 2015",Treatment,Birmingham,Alabama,35249,All,16.0,2015-03-01,2011-01-01,1520.0,1.0,35249
NCT01232452,30.20960108,A Study in Non-Small Cell Lung Cancer,Completed,Phase 2,Randomized,April 2011,June 2016,Treatment,Chicago,Illinois,60611,All,18.0,2016-06-01,2011-04-01,1888.0,1.0,60611
NCT01233687,2.222222222,AMG 102 and Erlotinib for Advanced Non-Small Cell Lung Cancer,Completed,Phase 1/Phase 2,,August 2011,November 2014,Treatment,Pittsburgh,Pennsylvania,15232,All,18.0,2014-11-01,2011-08-01,1188.0,1.0,15232
NCT01238861,11.50951213,Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma,Completed,Phase 2,Randomized,December 2010,August 2013,Treatment,Birmingham,Alabama,,All,18.0,2013-08-01,2010-12-01,974.0,1.0,35203
NCT01240746,7.670176499,Study of Quadrivalent Influenza Vaccine Among Children,Completed,Phase 3,Randomized,November 2010,February 2012,Prevention,Dothan,Alabama,36305,All,0.5,2012-02-01,2010-11-01,457.0,1.0,36305
NCT01248065,10.77943615,Study of the Effect of Vitamin D as an Add-on Therapy to Corticosteroids in Asthma,Completed,Phase 3,Randomized,April 2011,January 2014,Treatment,San Francisco,California,94143,All,18.0,2014-01-01,2011-04-01,1006.0,1.0,94143
NCT01248715,0.0,Rapid Empiric Treatment With Oseltamivir Study (RETOS),Completed,Phase 4,Randomized,November 2010,May 2016,Treatment,Louisville,Kentucky,40202,All,18.0,2016-05-01,2010-11-01,2008.0,1.0,40202
NCT01253369,27.27272727,Pazopanib in Patients With Relapsed or Refractory Small Cell Lung Cancer,Completed,Phase 2,,June 2010,December 2014,Treatment,Boston,Massachusetts,02114,All,18.0,2014-12-01,2010-06-01,1644.0,1.0,02114
NCT01253577,2.857142857,A Clinical Evaluation of a Steroid-Coated Sinus Stent When Used Following Functional Endoscopic Sinus Surgery in Patients With Chronic Sinusitis,Completed,Phase 3,Randomized,December 2009,October 2010,Treatment,Fresno,California,93720,All,18.0,2010-10-01,2009-12-01,304.0,1.0,93720
NCT01257230,5.341812676,Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma,Completed,Phase 3,Randomized,December 2010,December 2013,Treatment,Plymouth,Minnesota,,All,12.0,2013-12-01,2010-12-01,1096.0,1.0,02360
NCT01258595,0.6667852063,A Study of High-Dose Trivalent Inactivated Influenza Vaccine in Adults 50 to 64 Years of Age,Completed,Phase 2,Randomized,November 2010,April 2011,Prevention,Idaho Falls,Idaho,83404,All,50.0,2011-04-01,2010-11-01,151.0,1.0,83404
NCT01262560,1.863498719,Manuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung Cancer,Completed,Phase 2,Randomized,February 2012,November 2014,Supportive Care,Mobile,Alabama,36608,All,18.0,2014-11-01,2012-02-01,1004.0,1.0,36608
NCT01270464,13.94481305,A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma,Completed,Phase 3,Randomized,February 2011,September 2013,Treatment,Anaheim,California,,All,12.0,2013-09-01,2011-02-01,943.0,1.0,92801
NCT01277523,1.003207932,Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma,Completed,Phase 3,Randomized,January 2011,October 2013,Treatment,Stockton,California,,All,12.0,2013-10-01,2011-01-01,1004.0,1.0,08559
NCT01285323,12.28448276,A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma,Completed,Phase 3,Randomized,March 2011,April 2014,Treatment,Mobile,Alabama,,All,12.0,2014-04-01,2011-03-01,1127.0,1.0,36602
NCT01285609,36.53439758,Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Versus Placebo in Addition to Paclitaxel and Carboplatin,Completed,Phase 3,Randomized,"January 16, 2011","August 22, 2017",Treatment,San Diego,California,92123,All,18.0,2017-08-01,2011-01-01,2404.0,1.0,92123
NCT01287039,11.247909,A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma,Completed,Phase 3,Randomized,April 2011,March 2014,Treatment,Scottsdale,Arizona,,All,12.0,2014-03-01,2011-04-01,1065.0,1.0,85250
NCT01287364,10.28173954,Evaluation of a Novel Questionnaire to Assess Patient Satisfaction With and Preference of Intranasal Corticosteroids for the Treatment of Allergic Rhinitis,Completed,Phase 3,Randomized,February 2011,April 2011,Treatment,Mission Viejo,California,92691,All,12.0,2011-04-01,2011-02-01,59.0,1.1,92691
NCT01297491,38.48484848,Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer,Completed,Phase 2,Non-Randomized,May 2011,October 2014,Treatment,Chandler,Arizona,85224,All,18.0,2014-10-01,2011-05-01,1249.0,1.0,85224
NCT01307319,2.661531745,Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Allergies,Completed,Phase 3,Randomized,March 2011,August 2011,Treatment,Oxford,Alabama,36203,All,6.0,2011-08-01,2011-03-01,153.0,1.0,36203
NCT01311557,0.8448540707,Study of Adacel® Vaccine Administered to Persons 10 Years of Age,Completed,Phase 4,Non-Randomized,March 2011,January 2012,Prevention,Chandler,Arizona,85224,All,10.0,2012-01-01,2011-03-01,306.0,1.0,85224
NCT01312961,11.53846154,"Efficacy, Safety, and Tolerability of Dupilumab in Patients With Persistent Moderate to Severe Eosinophilic Asthma",Completed,Phase 2,Randomized,March 2011,October 2012,Treatment,Anaheim,California,92804,All,18.0,2012-10-01,2011-03-01,580.0,1.0,92804
NCT01313637,11.43583315,A 24-week Evaluation of GSK573719/Vilanterol (125/25mcg) and Components in COPD,Completed,Phase 3,Randomized,"March 1, 2011","April 19, 2012",Treatment,Jasper,Alabama,35501,All,40.0,2012-04-01,2011-03-01,397.0,4.2,35501
NCT01313650,11.90237429,A 24-week Evaluation of GSK573719/Vilanterol (62.5/25mcg) and Components in COPD,Completed,Phase 3,Randomized,"March 1, 2011","April 5, 2012",Treatment,Tucson,Arizona,85723,All,40.0,2012-04-01,2011-03-01,397.0,1.0,85723
NCT01313676,23.33027498,Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease,Completed,Phase 3,Randomized,"January 25, 2011","July 15, 2015",Treatment,Andalusia,Alabama,36420,All,40.0,2015-07-01,2011-01-01,1642.0,7.0,36420
NCT01316887,21.02377634,"A 52-Week, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Safety and Tolerability of GSK573719/GW642444 and GSK573719 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)",Completed,Phase 3,Randomized,"January 1, 2011","July 21, 2012",Other,Mobile,Alabama,36608,All,40.0,2012-07-01,2011-01-01,547.0,1.0,36608
NCT01316900,11.02450645,24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease,Completed,Phase 3,Randomized,"March 1, 2011","April 24, 2012",Treatment,Birmingham,Alabama,35216,All,40.0,2012-04-01,2011-03-01,397.0,1.0,35216
NCT01316913,12.76787826,24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease,Completed,Phase 3,Randomized,March 2011,April 2012,Treatment,Jasper,Alabama,35501,All,40.0,2012-04-01,2011-03-01,397.0,4.2,35501
NCT01323621,4.692192192,Study Evaluating the 24-Hour Pulmonary Function Profile of Fluticasone Furoate (FF) /GW642444 (Vilanterol) (VI) Inhalation Powder 100/25mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,"March 18, 2011","January 24, 2012",Treatment,Jasper,Alabama,35501,All,40.0,2012-01-01,2011-03-01,306.0,4.2,35501
NCT01323634,7.709385209,Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate (FF) /GW642444 (Vilanterol) (VI) Inhalation Powder 100/25mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease,Completed,Phase 3,Randomized,"March 18, 2011","December 14, 2011",Treatment,Los Angeles,California,90048,All,40.0,2011-12-01,2011-03-01,275.0,1.0,90048
NCT01323660,2.660152009,An Exercise Endurance Study to Evaluate the Effects of Treatment of Chronic Obstructive Pulmonary Disease (COPD) Patients With a Dual Bronchodilator: GSK573719/GW642444.Study B,Completed,Phase 3,Randomized,"March 16, 2011","July 16, 2012",Treatment,Jasper,Alabama,35501,Male,40.0,2012-07-01,2011-03-01,488.0,4.2,35501
NCT01328444,2.442528736,An Exercise Endurance Study to Evaluate the Effects of Treatment of Chronic Obstructive Pulmonary Disease (COPD) Patients With a Dual Bronchodilator: GSK573719/GW642444. Study A,Completed,Phase 3,Randomized,"March 1, 2011","June 14, 2012",Treatment,Phoenix,Arizona,85006,All,40.0,2012-06-01,2011-03-01,458.0,1.0,85006
NCT01330108,14.28571429,Safely Change From Bosentan to Ambrisentan in Pulmonary Hypertension,Completed,Phase 4,,May 2011,June 2012,Treatment,Birmingham,Alabama,35249,All,19.0,2012-06-01,2011-05-01,397.0,1.0,35249
NCT01332292,5.555555556,Pharmacokinetics and PharmacoDynamics of GW685698 in Paedeatric Asthmatic Patients,Completed,Phase 2,Randomized,May 2010,January 2011,Treatment,Cypress,California,90630,All,5.0,2011-01-01,2010-05-01,245.0,1.0,90630
NCT01335464,15.77193984,Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients,Completed,Phase 3,Randomized,April 2011,October 2013,Treatment,Birmingham,Alabama,,All,40.0,2013-10-01,2011-04-01,914.0,1.0,35203
NCT01335477,18.32729594,Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients II,Completed,Phase 3,Randomized,May 2011,October 2013,Treatment,Scottsdale,Arizona,,All,40.0,2013-10-01,2011-05-01,884.0,1.0,85250
NCT01336608,10.73084782,A 24-week Arterial Stiffness Study With Fluticasone Furoate/Vilanterol in COPD,Completed,Phase 3,Randomized,"March 4, 2011","November 4, 2014",Treatment,Birmingham,Alabama,35294,All,40.0,2014-11-01,2011-03-01,1341.0,1.0,35294
NCT01338415,29.66764418,FUTURE 3 Study Extension,Completed,Phase 3,Non-Randomized,"March 8, 2011","May 29, 2020",Treatment,Aurora,Colorado,80045,All,0.25,2020-05-01,2011-03-01,3349.0,1.0,80045
NCT01338636,0.0,An Open-Label Uncontrolled Study of the Safety and Efficacy of Ambrisentan in Participants With Exercise-Induced Pulmonary Arterial Hypertension (PAH),Completed,Phase 4,,September 2008,May 2016,Treatment,Boston,Massachusetts,02115,All,18.0,2016-05-01,2008-09-01,2799.0,1.0,02115
NCT01344759,3.333333333,Dexmedetomidine and Propofol in Children With History of Obstructive Sleep Apnea,Completed,Phase 4,Randomized,June 2009,November 2011,Treatment,Cincinnati,Ohio,45229,All,1.0,2011-11-01,2009-06-01,883.0,1.0,45229
NCT01344824,57.89473684,"Carboplatin, Pemetrexed Disodium, and Bevacizumab for Patients With Stage III or IV Non-Small Cell Lung Cancer Who Are Light/Never Smokers",Completed,Phase 2,,March 2010,"July 20, 2016",Treatment,Asheville,North Carolina,28801,All,18.0,2016-07-01,2010-03-01,2314.0,1.0,28801
NCT01346293,2.890606933,Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age,Completed,Phase 3,Randomized,April 2011,September 2013,Prevention,Birmingham,Alabama,35205,All,4.0,2013-09-01,2011-04-01,884.0,1.0,35205
NCT01349803,1.264124294,PT003 MDI Cardiovascular Safety Study,Completed,Phase 2,Randomized,May 2011,November 2011,Treatment,Glendale,Arizona,,All,40.0,2011-11-01,2011-05-01,184.0,1.0,42740
NCT01351415,11.56037415,A Study of Bevacizumab in Combination With Standard of Care Treatment in Participants With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC),Completed,Phase 3,Randomized,"June 25, 2011","June 25, 2016",Treatment,Mobile,Alabama,36688,All,18.0,2016-06-01,2011-06-01,1827.0,1.0,36688
NCT01360554,7.110091743,ARCHER 1009 : A Study Of Dacomitinib (PF-00299804) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung Cancer,Completed,Phase 3,Randomized,"June 16, 2011","September 14, 2015",Treatment,Birmingham,Alabama,35233,All,18.0,2015-09-01,2011-06-01,1553.0,1.0,35233
NCT01366209,5.585279069,Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF),Completed,Phase 3,Randomized,June 2011,February 2014,Treatment,Brisbane,California,94005,All,40.0,2014-02-01,2011-06-01,976.0,1.0,94005
NCT01366521,4.554865424,Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated Eosinophils,Completed,Phase 2,Randomized,February 2011,March 2012,Treatment,Winston-Salem,North Carolina,27103,All,18.0,2012-03-01,2011-02-01,394.0,1.0,27103
NCT01372410,0.8435582822,"A Randomized, Double Blind, Placebo Controlled, Incomplete Block, Crossover, Dose Ranging Study to Evaluate the Dose Response of GSK573719 Administered Once or Twice Daily Over 7 Days in Patients With Chronic Obstructive Pulmonary Disease (COPD)",Completed,Phase 2,Randomized,"July 1, 2011","October 27, 2011",Treatment,Costa Mesa,California,92626,All,40.0,2011-10-01,2011-07-01,92.0,1.0,92626
NCT01375049,4.761904762,Aztreonam Lysine for Pseudomonas Infection Eradication Study,Completed,Phase 2,,August 2011,May 2013,Treatment,Phoenix,Arizona,85016,All,0.25,2013-05-01,2011-08-01,639.0,1.0,85016
NCT01378429,2.380952381,Safety Study of the Potential Inhibitory Effects of Ciclesonide Nasal Aerosol on the Hypothalamic-Pituitary-Adrenal Axis in Subjects 6-11 Years With Perennial Allergic Rhinitis,Completed,Phase 3,Randomized,July 2011,November 2011,Treatment,Costa Mesa,California,92626,All,6.0,2011-11-01,2011-07-01,123.0,1.0,92626
NCT01380327,14.89247312,Biomarkers of Cockroach Sublingual Immunotherapy 2,Completed,Phase 1/Phase 2,Randomized,May 2011,June 2012,Treatment,Chicago,Illinois,60614,All,5.0,2012-06-01,2011-05-01,397.0,1.0,60614
NCT01387230,4.859335038,Evaluate the Efficacy and Safety of GSK573719 Delivered Via a Novel Dry Powder Inhaler in Subjects With COPD,Completed,Phase 3,Randomized,"July 1, 2011","February 13, 2012",Treatment,Sunset,Louisiana,70584,All,40.0,2012-02-01,2011-07-01,215.0,2.0,70584
NCT01387269,14.57031325,Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 1),Completed,Phase 3,Randomized,July 2011,February 2015,Treatment,Fullerton,California,,All,18.0,2015-02-01,2011-07-01,1311.0,1.0,58441
NCT01387282,16.96969697,Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 2),Completed,Phase 3,Randomized,July 2011,February 2015,Treatment,Corona,California,,All,18.0,2015-02-01,2011-07-01,1311.0,1.0,11368
NCT01395758,3.921568627,Erlotinib Plus Tivantinib (ARQ 197) Versus Single Agent Chemotherapy in Locally Advanced or Metastatic Non-Small Cell Lung Cancer,Completed,Phase 2,Randomized,July 2011,August 2016,Treatment,Stanford,California,94305,All,18.0,2016-08-01,2011-07-01,1858.0,1.0,94305
NCT01395914,13.05383023,Anamorelin HCl in the Treatment of Non-Small Cell Lung Cancer-Cachexia (NSCLC-C): An Extension Study (ROMANA 3),Completed,Phase 3,Randomized,July 2011,February 2015,Treatment,Corona,California,,All,18.0,2015-02-01,2011-07-01,1311.0,1.0,11368
NCT01401465,3.211009174,"Study To Evaluate Patient Preference, Satisfaction And Efficacy Of a Nasal Aerosol Versus an Aqueous Nasal Spray",Completed,Phase 3,Randomized,July 2011,November 2011,Treatment,Huntington Beach,California,92647,All,12.0,2011-11-01,2011-07-01,123.0,1.0,92647
NCT01404234,3.278688525,Safety of AZLI in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa in the Lower Airways,Completed,Phase 3,,December 2011,April 2013,Treatment,Aurora,Colorado,80045,All,18.0,2013-04-01,2011-12-01,487.0,1.0,80045
NCT01416571,2.564102564,Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Monovalent Pandemic H5N1 Vaccine in Adults,Completed,Phase 2,,"August 12, 2011","September 28, 2012",Prevention,Mesa,Arizona,85213,All,18.0,2012-09-01,2011-08-01,397.0,1.0,85213
NCT01424813,4.430379747,A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma,Completed,Phase 3,Randomized,December 2012,November 2013,Treatment,Birmingham,Alabama,,All,12.0,2013-11-01,2012-12-01,335.0,1.0,35203
NCT01427309,4.794210519,A Study of Fluzone® High-Dose Vaccine Compared With Fluzone® Vaccine In Elderly Adults,Completed,Phase 4,Randomized,September 2011,November 2013,Prevention,Mobile,Alabama,36608,All,65.0,2013-11-01,2011-09-01,792.0,1.0,36608
NCT01431274,13.78446802,Tiotropium+Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,September 2011,September 2013,Treatment,Jasper,Alabama,,All,40.0,2013-09-01,2011-09-01,731.0,1.0,14855
NCT01431287,17.06079737,Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,September 2011,November 2013,Treatment,Greer,California,,All,40.0,2013-11-01,2011-09-01,792.0,1.0,29650
NCT01431950,11.34453782,Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents,Completed,Phase 3,Randomized,September 2011,October 2012,Treatment,Long Beach,California,90808,All,12.0,2012-10-01,2011-09-01,396.0,1.0,90808
NCT01436071,6.611570248,Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma,Completed,Phase 3,Randomized,September 2011,August 2012,Treatment,Long Beach,California,90808,All,12.0,2012-08-01,2011-09-01,335.0,1.0,90808
NCT01436110,10.67013502,Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma,Completed,Phase 3,Randomized,September 2011,September 2012,Treatment,Los Angeles,California,90025,All,12.0,2012-09-01,2011-09-01,366.0,1.0,90025
NCT01437397,19.35722905,"Efficacy, Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)",Completed,Phase 3,Randomized,September 2011,February 2013,Treatment,Anniston,Alabama,36207,All,40.0,2013-02-01,2011-09-01,519.0,1.0,36207
NCT01437540,26.90166976,Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease,Completed,Phase 3,Randomized,"September 19, 2011","April 30, 2013",Treatment,Birmingham,Alabama,35209,All,40.0,2013-04-01,2011-09-01,578.0,1.0,35209
NCT01438307,0.0,Phase II Study of Cabazitaxel-XRP6258 in Advanced Non-Small Cell Lung Cancer,Completed,Phase 2,Randomized,September 2011,September 2015,Treatment,Birmingham,Alabama,35294,All,19.0,2015-09-01,2011-09-01,1461.0,1.0,35294
NCT01439165,1.35278224,Safety and Immunogenicity in Adults of Revaccination With Adacel® Vaccine 10 Years After a Previous Dose,Completed,Phase 4,Randomized,November 2011,February 2017,Prevention,Huntsville,Alabama,35802,All,18.0,2017-02-01,2011-11-01,1919.0,1.0,35802
NCT01443078,4.761904762,"Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN)",Completed,Phase 2,,October 2011,April 2015,Treatment,Basking Ridge,New Jersey,11725,All,18.0,2015-04-01,2011-10-01,1278.0,1.0,11725
NCT01443845,20.74199622,Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS),Completed,Phase 4,Randomized,"September 30, 2011","January 31, 2016",Treatment,Anniston,Alabama,36207,All,40.0,2016-01-01,2011-09-01,1583.0,1.0,36207
NCT01444430,1.094658869,A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents,Completed,Phase 3,Randomized,December 2011,October 2015,Treatment,Birmingham,Alabama,,All,12.0,2015-10-01,2011-12-01,1400.0,1.0,35203
NCT01448850,20.07621951,A Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease,Completed,Phase 2,Randomized,November 2011,February 2014,Treatment,Peoria,Arizona,,All,45.0,2014-02-01,2011-11-01,823.0,1.0,61602
NCT01450761,30.47976513,Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone,Completed,Phase 3,Randomized,"December 13, 2011","May 17, 2017",Treatment,Hot Springs,Arkansas,71913,All,18.0,2017-05-01,2011-12-01,1978.0,1.0,71913
NCT01451541,10.16264114,A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).,Completed,Phase 3,Randomized,October 2011,December 2012,Treatment,Hot Springs,Arkansas,71913,All,6.0,2012-12-01,2011-10-01,427.0,1.0,71913
NCT01453023,3.846153846,"Inhaled Fluticasone Furoate/Vilanterol Safety and Tolerability, PK and PD Study",Completed,Phase 2,Randomized,October 2011,June 2012,Treatment,Huntington Beach,California,92647,All,5.0,2012-06-01,2011-10-01,244.0,1.0,92647
NCT01453296,5.357142857,Pharmacokinetics and Pharacodynamics of GW642444 in Paedetric Subjects,Completed,Phase 2,Randomized,August 2010,April 2011,Treatment,Cypress,California,90630,All,5.0,2011-04-01,2010-08-01,243.0,1.0,90630
NCT01454934,20.37037037,"A Randomized, Open-label, Multicenter, Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Treatment of Physician's Choice in Subjects With Advanced Non-Small Cell Lung Cancer",Completed,Phase 3,Randomized,"December 9, 2011","May 2, 2016",Treatment,Los Angeles,California,,All,18.0,2016-05-01,2011-12-01,1613.0,1.0,90001
NCT01458275,4.249471635,A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Seasonal Allergic Rhinitis (SAR),Completed,Phase 3,Randomized,November 2011,March 2013,Treatment,Little Rock,Arkansas,72205,All,6.0,2013-03-01,2011-11-01,486.0,1.0,72205
NCT01462344,10.51815049,6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old,Completed,Phase 4,Randomized,"November 17, 2011","November 3, 2015",Treatment,Birmingham,Alabama,35209,All,4.0,2015-11-01,2011-11-01,1461.0,1.0,35209
NCT01465802,20.7012664,Study Of Dacomitinib (PF-00299804) In Advanced NSCLC Patients (Post Chemo Or Select First Line) To Evaluate Prophylactic Intervention On Derm And GI AEs And PRO,Completed,Phase 2,Non-Randomized,"December 26, 2011","May 18, 2015",Treatment,Duarte,California,91010,All,18.0,2015-05-01,2011-12-01,1247.0,1.0,91010
NCT01475721,0.1369981522,SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma.,Completed,Phase 4,Randomized,"November 18, 2011","June 23, 2015",Treatment,Athens,Alabama,35611,All,12.0,2015-06-01,2011-11-01,1308.0,4.2,35611
NCT01479595,4.653679654,A Study to Establish the Efficacy of QBX258 in Patients With Moderate to Severe Asthma,Completed,Phase 2,Randomized,February 2012,February 2015,Treatment,Anaheim,California,92801,All,18.0,2015-02-01,2012-02-01,1096.0,1.0,92801
NCT01479621,11.57580284,A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids,Completed,Phase 2,Randomized,January 2012,July 2013,Treatment,Homewood,Alabama,,All,12.0,2013-07-01,2012-01-01,547.0,1.0,60430
NCT01483625,5.555555556,Tiotropium (18mcg) in Chronic Obstructive Pulmonary Disease (COPD) Patients With a Respiratory Infection,Completed,Phase 4,Randomized,November 2011,December 2012,Treatment,Tucson,Arizona,,All,40.0,2012-12-01,2011-11-01,396.0,1.0,85701
NCT01500720,7.833957553,Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer,Completed,Phase 2,Randomized,March 2012,April 2014,Treatment,Muscle Shoals,Alabama,35661,All,18.0,2014-04-01,2012-03-01,761.0,1.0,35661
NCT01504867,1.538461538,LIPS-A: Lung Injury Prevention Study With Aspirin,Completed,Phase 2,Randomized,January 2012,September 2015,Prevention,Stanford,California,94305,All,18.0,2015-09-01,2012-01-01,1339.0,1.0,94305
NCT01508936,21.53368885,Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma,Completed,Phase 3,Randomized,February 2012,August 2013,Treatment,Birmingham,Alabama,,All,18.0,2013-08-01,2012-02-01,547.0,1.0,35203
NCT01519661,31.21019108,Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis,Completed,Phase 4,Non-Randomized,January 2012,January 2014,Treatment,Little Rock,Arkansas,72205,All,6.0,2014-01-01,2012-01-01,731.0,1.0,72205
NCT01523587,21.06890696,LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy,Completed,Phase 3,Randomized,"March 5, 2012","December 27, 2017",Treatment,Chandler,Arizona,85224,All,18.0,2017-12-01,2012-03-01,2101.0,1.0,85224
NCT01525615,6.728588421,A Study to Determine the Effect of Tiotropium + Olodaterol Fixed Dose Combination on Exercise Endurance Time During Constant Work Rate Cycle Ergometry Test in COPD,Completed,Phase 3,Randomized,February 2012,September 2013,Treatment,Torrance,California,,All,40.0,2013-09-01,2012-02-01,578.0,1.0,90501
NCT01529112,8.878847093,"A Study Comparing the Combination of the Best Supportive Care Plus E7080 Versus Best Supportive Care Alone, in Patients With Advanced Lung Cancer or Lung Cancer That Has Spread, Who Have Been Previously Treated, Unsuccessfully, With at Least 2 Different Treatments",Completed,Phase 2,Randomized,November 2011,"June 27, 2015",Treatment,Casa Grande,Arizona,85122,All,18.0,2015-06-01,2011-11-01,1308.0,1.0,85122
NCT01531673,0.0,Study of VX-661 Alone and in Combination With Ivacaftor in Subjects Homozygous or Heterozygous to the F508del-Cystic Fibrosis Transmembrane Conductance Regulator(CFTR) Mutation,Completed,Phase 2,Randomized,February 2012,March 2014,Treatment,Birmingham,Alabama,,All,12.0,2014-03-01,2012-02-01,759.0,1.0,35203
NCT01533181,0.0,Linsitinib or Topotecan Hydrochloride in Treating Patients With Relapsed Small Cell Lung Cancer,Completed,Phase 2,Randomized,February 2012,November 2014,Treatment,Scottsdale,Arizona,85259,All,18.0,2014-11-01,2012-02-01,1004.0,1.0,85259
NCT01533922,2.847457627,Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients,Completed,Phase 3,Randomized,March 2012,November 2013,Treatment,Torrance,California,,All,40.0,2013-11-01,2012-03-01,610.0,1.0,90501
NCT01533935,2.886597938,Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients.,Completed,Phase 3,Randomized,February 2012,November 2013,Treatment,Phoenix,Arizona,,All,40.0,2013-11-01,2012-02-01,639.0,1.0,13135
NCT01535040,38.46153846,Memantine Hydrochloride in Helping Cancer Survivors Stop Smoking,Completed,Phase 2,Randomized,"August 1, 2012","February 1, 2014",Supportive Care,Winston-Salem,North Carolina,27157,All,18.0,2014-02-01,2012-08-01,549.0,1.0,27157
NCT01537081,2.792632204,Safety and Efficacy of Mucinex and IR Guaifenesin the Treatment of Symptoms of Acute Upper Respiratory Tract Infections,Completed,Phase 2/Phase 3,Randomized,September 2011,July 2012,Treatment,Hoover,Alabama,35216,All,12.0,2012-07-01,2011-09-01,304.0,1.0,35216
NCT01557166,22.27808814,Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea,Completed,Phase 3,Randomized,"June 7, 2012","June 17, 2013",Treatment,Glendale,California,91206,All,18.0,2013-06-01,2012-06-01,365.0,1.0,91206
NCT01560988,14.51612903,Borage and Echium Seed Oils for Asthma,Completed,Phase 3,Randomized,February 2013,May 2015,Treatment,Boston,Massachusetts,02115,All,18.0,2015-05-01,2013-02-01,819.0,1.0,02115
NCT01563029,5.730142905,A Dose-ranging Study of Fluticasone Furoate (FF),Completed,Phase 2,Randomized,"March 28, 2012","September 24, 2014",Treatment,Little Rock,Arkansas,72205,All,5.0,2014-09-01,2012-03-01,914.0,1.0,72205
NCT01572792,45.19236583,"Efficacy, Safety and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate and Placebo for 28-Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD)",Completed,Phase 3,Randomized,April 2012,June 2013,Treatment,Anniston,Alabama,36207,All,40.0,2013-06-01,2012-04-01,426.0,1.0,36207
NCT01573624,1.153715643,"Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma",Completed,Phase 2,Randomized,"April 3, 2012","February 4, 2013",Diagnostic,Saint Louis,Missouri,63141,All,18.0,2013-02-01,2012-04-01,306.0,1.0,63141
NCT01573767,3.068336,Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children,Completed,Phase 2,Randomized,April 2012,April 2014,Treatment,Birmingham,Alabama,35209,All,5.0,2014-04-01,2012-04-01,730.0,1.0,35209
NCT01576718,9.016046553,A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications,Completed,Phase 2,Randomized,April 2012,October 2013,Treatment,Birmingham,Alabama,,All,12.0,2013-10-01,2012-04-01,548.0,1.0,35203
NCT01579916,3.085625254,A Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults,Completed,Phase 4,Randomized,May 2012,November 2012,Prevention,Miami,Florida,33143,All,18.0,2012-11-01,2012-05-01,184.0,1.0,33143
NCT01588405,3.03030303,Remodulin® to Oral Treprostinil Transition,Completed,Phase 2,,April 2012,December 2014,Treatment,Phoenix,Arizona,85013,All,15.0,2014-12-01,2012-04-01,974.0,1.0,85013
NCT01597375,4.678848283,Therapeutic Control of Aspirin-Exacerbated Respiratory Disease (Aspirin),Completed,Phase 2,Randomized,"August 31, 2012","December 14, 2016",Supportive Care,Boston,Massachusetts,02115,All,18.0,2016-12-01,2012-08-01,1583.0,1.0,02115
NCT01603277,19.34021263,Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids,Completed,Phase 2,Randomized,July 2012,January 2014,Treatment,Birmingham,Alabama,35216,All,16.0,2014-01-01,2012-07-01,549.0,1.0,35216
NCT01606319,19.0,Acetaminophen Versus Ibuprofen in Children With Asthma,Completed,Phase 3,Randomized,February 2013,April 2015,Treatment,Tucson,Arizona,85724,All,1.0,2015-04-01,2013-02-01,789.0,1.0,85724
NCT01612000,8.803742427,Safety and Immunogenicity of PanBlok Influenza Vaccine in Healthy Adults,Completed,Phase 1/Phase 2,Randomized,May 2012,December 2013,Prevention,Omaha,Nebraska,68134,All,18.0,2013-12-01,2012-05-01,579.0,1.0,68134
NCT01614457,2.941176471,Study of Ivacaftor in Subjects With Cystic Fibrosis (CF) Who Have the R117H-CF Transmembrane Conductance Regulator (CFTR) Mutation (KONDUCT),Completed,Phase 3,Randomized,July 2012,October 2013,Treatment,Birmingham,Alabama,,All,6.0,2013-10-01,2012-07-01,457.0,1.0,35203
NCT01623310,32.28699552,12-Month OL Intranasal Fluticasone Propionate BID Using OptiNose Device,Completed,Phase 3,,September 2013,October 2015,Treatment,Birmingham,Alabama,35216,All,18.0,2015-10-01,2013-09-01,760.0,1.0,35216
NCT01627327,6.730907967,Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25mcg Once Daily Compared With Tiotropium Bromide Inhalation Powder 18mcg Once Daily in Subjects With COPD Who Have or Are At Risk for Co-morbid Cardiovascular Disease,Completed,Phase 3,Randomized,"April 1, 2012","December 21, 2012",Treatment,Newport Beach,California,92663,All,40.0,2012-12-01,2012-04-01,244.0,1.0,92663
NCT01629589,3.545560225,Immunogenicity of Adacel® and BOOSTRIX® Vaccines in Adolescents,Completed,Phase 4,Randomized,June 2012,June 2013,Prevention,Sacramento,California,95816,All,11.0,2013-06-01,2012-06-01,365.0,1.0,95816
NCT01634113,1.075268817,Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma,Completed,Phase 2,Randomized,July 2012,December 2014,Treatment,Columbia,Missouri,,All,18.0,2014-12-01,2012-07-01,883.0,1.0,06237
NCT01634139,5.260578645,Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma,Completed,Phase 3,Randomized,July 2012,December 2015,Treatment,Columbia,Missouri,,All,6.0,2015-12-01,2012-07-01,1248.0,1.0,06237
NCT01634152,2.26576394,Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma,Completed,Phase 3,Randomized,July 2012,May 2015,Treatment,Rolling Hills Estates,California,,All,6.0,2015-05-01,2012-07-01,1034.0,1.0,03243
NCT01638546,4.294871795,Temozolomide With or Without Veliparib in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer,Completed,Phase 2,Randomized,June 2012,January 2017,Treatment,Tampa,Florida,33612,All,18.0,2017-01-01,2012-06-01,1675.0,1.0,33612
NCT01641692,0.9642857143,A 3-period Crossover Study With GSK573719 as Monotherapy in Adult Subjects With Asthma,Completed,Phase 2,Randomized,May 2012,February 2013,Treatment,Newport Beach,California,92663,All,18.0,2013-02-01,2012-05-01,276.0,1.0,92663
NCT01641822,14.32459179,Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF,Completed,Phase 3,Randomized,December 2012,January 2015,Treatment,Birmingham,Alabama,35233,All,6.0,2015-01-01,2012-12-01,761.0,1.0,35233
NCT01645735,6.25,Evaluation of Ceftaroline Fosamil Versus a Comparator in Adult Subjects With Community-acquired Bacterial Pneumonia (CABP) With Risk for Methicillin-resistant Staphylococcus Aureus,Completed,Phase 4,Randomized,October 2012,December 2013,Treatment,Phoenix,Arizona,85008,All,18.0,2013-12-01,2012-10-01,426.0,1.0,85008
NCT01654224,6.787434075,Randomized Trial of High Dose Influenza Vaccine in Long Term Care Setting,Completed,Phase 4,Randomized,November 2011,June 2014,Prevention,Pittsburgh,Pennsylvania,15213,All,65.0,2014-06-01,2011-11-01,943.0,1.0,15213
NCT01654289,14.54212067,University of Wisconsin Meditation & Exercise Cold Study,Completed,Phase 2,Randomized,July 2012,June 2016,Prevention,Madison,Wisconsin,53715,All,30.0,2016-06-01,2012-07-01,1431.0,1.0,53715
NCT01654536,8.412866737,A 6 Month Safety Study Of Ciclesonide Nasal Aerosol (Zetonna®) And Ciclesonide Nasal Spray (Omnaris®) In Subjects 12 Years And Older With Perennial Allergic Rhinitis (PAR),Completed,Phase 4,Randomized,September 2012,July 2013,Treatment,Mission Viejo,California,92691,All,12.0,2013-07-01,2012-09-01,303.0,1.1,92691
NCT01659996,2.000965968,Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age,Completed,Phase 4,Randomized,July 2012,September 2015,Prevention,Birmingham,Alabama,35235,All,0.75,2015-09-01,2012-07-01,1157.0,1.0,35235
NCT01662986,39.74358974,Investigate the Impact of Early Treatment Initiation With Tiotropium in Patients Recovering From Hospitalization for an Acute COPD Exacerbation 2,Completed,Phase 4,Randomized,"August 1, 2012","April 1, 2014",Treatment,Montgomery,Alabama,,All,40.0,2014-04-01,2012-08-01,608.0,1.0,12549
NCT01663987,24.16666667,Investigate the Impact of Early Treatment Initiation With Tiotropium in Patients Recovering From Hospitalization for an Acute COPD Exacerbation 1,Completed,Phase 4,Randomized,"August 1, 2012","May 1, 2014",Treatment,Birmingham,Alabama,,All,40.0,2014-05-01,2012-08-01,638.0,1.0,35203
NCT01666782,1.0,Study Comparing High-Dose Flu Vaccine to Standard Vaccine in Cancer Patients Less Than 65 Receiving Chemotherapy,Completed,Phase 2,Randomized,August 2012,December 2015,Prevention,Rochester,New York,14621,All,18.0,2015-12-01,2012-08-01,1217.0,1.0,14621
NCT01669174,17.9144385,BYM338 in Chronic Obstructive Pulmonary Disease (COPD) Patients With Cachexia,Completed,Phase 2,Randomized,September 2012,December 2014,Supportive Care,Torrance,California,90502,All,40.0,2014-12-01,2012-09-01,821.0,1.0,90502
NCT01682863,9.271099744,A Multi-centre Randomized Double Blind 52-week Study to Assess the Safety of QVA149 Compared to QAB149 in Patients With COPD Who Have Moderate to Severe Airflow Limitation,Completed,Phase 3,Randomized,October 2012,June 2014,Treatment,Vestavia,Alabama,35216,All,40.0,2014-06-01,2012-10-01,608.0,1.0,35216
NCT01685060,23.57142857,LDK378 in Adult Patients With ALK-activated NSCLC Previously Treated With Chemotherapy and Crizotinib,Completed,Phase 2,,"November 26, 2012","March 29, 2016",Treatment,Fayetteville,Arkansas,72703,All,18.0,2016-03-01,2012-11-01,1216.0,1.0,72703
NCT01686633,3.656999439,"An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (mcg) , FF/VI 100/25 mcg, and FF 100 mcg in Adults and Adolescents With Persistent Asthma.",Completed,Phase 3,Randomized,"September 20, 2012","October 15, 2013",Treatment,Little Rock,Arkansas,72205,All,12.0,2013-10-01,2012-09-01,395.0,1.0,72205
NCT01688921,1.924877557,Jet Injection for Influenza,Completed,Phase 4,Randomized,October 2012,March 2013,Prevention,Fort Collins,Colorado,80524,All,18.0,2013-03-01,2012-10-01,151.0,1.0,80524
NCT01691508,5.204216074,Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma,Completed,Phase 3,Randomized,October 2012,December 2013,Treatment,Long Beach,California,90808,All,12.0,2013-12-01,2012-10-01,426.0,1.0,90808
NCT01691521,5.216710746,Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma,Completed,Phase 3,Randomized,"October 8, 2012","January 18, 2014",Treatment,Birmingham,Alabama,35294,All,12.0,2014-01-01,2012-10-01,457.0,1.0,35294
NCT01694771,6.978976448,Co-administration of Olodaterol Respimat® and Tiotropium Handihaler®,Completed,Phase 3,Randomized,September 2012,August 2013,Treatment,Florence,Alabama,,All,40.0,2013-08-01,2012-09-01,334.0,1.0,01062
NCT01696058,6.082365069,Co-administration of Olodaterol Respimat® and Tiotropium Handihaler®,Completed,Phase 3,Randomized,September 2012,October 2013,Treatment,Anniston,Alabama,,All,40.0,2013-10-01,2012-09-01,395.0,1.0,36201
NCT01697696,16.37045568,Long Term Safety Study of NVA237 vs QAB149 in COPD Patients,Completed,Phase 3,Randomized,October 2012,November 2014,Treatment,Gulf Shores,Alabama,36547,All,40.0,2014-11-01,2012-10-01,761.0,7.0,36547
NCT01697956,2.370478983,Hypothalamic-Pituitary-Adrenal (HPA)-Axis Study in Pediatric Subjects With Perennial Allergic Rhinitis (PAR),Completed,Phase 3,Randomized,October 2012,February 2013,Treatment,Long Beach,California,,All,6.0,2013-02-01,2012-10-01,123.0,1.0,11561
NCT01706328,7.125186706,A Study to Assess the Efficacy of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25 mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50 mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,"October 15, 2012","June 17, 2013",Treatment,Clearwater,Florida,33765,All,40.0,2013-06-01,2012-10-01,243.0,1.0,33765
NCT01706536,6.089626566,A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease,Completed,Phase 2,Randomized,October 2012,April 2013,Treatment,Jasper,Alabama,35501,All,35.0,2013-04-01,2012-10-01,182.0,4.2,35501
NCT01707290,20.66115702,Rollover Study of Ivacaftor in Subjects With Cystic Fibrosis and a Non G551D CFTR Mutation,Completed,Phase 3,Non-Randomized,February 2013,April 2016,Treatment,Birmingham,Alabama,,All,6.0,2016-04-01,2013-02-01,1155.0,1.0,35203
NCT01709864,3.631371097,NVA237 Versus Placebo 12-week Efficacy Study,Completed,Phase 3,Randomized,November 2012,October 2013,Treatment,Homewood,Alabama,35209-6870,All,40.0,2013-10-01,2012-11-01,334.0,1.0,35209
NCT01711645,25.45454545,Tdap Vaccine in Post-Partum Women,Completed,Phase 4,,"October 26, 2012","August 28, 2015",Prevention,Nashville,Tennessee,37232-2573,Female,18.0,2015-08-01,2012-10-01,1034.0,1.0,37232
NCT01712334,1.176470588,A Study of the Comparable Efficacy and Safety of Pulmozyme (Dornase Alfa) Delivered by the eRapid Nebulizer System in Patients With Cystic Fibrosis,Completed,Phase 4,Randomized,December 2012,June 2013,Treatment,Phoenix,Arizona,85016,All,6.0,2013-06-01,2012-12-01,182.0,1.0,85016
NCT01712516,2.899241588,"A 12-week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation",Completed,Phase 3,Randomized,December 2012,February 2014,Treatment,Huntsville,Alabama,35801,All,40.0,2014-02-01,2012-12-01,427.0,1.0,35801
NCT01712984,1.350186635,Study of Intradermal Quadrivalent Influenza Vaccine in Adults Aged 18 Through 64 Years,Completed,Phase 3,Randomized,October 2012,October 2013,Prevention,Hoover,Alabama,35216,All,18.0,2013-10-01,2012-10-01,365.0,1.0,35216
NCT01715298,4.166666667,NVA237 BID Versus Placebo Twelve-week Efficacy Study,Completed,Phase 3,Randomized,November 2012,December 2013,Treatment,*See Various Dept.'s*,Arizona,85224,All,40.0,2013-12-01,2012-11-01,395.0,1.0,85224
NCT01716754,5.091237497,Efficacy and Safety of QGE031versus Placebo and Omalizumab in Patients Aged 18-75 Years With Asthma,Completed,Phase 2,Randomized,December 2012,January 2016,Treatment,Fresno,California,93720,All,18.0,2016-01-01,2012-12-01,1126.0,1.0,93720
NCT01727141,2.20674919,"A 12 Week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation.",Completed,Phase 3,Randomized,November 2012,February 2014,Treatment,Birmingham,Alabama,35205,All,40.0,2014-02-01,2012-11-01,457.0,1.0,35205
NCT01729559,13.52693603,Venous Thromboembolic Prophylaxis After Trauma: Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin,Completed,Phase 4,Randomized,November 2012,October 2014,Prevention,San Diego,California,92103,All,18.0,2014-10-01,2012-11-01,699.0,1.0,92103
NCT01732536,2.007226014,Steroid-Releasing S8 Sinus Implant for Recurrent Nasal Polyps,Completed,Phase 2/Phase 3,Randomized,January 2013,May 2014,Treatment,Atherton,California,94027,All,18.0,2014-05-01,2013-01-01,485.0,1.0,94027
NCT01743001,0.4385964912,Clinical Study to Evaluate the Effects of Macitentan on Exercise Capacity in Subjects With Eisenmenger Syndrome,Completed,Phase 3,Randomized,"May 21, 2013","December 1, 2016",Treatment,Los Angeles,California,90095,All,12.0,2016-12-01,2013-05-01,1310.0,1.0,90095
NCT01745848,23.07692308,Roflumilast on Markers of Bone Metabolism and Endothelial Function in COPD,Completed,Phase 4,,February 2013,"June 30, 2016",Treatment,Pittsburgh,Pennsylvania,15213,All,50.0,2016-06-01,2013-02-01,1216.0,1.0,15213
NCT01747629,8.117647059,Efficacy of Inhaled Albuterol Spiromax® in Subjects With Persistent Asthma With Steady State Pharmacokinetics,Completed,Phase 3,Randomized,December 2012,November 2013,Treatment,Costa Mesa,California,,All,12.0,2013-11-01,2012-12-01,335.0,1.0,92626
NCT01755091,19.45955279,Safety and Efficacy Study of Dronabinol to Treat Obstructive Sleep Apnea,Completed,Phase 2,Randomized,February 2013,"December 31, 2016",Treatment,Chicago,Illinois,60611,All,21.0,2016-12-01,2013-02-01,1399.0,1.0,60611
NCT01764841,17.24464264,Ciprofloxacin Dry Powder for Inhalation in Non-cystic Fibrosis Bronchiectasis (Non-CF BE),Completed,Phase 3,Randomized,"May 2, 2013","March 9, 2016",Treatment,Jasper,Alabama,35501,All,18.0,2016-03-01,2013-05-01,1035.0,4.2,35501
NCT01766921,2.797258297,Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Elderly Subjects,Completed,Phase 2,Randomized,January 2013,July 2014,Prevention,Phoenix,Arizona,85253,All,65.0,2014-07-01,2013-01-01,546.0,1.0,85253
NCT01769391,7.081339713,A Study of Necitumumab and Chemotherapy in Participants With Stage IV Squamous Non-Small Cell Lung Cancer,Completed,Phase 2,Randomized,January 2013,July 2017,Treatment,Jonesboro,Arkansas,72401,All,18.0,2017-07-01,2013-01-01,1642.0,1.0,72401
NCT01772134,5.695839311,Efficacy and Safety of the Addition of Fluticanse Propionate/Salmeterol (250/50mcg) Twice-daily to 2 Doses of Umeclidinium Bromide (62.5 or 125mcg) Once-daily Over 12 Weeks,Completed,Phase 3,Randomized,"January 1, 2013","July 22, 2013",Treatment,Jasper,Alabama,35501,All,40.0,2013-07-01,2013-01-01,181.0,4.2,35501
NCT01772147,8.253433607,Efficacy and Safety of the Addition of Fluticasone Propionate/Salmeterol (250/50mcg) Twice-daily to 2 Doses of Umeclidinium Bromide Inhalation Powder (62.5 or 125mcg) Once-daily Over 12 Weeks.,Completed,Phase 3,Randomized,January 2013,August 2013,Treatment,Mobile,Alabama,36608,All,40.0,2013-08-01,2013-01-01,212.0,1.0,36608
NCT01776541,12.96534339,Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Healthy Adults,Completed,Phase 2,Randomized,January 2013,May 2014,Prevention,Miami,Florida,33143,All,18.0,2014-05-01,2013-01-01,485.0,1.0,33143
NCT01776554,6.045089449,Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Children,Completed,Phase 2,Randomized,January 2013,June 2014,Prevention,Miami,Florida,68005,All,0.5,2014-06-01,2013-01-01,516.0,1.0,68005
NCT01777334,7.954423357,The Purpose of This Study is to Evaluate the Spirometric Effect (Trough FEV1) of Umeclidinium/Vilanterol 62.5/25 mcg Once Daily Compared With Tiotriopium 18 mcg Once Daily Over a 24-week Treatment Period in Subjects With COPD,Completed,Phase 3,Randomized,"January 23, 2013","September 24, 2013",Treatment,Tucson,Arizona,85723,All,40.0,2013-09-01,2013-01-01,243.0,1.0,85723
NCT01783548,9.152605644,Study of an Investigational Nasal Aerosol or Placebo in Children (Ages 4 to 11) With Perennial Allergic Rhinitis (PAR),Completed,Phase 3,Randomized,January 2013,October 2013,Treatment,Hot Springs,Arkansas,,All,4.0,2013-10-01,2013-01-01,273.0,1.0,24445
NCT01788228,2.040816327,Safety and Tolerability Study of GlaxoSmithKline (GSK)1557484A Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure,Completed,Phase 3,Non-Randomized,"March 22, 2013","February 25, 2015",Prevention,Stockbridge,Georgia,30281,All,18.0,2015-02-01,2013-03-01,702.0,1.0,30281
NCT01788566,1.639344262,A Study of Gemcitabine-Cisplatin Chemotherapy Plus Necitumumab in the First-Line Treatment of Participants With Squamous Lung Cancer,Completed,Phase 2,,March 2013,December 2015,Treatment,Birmingham,Alabama,35294,All,18.0,2015-12-01,2013-03-01,1005.0,1.0,35294
NCT01793883,4.536933784,Efficacy and Safety Study of Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Adults With Influenza,Completed,Phase 2,Randomized,May 2013,May 2014,Treatment,Scottsboro,Alabama,35768,All,18.0,2014-05-01,2013-05-01,365.0,4.0,35768
NCT01799993,20.7808604,Inhaled Amikacin Solution BAY41-6551 as Adjunctive Therapy in the Treatment of Gram-Negative Pneumonia,Completed,Phase 3,Randomized,"April 13, 2013","April 7, 2017",Treatment,Birmingham,Alabama,35233,All,18.0,2017-04-01,2013-04-01,1461.0,1.0,35233
NCT01801111,12.31884058,A Study of Alectinib (RO5424802) in Participants With Non-Small Cell Lung Cancer Who Have Anaplastic Lymphoma Kinase (ALK) Mutation and Failed Crizotinib Treatment,Completed,Phase 1/Phase 2,,"June 20, 2013","October 27, 2017",Treatment,Birmingham,Alabama,35233,All,18.0,2017-10-01,2013-06-01,1583.0,1.0,35233
NCT01807923,3.647044925,A Study of Lumacaftor in Combination With Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Who Are Homozygous for the F508del-CFTR Mutation,Completed,Phase 3,Randomized,May 2013,April 2014,Treatment,Birmingham,Alabama,,All,12.0,2014-04-01,2013-05-01,335.0,1.0,35203
NCT01807949,3.222045575,A Study of Lumacaftor in Combination With Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Who Are Homozygous for the F508del-CFTR Mutation,Completed,Phase 3,Randomized,April 2013,April 2014,Treatment,Oakland,California,,All,12.0,2014-04-01,2013-04-01,365.0,1.0,02858
NCT01817764,7.932011331,A Study to Compare the Efficacy and Safety of Umeclidinium/Vilanterol and Fluticasone Propionate/Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,"March 1, 2013","October 25, 2013",Treatment,Jasper,Alabama,35501,All,40.0,2013-10-01,2013-03-01,214.0,4.2,35501
NCT01817790,1.918993957,Assessment of Fluticasone Propionate on Ocular Allergy Symptoms,Completed,Phase 3,Randomized,December 2012,February 2013,Treatment,Wilmington,North Carolina,28401-3331,All,12.0,2013-02-01,2012-12-01,62.0,1.0,28401
NCT01825200,0.45682387,"Comparison of the Safety of Flublok® Versus Licensed IIV in Healthy, Medically Stable Adults ≥ 50 Years of Age",Completed,Phase 3,Randomized,March 2013,May 2013,Prevention,Tucson,Arizona,85704-1152,All,50.0,2013-05-01,2013-03-01,61.0,1.0,85704
NCT01827267,2.325581395,Neratinib With and Without Temsirolimus for Patients With HER2 Activating Mutations in Non-Small Cell Lung Cancer,Completed,Phase 2,Randomized,"July 1, 2013","October 6, 2017",Treatment,Duarte,California,91010,All,18.0,2017-10-01,2013-07-01,1553.0,1.0,91010
NCT01829113,36.18048618,Phase II Trial of Carboplatin and Pemetrexed +/- OGX-427 in Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer,Completed,Phase 2,Randomized,July 2013,"April 19, 2017",Treatment,Denver,Colorado,80218,All,18.0,2017-04-01,2013-07-01,1370.0,1.0,80218
NCT01841762,33.09859155,Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument,Completed,Phase 3,,"April 1, 2013","November 1, 2015",Treatment,Birmingham,Alabama,35243,All,18.0,2015-11-01,2013-04-01,944.0,1.0,35243
NCT01846416,6.451612903,A Study of Atezolizumab in Participants With Programmed Death-Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) [FIR],Completed,Phase 2,Non-Randomized,"May 30, 2013","December 18, 2017",Treatment,Scottsdale,Arizona,85258,All,18.0,2017-12-01,2013-05-01,1675.0,1.0,85258
NCT01854047,8.52320717,An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma,Completed,Phase 2,Randomized,June 2013,April 2015,Treatment,Fullerton,California,92835,All,18.0,2015-04-01,2013-06-01,669.0,1.0,92835
NCT01854645,14.83341148,"Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD); (PINNACLE 1)",Completed,Phase 3,Randomized,May 2013,February 2015,Treatment,Andalusia,Alabama,,All,40.0,2015-02-01,2013-05-01,641.0,1.0,36420
NCT01854658,14.30036523,"Multi-Center Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD (PINNACLE 2)",Completed,Phase 3,Randomized,July 2013,March 2015,Treatment,Birmingham,Alabama,u,All,40.0,2015-03-01,2013-07-01,608.0,1.0,u
NCT01857323,20.18927445,Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI),Completed,Phase 3,,May 2013,September 2013,Treatment,Phoenix,Arizona,,All,4.0,2013-09-01,2013-05-01,123.0,1.0,13135
NCT01858389,40.90909091,A Study Of Dacomitinib (PF-00299804) In Patients With Advanced Non-Small Cell Lung Cancer,Completed,Phase 2,Non-Randomized,July 2013,September 2015,Treatment,Beverly Hills,California,90211,All,18.0,2015-09-01,2013-07-01,792.0,1.0,90211
NCT01859143,0.4166666667,Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults,Completed,Phase 4,Randomized,May 2013,December 2013,Prevention,Miami,Florida,,All,18.0,2013-12-01,2013-05-01,214.0,1.0,33122
NCT01859390,5.405405405,Effects of an Antioxidant-Enriched Multivitamin Supplement on Inflammation and Oxidative Stress in Cystic Fibrosis,Completed,Phase 2,Randomized,June 2013,July 2016,Treatment,Tucson,Arizona,85724,All,10.0,2016-07-01,2013-06-01,1126.0,1.0,85724
NCT01868009,0.5226480836,DISKUS vs. ELLIPTA Device Preference Study in Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,May 2013,July 2013,Treatment,Jasper,Alabama,35501,All,40.0,2013-07-01,2013-05-01,61.0,4.2,35501
NCT01871805,14.94252874,A Study of Alectinib (CH5424802/RO5424802) in Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC),Completed,Phase 1/Phase 2,Non-Randomized,"September 30, 2013","August 31, 2017",Treatment,Birmingham,Alabama,35233,All,18.0,2017-08-01,2013-09-01,1430.0,1.0,35233
NCT01872689,29.19268017,A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF),Completed,Phase 2,Randomized,"October 13, 2013","November 6, 2017",Treatment,Birmingham,Alabama,35294,All,40.0,2017-11-01,2013-10-01,1492.0,1.0,35294
NCT01879410,7.463030662,A Study to Compare the Efficacy and Safety of Umeclidinium/Vilanterol With Fluticasone Propionate/Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,"June 13, 2013","January 9, 2014",Treatment,Tucson,Arizona,85723,All,40.0,2014-01-01,2013-06-01,214.0,1.0,85723
NCT01899742,5.465587045,The Purpose of the This Study is to Evaluate the Spirometric Effect (Trough FEV1) of Umeclidinium/Vilanterol 62.5/25 mcg Once Daily Compared With Tiotropium 18mcg Once Daily Over a a 12-week Treatment Period in Subjects With COPD Who Continue to Have Symptoms on Tiotropium,Completed,Phase 3,Randomized,"September 15, 2014","July 22, 2015",Treatment,Medford,Oregon,97504,All,40.0,2015-07-01,2014-09-01,303.0,1.0,97504
NCT01900652,5.378657487,A Study of Emibetuzumab in Non Small Cell Lung Cancer (NSCLC) Participants,Completed,Phase 2,Randomized,August 2013,March 2016,Treatment,Birmingham,Alabama,35294,All,18.0,2016-03-01,2013-08-01,943.0,1.0,35294
NCT01903993,7.328088578,"A Randomized Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum Therapy - ""POPLAR""",Completed,Phase 2,Randomized,"August 6, 2013","September 6, 2018",Treatment,Tucson,Arizona,85704,All,18.0,2018-09-01,2013-08-01,1857.0,1.0,85704
NCT01914757,8.789436987,Efficacy and Safety Study of Benralizumab in Adults and Adolescents Inadequately Controlled on Inhaled Corticosteroid Plus Long-acting β2 Agonist,Completed,Phase 3,Randomized,August 2013,March 2016,Treatment,Andalusia,Alabama,,All,12.0,2016-03-01,2013-08-01,943.0,1.0,36420
NCT01916226,0.7327141383,A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis,Completed,Phase 4,Randomized,"August 1, 2013","October 17, 2013",Treatment,Little Rock,Arkansas,72205,All,18.0,2013-10-01,2013-08-01,61.0,1.0,72205
NCT01920893,11.66666667,An Evaluation of Dupilumab in Patients With Nasal Polyposis And Chronic Symptoms Of Sinusitis,Completed,Phase 2,Randomized,August 2013,November 2014,Treatment,Rolling Hills Estates,California,90274,All,18.0,2014-11-01,2013-08-01,457.0,1.0,90274
NCT01922037,17.71576898,A Study in Participants With Asthma Initiating Treatment With Omalizumab (Xolair),Completed,Phase 4,,"June 19, 2013","March 31, 2016",Treatment,Birmingham,Alabama,35209,All,12.0,2016-03-01,2013-06-01,1004.0,1.0,35209
NCT01928771,9.804986808,Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma,Completed,Phase 3,Randomized,"September 19, 2013","April 5, 2016",Treatment,Foley,Alabama,,All,12.0,2016-04-01,2013-09-01,943.0,1.0,36535
NCT01931839,8.914797669,A Phase 3 Rollover Study of Lumacaftor in Combination With Ivacaftor in Subjects 12 Years and Older With Cystic Fibrosis,Completed,Phase 3,Randomized,October 2013,April 2016,Treatment,Birmingham,Alabama,,All,12.0,2016-04-01,2013-10-01,913.0,1.0,35203
NCT01933048,5.088866245,Self-Administered Nasal Influenza Feasibility Study,Completed,Phase 4,Randomized,September 2012,October 2013,Other,San Diego,California,92134,All,18.0,2013-10-01,2012-09-01,395.0,1.0,92134
NCT01946425,1.666666667,Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent Influenza Virus Vaccine,Completed,Phase 4,Non-Randomized,September 2013,July 2014,Prevention,Bardstown,Kentucky,40040,All,0.5,2014-07-01,2013-09-01,303.0,10.0,40040
NCT01946438,1.923076923,"Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose Influenza Virus Vaccines in Adults",Completed,Phase 4,Randomized,September 2013,July 2014,Prevention,Santa Rosa,California,95405,All,18.0,2014-07-01,2013-09-01,303.0,1.0,95405
NCT01949090,3.666666667,Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 65 Years of Age and Older,Completed,Phase 2,Randomized,"September 25, 2013","October 23, 2014",Prevention,Hollywood,Florida,33024,All,65.0,2014-10-01,2013-09-01,395.0,1.0,33024
NCT01951586,8.879071379,Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer,Completed,Phase 2,Randomized,"December 31, 2013","November 28, 2017",Treatment,Goodyear,Arizona,85338,All,18.0,2017-11-01,2013-12-01,1431.0,2.0,85338
NCT01957163,4.039053828,"Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD)",Completed,Phase 3,Randomized,"October 1, 2013","April 1, 2014",Treatment,Jasper,Alabama,35501,All,40.0,2014-04-01,2013-10-01,182.0,4.2,35501
NCT01959412,0.1831501832,"Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Different Doses of Indacaterol in Patients With Persistent Asthma",Completed,Phase 2,Randomized,November 2013,March 2014,Treatment,Huntington Beach,California,92647,All,18.0,2014-03-01,2013-11-01,120.0,1.0,92647
NCT01964352,5.533456127,Tiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1),Completed,Phase 3,Randomized,November 2013,November 2014,Treatment,Wheat Ridge,Colorado,,All,40.0,2014-11-01,2013-11-01,365.0,1.0,80033
NCT01966003,10.39692403,Efficacy and Safety Study of ABP 215 Compared With Bevacizumab in Patients With Advanced Non-Small Cell Lung Cancer,Completed,Phase 3,Randomized,"November 11, 2013","July 23, 2015",Treatment,Bismarck,North Dakota,58501,All,18.0,2015-07-01,2013-11-01,607.0,1.0,58501
NCT01966107,37.13830865,Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and Exacerbations in Moderate to Very Severe COPD Patients.,Completed,Phase 4,Randomized,"October 16, 2013","September 21, 2017",Treatment,Birmingham,Alabama,35209,All,40.0,2017-09-01,2013-10-01,1431.0,1.0,35209
NCT01967173,23.68730324,Best African American Response to Asthma Drugs,Completed,Phase 3,Randomized,February 2014,"July 1, 2017",Treatment,Tucson,Arizona,85724,All,5.0,2017-07-01,2014-02-01,1246.0,1.0,85724
NCT01967628,16.25,Human Lung Responses to Respiratory Pathogens,Completed,Phase 1/Phase 2,Randomized,June 2007,October 2010,Basic Science,Iowa City,Iowa,52242,All,18.0,2010-10-01,2007-06-01,1218.0,1.0,52242
NCT01969799,2.083333333,Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia,Completed,Phase 2,Randomized,December 2013,April 2016,Treatment,Los Angeles,California,90033,All,18.0,2016-04-01,2013-12-01,852.0,1.0,90033
NCT01970878,2.76069181,"Extension Study to Evaluate the Safety and Efficacy of PT003, PT001, and PT005 in Subjects With Moderate to Very Severe COPD, With Spiriva® Handihaler® (PINNACLE 3)",Completed,Phase 3,Randomized,November 2013,March 2015,Treatment,Andalusia,Alabama,,All,40.0,2015-03-01,2013-11-01,485.0,1.0,36420
NCT01974895,9.554527751,Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children From 6 to 35 Months of Age,Completed,Phase 2,Randomized,"October 23, 2013","July 3, 2014",Prevention,Sacramento,California,95822,All,0.5,2014-07-01,2013-10-01,273.0,1.0,95822
NCT01978262,11.95652174,Immune and Hormone Response to Influenza Vaccine,Completed,Phase 4,,October 2013,August 2017,Other,Baltimore,Maryland,21205,Female,18.0,2017-08-01,2013-10-01,1400.0,1.0,21205
NCT01979952,12.40601504,Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF),Completed,Phase 3,Randomized,"November 26, 2013","October 27, 2016",Treatment,Danbury,Connecticut,06810,All,40.0,2016-10-01,2013-11-01,1065.0,1.0,06810
NCT01992094,3.007165732,Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older,Completed,Phase 3,Randomized,November 2013,July 2014,Prevention,Huntsville,Alabama,35802,All,18.0,2014-07-01,2013-11-01,242.0,1.0,35802
NCT01992107,5.876088124,Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old,Completed,Phase 3,Randomized,November 2013,August 2014,Prevention,Huntsville,Alabama,35802,All,4.0,2014-08-01,2013-11-01,273.0,1.0,35802
NCT02006732,4.20243379,Tiotropium+Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 2),Completed,Phase 3,Randomized,November 2013,November 2014,Treatment,Jasper,Alabama,,All,40.0,2014-11-01,2013-11-01,365.0,1.0,14855
NCT02020889,5.147058824,A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis,Completed,Phase 3,Randomized,"February 5, 2014","September 5, 2016",Treatment,Denver,Colorado,80206,All,18.0,2016-09-01,2014-02-01,943.0,1.0,80206
NCT02031640,4.245283019,A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma,Completed,Phase 3,Randomized,December 2013,December 2014,Treatment,Costa Mesa,California,,All,12.0,2014-12-01,2013-12-01,365.0,1.0,92626
NCT02035696,1.789260581,Safety and Immunogenicity of a Four Influenza Vaccines in Children Ages 6 Months Old to Less Than 48 Months Old,Completed,Phase 1/Phase 2,Randomized,December 2013,December 2014,Prevention,Phoenix,Arizona,,All,0.5,2014-12-01,2013-12-01,365.0,1.0,13135
NCT02040766,6.680874891,A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants Ages 4-11 Years Old With Persistent Asthma,Completed,Phase 3,Randomized,December 2013,March 2016,Treatment,Hoover,Alabama,,All,4.0,2016-03-01,2013-12-01,821.0,1.0,15936
NCT02040779,6.231530145,A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma,Completed,Phase 3,Randomized,"December 26, 2013","December 24, 2014",Treatment,Huntington Beach,California,,All,12.0,2014-12-01,2013-12-01,365.0,1.0,92646
NCT02054130,10.01269438,"Study to Evaluate the Efficacy and Safety of MEDI9929 (AMG 157) in Adult Subjects With Inadequately Controlled, Severe Asthma",Completed,Phase 2,Randomized,"December 13, 2013","March 1, 2017",Treatment,Los Angeles,California,90025,All,18.0,2017-03-01,2013-12-01,1186.0,1.0,90025
NCT02061280,40.66666667,Use of Mobile Devices and the Internet to Streamline an Asthma Clinical Trial,Completed,Phase 4,Randomized,October 2013,"February 17, 2017",Other,Wilmington,Delaware,19803,All,12.0,2017-02-01,2013-10-01,1219.0,1.0,19803
NCT02064439,9.594677461,Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism),Completed,Phase 3,Randomized,"March 5, 2014","November 4, 2016",Prevention,Beverly Hills,California,90211,All,18.0,2016-11-01,2014-03-01,976.0,1.0,90211
NCT02073682,26.85684829,Cancer Venous Thromboembolism (VTE),Completed,Phase 3,Randomized,"July 16, 2015","September 15, 2017",Treatment,Brandon,Florida,,All,18.0,2017-09-01,2015-07-01,793.0,1.0,05733
NCT02075255,3.197361745,Efficacy and Safety Study of Benralizumab to Reduce OCS Use in Patients With Uncontrolled Asthma on High Dose Inhaled Corticosteroid Plus LABA and Chronic OCS Therapy,Completed,Phase 3,Randomized,"April 28, 2014","August 8, 2016",Treatment,Los Angeles,California,90025,All,18.0,2016-08-01,2014-04-01,853.0,1.0,90025
NCT02085161,12.22368421,To Evaluate the Effect of Inhaled Medication Together With Exercise and Activity Training on Exercise Capacity and Daily Activities in Patients With Chronic Lung Disease With Obstruction of Airways,Completed,Phase 3,Randomized,March 2014,October 2015,Treatment,San Diego,California,,All,40.0,2015-10-01,2014-03-01,579.0,1.0,78384
NCT02091986,9.294431732,"A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg",Completed,Phase 3,Randomized,April 2014,April 2016,Treatment,Hoover,Alabama,,All,6.0,2016-04-01,2014-04-01,731.0,1.0,15936
NCT02098369,4.040953337,Comparative Effectiveness of a Peer-led O2 Infoline for Patients and Caregivers,Completed,Phase 4,Randomized,April 2015,October 2016,Treatment,Lake Forest,California,92630,All,18.0,2016-10-01,2015-04-01,549.0,1.1,92630
NCT02105948,10.70460777,Study to Evaluate Efficacy and Safety of Mepolizumab for Frequently Exacerbating Chronic Obstructive Pulmonary Disease (COPD) Patients,Completed,Phase 3,Randomized,"April 15, 2014","January 17, 2017",Treatment,Newport Beach,California,92663,All,40.0,2017-01-01,2014-04-01,1006.0,1.0,92663
NCT02105961,10.95862123,Efficacy and Safety of Mepolizumab as an Add-on Treatment in Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,"April 24, 2014","January 16, 2017",Treatment,Birmingham,Alabama,35294,All,40.0,2017-01-01,2014-04-01,1006.0,1.0,35294
NCT02105974,3.885630499,Study Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Inhalation Powder (FF/VI) Compared With Vilanterol Inhalation Powder (VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,"April 7, 2014","July 8, 2015",Treatment,Riverside,California,92506,All,40.0,2015-07-01,2014-04-01,456.0,1.0,92506
NCT02106832,13.29999815,Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-cystic Fibrosis Bronchiectasis (Non-CF BE),Completed,Phase 3,Randomized,"April 30, 2014","October 19, 2016",Treatment,Peoria,Arizona,85381,All,18.0,2016-10-01,2014-04-01,914.0,1.0,85381
NCT02119286,4.204774635,"Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2",Completed,Phase 3,Randomized,October 2013,April 2014,Treatment,Mobile,Alabama,36608,All,40.0,2014-04-01,2013-10-01,182.0,1.0,36608
NCT02130193,18.19444444,"Investigation of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of Oral Danirixin in Symptomatic COPD Subjects With Mild to Moderate Airflow Limitation at Risk for Exacerbations",Completed,Phase 2,Randomized,"February 13, 2014","August 29, 2016",Treatment,Birmingham,Alabama,35294,All,40.0,2016-08-01,2014-02-01,912.0,1.0,35294
NCT02135692,7.079646018,"A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects",Completed,Phase 3,,"May 29, 2014","October 5, 2017",Treatment,Newport Beach,California,92663,All,12.0,2017-10-01,2014-05-01,1249.0,1.0,92663
NCT02139644,5.403697078,Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma,Completed,Phase 3,Randomized,June 2014,September 2015,Treatment,Birmingham,Alabama,,All,12.0,2015-09-01,2014-06-01,457.0,1.0,35203
NCT02141854,5.479452055,Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent Asthma,Completed,Phase 3,Randomized,June 2014,September 2015,Treatment,Birmingham,Alabama,,All,12.0,2015-09-01,2014-06-01,457.0,1.0,35203
NCT02148445,0.0,Smoking Cessation Versus Long-term Nicotine Replacement Among High-risk Smokers,Completed,Phase 3,Randomized,May 2014,December 2016,Treatment,Kansas City,Kansas,66160,All,18.0,2016-12-01,2014-05-01,945.0,1.0,66160
NCT02152605,4.233870968,A Phase IIIb Study to Evaluate the Efficacy of Umeclidinium/Vilanterol (UMEC/VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 3,Randomized,"September 1, 2014","March 5, 2015",Treatment,Phoenix,Arizona,85006,All,40.0,2015-03-01,2014-09-01,181.0,1.0,85006
NCT02157935,7.372980365,Comparing the Efficacy of Symbicort® pMDI and Formoterol Turbuhaler in Reducing Exacerbations in Patients With Cronic Obstructive Pulmonary Disease,Completed,Phase 3,Randomized,"June 27, 2014","February 8, 2016",Treatment,Andalusia,Alabama,36420,All,40.0,2016-02-01,2014-06-01,610.0,7.0,36420
NCT02161757,11.65465114,A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma,Completed,Phase 3,Randomized,"June 13, 2014","July 18, 2017",Treatment,Birmingham,Alabama,35209,All,12.0,2017-07-01,2014-06-01,1126.0,1.0,35209
NCT02164513,11.17288302,"A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)",Completed,Phase 3,Randomized,"June 30, 2014","July 17, 2017",Treatment,Athens,Alabama,35611,All,40.0,2017-07-01,2014-06-01,1126.0,4.2,35611
NCT02164539,3.539621398,Evaluation of Umeclidinium Bromide in Combination With Fluticasone Furoate in COPD Subjects With an Asthmatic Component,Completed,Phase 2,Randomized,"July 1, 2014","July 18, 2015",Treatment,Newport Beach,California,92663,All,18.0,2015-07-01,2014-07-01,365.0,1.0,92663
NCT02175771,11.95443444,Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent Asthma,Completed,Phase 3,Randomized,July 2014,July 2015,Treatment,Birmingham,Alabama,,All,12.0,2015-07-01,2014-07-01,365.0,1.0,35203
NCT02191137,12.0,Measuring Outcomes In Patients With Pulmonary Arterial Hypertension Not on Active Treatment (MOTION),Completed,Phase 4,,"September 23, 2014","July 16, 2016",Treatment,Tucson,Arizona,85724,All,18.0,2016-07-01,2014-09-01,669.0,1.0,85724
NCT02194699,12.78520041,A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma,Completed,Phase 3,Randomized,"October 30, 2014","September 21, 2017",Treatment,Birmingham,Alabama,35294,All,12.0,2017-09-01,2014-10-01,1066.0,1.0,35294
NCT02207413,1.025789604,A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Candidate Vaccine (GSK2321138A) Manufactured Using a New Process in Adults and Children,Completed,Phase 3,Randomized,"August 18, 2014","April 18, 2015",Prevention,Wichita,Kansas,67207,All,0.5,2015-04-01,2014-08-01,243.0,1.0,67207
NCT02207829,5.407584735,A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium Compared With Tiotropium in Subjects With Chronic Obstructive Pulmonary Disease,Completed,Phase 3,Randomized,"September 1, 2014","June 15, 2015",Treatment,Spartanburg,South Carolina,29303,All,40.0,2015-06-01,2014-09-01,273.0,1.0,29303
NCT02214225,2.487190088,A Study to Evaluate the Immunogenicity and Safety of bioCSL Quadrivalent Influenza Vaccine (QIV) in Adults Aged 18 Years and Above.,Completed,Phase 3,Randomized,August 2014,April 2015,Prevention,Huntsville,Alabama,35802,All,18.0,2015-04-01,2014-08-01,243.0,1.0,35802
NCT02230332,6.513157895,Alendronate to Prevent Loss of Bronchoprotection in Asthma,Completed,Phase 2/Phase 3,Randomized,January 2015,September 2016,Treatment,Tucson,Arizona,85724,All,18.0,2016-09-01,2015-01-01,609.0,1.0,85724
NCT02238483,13.20872274,A Phase IIa Study to Investigate the Efficacy and Safety of AZD7624 in Chronic Obstructive Pulmonary Disease (COPD) Patients While on Maintenance Therapy,Completed,Phase 2,Randomized,"October 28, 2014","April 4, 2016",Treatment,Los Angeles,California,90036,All,40.0,2016-04-01,2014-10-01,548.0,1.0,90036
NCT02242643,6.311478032,Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine (GSK2282512A) Compared to Fluzone® Quadrivalent in Children 6 to 35 Months of Age,Completed,Phase 3,Randomized,"October 1, 2014","June 23, 2015",Prevention,Birmingham,Alabama,35235,All,0.5,2015-06-01,2014-10-01,243.0,1.0,35235
NCT02250274,0.0,Randomized Study of Immune Response to Licensed Influenza Vaccines in Children and Adolescents,Completed,Phase 4,Randomized,September 2014,April 2015,Basic Science,Marshfield,Wisconsin,54449,All,5.0,2015-04-01,2014-09-01,212.0,4.0,54449
NCT02256488,1.538461538,Safety and Immunogenicity of Two Trivalent Subunit Influenza Vaccines in Healthy Adult Subjects,Completed,Phase 3,Randomized,September 2014,December 2014,Other,Anaheim,California,,All,18.0,2014-12-01,2014-09-01,91.0,1.0,92801
NCT02258334,0.5,"Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines in Adults",Completed,Phase 4,Randomized,October 2014,December 2014,Prevention,Santa Rosa,California,95405,All,18.0,2014-12-01,2014-10-01,61.0,1.0,95405
NCT02259582,7.305418719,"A Study of Carboplatin, Pemetrexed Plus Placebo vs Carboplatin, Pemetrexed Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With Non-Squamous Non-Small Cell Lung Cancer",Completed,Phase 2,Randomized,February 2015,"April 7, 2017",Treatment,Rancho Mirage,California,92270,All,21.0,2017-04-01,2015-02-01,790.0,1.0,92270
NCT02266875,18.96551724,Nebulized Hypertonic Saline for Inpatient Use in COPD,Completed,Phase 4,Randomized,October 2014,"January 30, 2017",Treatment,Columbus,Ohio,43228,All,18.0,2017-01-01,2014-10-01,823.0,1.0,43228
NCT02268396,7.246376812,Glycopyrronium and Formoterol Fumarate (GFF) Metered Dose Inhaler (MDI) Dose Indicator Study in Adults With Moderate to Very Severe COPD,Completed,Phase 3,,November 2014,May 2015,Treatment,Clearwater,Florida,,All,40.0,2015-05-01,2014-11-01,181.0,1.0,33755
NCT02276222,19.15443721,A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD,Completed,Phase 3,Randomized,October 2014,February 2016,Treatment,Andalusia,Alabama,36420,All,40.0,2016-02-01,2014-10-01,488.0,7.0,36420
NCT02279498,13.94383394,SOLUTION: Study of Oral Liprotamase Unit-Matched Therapy Of Non-Porcine Origin in Patients With Cystic Fibrosis,Completed,Phase 3,Randomized,June 2015,"January 20, 2017",Treatment,Long Beach,California,90806,All,7.0,2017-01-01,2015-06-01,580.0,1.0,90806
NCT02281318,2.717462911,Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma Control,Completed,Phase 3,Randomized,"December 11, 2014","June 10, 2016",Treatment,Birmingham,Alabama,35243,All,12.0,2016-06-01,2014-12-01,548.0,1.0,35243
NCT02281357,7.857142857,Phase 3 Study to Evaluate the Efficacy & Safety of Tralokinumab in Adults & Adolescents With OCS Dependent Asthma,Completed,Phase 3,Randomized,"February 19, 2015","September 7, 2017",Treatment,New Haven,Connecticut,06520,All,12.0,2017-09-01,2015-02-01,943.0,1.0,06520
NCT02285998,5.719449012,Protective Efficacy of Flublok® Quadrivalent Versus Licensed Inactivated Influenza Vaccine in Adults ≥50 Years of Age,Completed,Phase 3,Randomized,October 2014,May 2015,Prevention,Mobile,Alabama,36608,All,50.0,2015-05-01,2014-10-01,212.0,1.0,36608
NCT02289833,6.896551724,"A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor (HER)2 Immunohistochemistry (IHC)-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)",Completed,Phase 2,,"December 15, 2014","August 20, 2018",Treatment,Jacksonville,Florida,32256,All,18.0,2018-08-01,2014-12-01,1339.0,1.0,32256
NCT02290691,1.72858276,Inactivated Influenza Via Jet Injection,Completed,Phase 4,Randomized,November 2014,January 2015,Prevention,Huntsville,Alabama,35802,All,18.0,2015-01-01,2014-11-01,61.0,1.0,35802
NCT02291549,0.753806724,S8 Sinus Implant in Chronic Sinusitis Patients With Recurrent Nasal Polyps,Completed,Phase 3,Randomized,December 2014,October 2016,Treatment,Birmingham,Alabama,35233,All,18.0,2016-10-01,2014-12-01,670.0,1.0,35233
NCT02296138,13.51478159,Comparing the Efficacy of Tiotropium + Olodaterol (5/5 µg) Fixed Dose Combination (FDC) Over Tiotropium 5µg in Reducing Moderate to Severe Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease.,Completed,Phase 3,Randomized,"January 13, 2015","March 29, 2017",Treatment,Andalusia,Alabama,,All,40.0,2017-03-01,2015-01-01,790.0,1.0,36420
NCT02301975,4.385720717,"An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol 100/25 Microgram (mcg) Inhalation Powder, Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and Fluticasone Propionate 250 mcg Inhalation Powder in Adults and Adolescents With Persistent Asthma",Completed,Phase 3,Randomized,"March 1, 2015","November 25, 2016",Treatment,Huntington Beach,California,92647,All,12.0,2016-11-01,2015-03-01,611.0,1.0,92647
NCT02322775,5.215633423,Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma,Completed,Phase 3,Randomized,"February 2, 2015","October 7, 2015",Treatment,Los Angeles,California,90048,All,18.0,2015-10-01,2015-02-01,242.0,1.0,90048
NCT02347657,6.338205645,"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor",Completed,Phase 3,Randomized,January 2015,"January 20, 2017",Treatment,Little Rock,Arkansas,,All,12.0,2017-01-01,2015-01-01,731.0,1.0,29567
NCT02347774,22.67236819,Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4),Completed,Phase 3,Randomized,February 2015,December 2015,Treatment,Andalusia,Alabama,36420,All,40.0,2015-12-01,2015-02-01,303.0,7.0,36420
NCT02364999,7.787570219,A Comparative Study Of PF-06439535 Plus Paclitaxel-Carboplatin And Bevacizumab Plus Paclitaxel-Carboplatin Patients With Advanced Non-Squamous NSCLC,Completed,Phase 3,Randomized,April 2015,December 2017,Treatment,Daphne,Alabama,36526,All,18.0,2017-12-01,2015-04-01,975.0,4.1,36526
NCT02377427,11.53846154,Pharmacokinetics and Pharmacodynamics of Mepolizumab Administered Subcutaneously in Children,Completed,Phase 2,Non-Randomized,"August 25, 2015","January 31, 2018",Other,San Diego,California,92123,All,6.0,2018-01-01,2015-08-01,884.0,1.0,92123
NCT02390219,23.91304348,Study to Evaluate Lumacaftor and Ivacaftor Combination Therapy in Subjects 12 Years and Older With Advanced Lung Disease,Completed,Phase 3,,March 2015,October 2016,Treatment,Denver,Colorado,,All,12.0,2016-10-01,2015-03-01,580.0,1.0,12421
NCT02411292,20.21276596,Enoxaparin Metabolism in Reconstructive Surgery Patients,Completed,Phase 2,,March 2015,June 2016,Other,Salt Lake City,Utah,84132,All,18.0,2016-06-01,2015-03-01,458.0,1.0,84132
NCT02414854,7.089750492,Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest),Completed,Phase 3,Randomized,"April 27, 2015","November 23, 2017",Treatment,Birmingham,Alabama,35209,All,12.0,2017-11-01,2015-04-01,945.0,1.0,35209
NCT02417961,3.448275862,"Study to Assess Functionality, Reliability, and Performance of a Pre-filled Syringe With Benralizumab Administered at Home",Completed,Phase 3,,"April 27, 2015","March 14, 2016",Treatment,Fountain Valley,California,,All,18.0,2016-03-01,2015-04-01,335.0,1.0,92708
NCT02438137,20.995671,Dimethyl Fumarate for Obstructive Sleep Apnea,Completed,Phase 2,Randomized,May 2015,May 2016,Treatment,Ann Arbor,Michigan,48109,All,18.0,2016-05-01,2015-05-01,366.0,1.0,48109
NCT02449018,3.571428571,"A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251",Completed,Phase 2,Randomized,"April 30, 2015","January 23, 2017",Treatment,Birmingham,Alabama,35294,All,18.0,2017-01-01,2015-04-01,641.0,1.0,35294
NCT02471183,5.882352941,Study to Assess the Tolerability and the Safety of the Transition From Inhaled Treprostinil to Oral Selexipag in Patients With Pulmonary Arterial Hypertension,Completed,Phase 3,,"October 12, 2015","December 5, 2016",Treatment,La Jolla,California,,All,18.0,2016-12-01,2015-10-01,427.0,1.0,92037
NCT02473510,1.25,Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults for the 2015-2016 Season,Completed,Phase 4,Randomized,June 2015,January 2016,Prevention,South Miami,Florida,,All,18.0,2016-01-01,2015-06-01,214.0,1.0,33122
NCT02483975,1.818181818,Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma,Completed,Phase 3,Randomized,"October 9, 2015","June 21, 2016",Treatment,Little Rock,Arkansas,72211,All,5.0,2016-06-01,2015-10-01,244.0,1.0,72211
NCT02501629,5.094484168,An Efficacy and Safety Study of Reslizumab Subcutaneous in Patients With Oral Corticosteroid Dependent Asthma and Elevated Blood Eosinophils,Completed,Phase 3,Randomized,"September 29, 2015","December 4, 2017",Treatment,Bakersfield,California,93301,All,12.0,2017-12-01,2015-09-01,822.0,1.0,93301
NCT02513160,10.75452455,Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma,Completed,Phase 3,Randomized,"September 30, 2015","March 31, 2016",Treatment,Peoria,Arizona,,All,12.0,2016-03-01,2015-09-01,182.0,1.0,61602
NCT02514473,3.912332981,"A Study to Evaluate the Efficacy and Safety of Lumacaftor in Combination With Ivacaftor in Subjects With CF, Homozygous for the F508del-CFTR Mutation",Completed,Phase 3,Randomized,July 2015,September 2016,Treatment,Birmingham,Alabama,,All,6.0,2016-09-01,2015-07-01,428.0,1.0,35203
NCT02516410,1.204819277,"A Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Heterozygous for the F508del-CFTR Mutation",Completed,Phase 3,Randomized,August 2015,"June 7, 2016",Treatment,Birmingham,Alabama,,All,12.0,2016-06-01,2015-08-01,305.0,1.0,35203
NCT02528214,1.45631068,Evaluation of Dupilumab in Patients With Severe Steroid Dependent Asthma,Completed,Phase 3,Randomized,"October 15, 2015","November 13, 2017",Treatment,Los Angeles,California,90048,All,12.0,2017-11-01,2015-10-01,762.0,1.0,90048
NCT02531438,5.943859837,Omadacycline vs Moxifloxacin for the Treatment of CABP (EudraCT #2013-004071-13),Completed,Phase 3,Randomized,November 2015,"March 10, 2017",Treatment,Birmingham,Alabama,35215,All,18.0,2017-03-01,2015-11-01,486.0,1.0,35215
NCT02545543,5.269733994,A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 5 Through 17 Years of Age,Completed,Phase 3,Randomized,September 2015,June 2016,Prevention,Huntsville,Alabama,35802,All,5.0,2016-06-01,2015-09-01,274.0,1.0,35802
NCT02563106,14.32038835,A Study of SYN-004 for the Prevention of C.Diff in Patients With a LRTI,Completed,Phase 2,Randomized,October 2015,November 2016,Prevention,Little Rock,Arkansas,72205,All,50.0,2016-11-01,2015-10-01,397.0,1.0,72205
NCT02570165,2.498568345,Dose-Finding Study of Batefenterol (GSK961081) Via Dry Powder Inhaler in Patients With Chronic Obstructive Pulmonary Disease (COPD),Completed,Phase 2,Randomized,"November 6, 2015","July 6, 2016",Treatment,Hialeah,Florida,33013,All,40.0,2016-07-01,2015-11-01,243.0,1.0,33013
NCT02573870,11.9047619,Batefenterol/Fluticasone Furoate in Treatment of Chronic Obstructive Pulmonary Disease,Completed,Phase 2,Randomized,"December 1, 2015","July 5, 2016",Treatment,Phoenix,Arizona,85006,All,40.0,2016-07-01,2015-12-01,213.0,1.0,85006
NCT02579603,5.80836108,"Safety, Tolerability and PK of Nintedanib in Combination With Pirfenidone in IPF",Completed,Phase 4,Randomized,"October 16, 2015","January 31, 2017",Treatment,Danbury,Connecticut,06810,All,40.0,2017-01-01,2015-10-01,458.0,1.0,06810
NCT02584660,13.21195145,A Study of Rivaroxaban for Early Discharge of Low Risk Pulmonary Embolism From the Emergency Department,Completed,Phase 4,Randomized,"October 15, 2015","March 22, 2017",Treatment,Montgomery,Alabama,,All,18.0,2017-03-01,2015-10-01,517.0,1.0,12549
NCT02586493,4.316546763,Ease of Use and Correct Use Study of Placebo ELLIPTA® Inhaler in COPD Subjects,Completed,Phase 4,,"October 1, 2015","March 15, 2016",Other,Jasper,Alabama,35501,All,40.0,2016-03-01,2015-10-01,152.0,4.2,35501
NCT02586506,3.474903475,Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma,Completed,Phase 4,,"October 1, 2015","February 4, 2016",Other,Mobile,Alabama,36608,All,18.0,2016-02-01,2015-10-01,123.0,1.0,36608
NCT02598193,17.97752809,Safety and Tolerability Study of Pirfenidone in Combination With Nintedanib in Participants With Idiopathic Pulmonary Fibrosis (IPF),Completed,Phase 4,,"January 14, 2016","May 16, 2017",Treatment,Los Angeles,California,90095-1690,All,40.0,2017-05-01,2016-01-01,486.0,1.0,90095
NCT02603952,1.5625,A Phase 2a to Evaluate the Safety of MEDI8852 in Adults With Uncomplicated Influenza,Completed,Phase 1/Phase 2,Randomized,"December 7, 2015","December 9, 2016",Treatment,Canoga Park,California,91303,All,18.0,2016-12-01,2015-12-01,366.0,1.0,91303
NCT02631551,3.475516912,Efficacy and Safety of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Seasonal Allergic Rhinitis (SAR),Completed,Phase 3,Randomized,March 2016,July 2016,Treatment,Mission Viejo,California,,All,12.0,2016-07-01,2016-03-01,122.0,1.0,92691
NCT02654145,4.137931034,Omalizumab to Mepolizumab Switch Study in Severe Eosinophilic Asthma Patients,Completed,Phase 4,,"March 17, 2016","May 31, 2017",Treatment,Birmingham,Alabama,35209,All,12.0,2017-05-01,2016-03-01,426.0,1.0,35209
NCT02709538,21.92791798,Long Term Safety and Efficacy of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Perennial Allergic Rhinitis (PAR),Completed,Phase 3,Randomized,April 2016,July 2017,Treatment,Hot Springs,Arkansas,,All,12.0,2017-07-01,2016-04-01,456.0,1.0,24445
NCT02730351,2.702702703,Crossover Study Comparing Fluticasone Furoate (FF)/Vilanterol (VI) Once Daily Versus Fluticasone Propionate (FP) Twice Daily in Subjects With Asthma and Exercise-Induced Bronchoconstriction (EIB),Completed,Phase 4,Randomized,"May 25, 2016","February 3, 2017",Treatment,Huntington Beach,California,92647,All,12.0,2017-02-01,2016-05-01,276.0,1.0,92647
NCT02743117,1.054926507,Study to Evaluate the Safety of 1 New 6:2 Influenza Virus Reassortant in Adults for the 2016-2017 Season,Completed,Phase 4,Randomized,"May 2, 2016","November 30, 2016",Prevention,South Miami,Florida,33143,All,18.0,2016-11-01,2016-05-01,184.0,1.0,33143
NCT02794480,0.7258064516,Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use,Completed,Phase 4,Randomized,"August 22, 2016","December 15, 2016",Treatment,Huntington Beach,California,92648,All,18.0,2016-12-01,2016-08-01,122.0,1.0,92648
NCT02796677,8.501747625,AMPLIFY - D6571C00001 Duaklir USA Phase III Study,Completed,Phase 3,Randomized,"July 5, 2016","June 8, 2017",Treatment,Gulf Shores,Alabama,36542,All,40.0,2017-06-01,2016-07-01,335.0,7.0,36542
NCT02799784,2.118644068,An Efficacy Study of Umeclidinium/Vilanterol With Tiotropium/Olodaterol in COPD Patients,Completed,Phase 4,Randomized,"July 14, 2016","April 27, 2017",Treatment,Clearwater,Florida,33765,All,40.0,2017-04-01,2016-07-01,274.0,1.0,33765
NCT02814643,3.865007541,Study to Evaluate the Potential Effect of Benralizumab on the Humoral Immune Response to the Seasonal Influenza Vaccination in Adolescent and Young Adult Patients With Severe Asthma,Completed,Phase 3,Randomized,"July 1, 2016","January 24, 2017",Supportive Care,Birmingham,Alabama,35209,All,12.0,2017-01-01,2016-07-01,184.0,1.0,35209
NCT02823964,12.0,EASY: Extended Access to Sollpura Over Years,Completed,Phase 4,,September 2016,March 2018,Treatment,Aurora,Colorado,80045,All,7.0,2018-03-01,2016-09-01,546.0,1.0,80045
NCT02864342,20.47974414,Adherence Study in COPD Patients,Completed,Phase 4,Randomized,"August 12, 2016","October 31, 2017",Treatment,Clearwater,Florida,37765,All,40.0,2017-10-01,2016-08-01,426.0,10.0,37765
NCT02915302,7.356109147,Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children,Completed,Phase 4,Randomized,"September 23, 2016","March 6, 2017",Prevention,Birmingham,Alabama,35205,All,0.5,2017-03-01,2016-09-01,181.0,1.0,35205
NCT02918071,2.479338843,"Study to Assess Functionality, Reliability, and Performance of a Single-Use Auto-Injector With Benralizumab Administered at Home",Completed,Phase 3,,"November 10, 2016","August 21, 2017",Treatment,Northridge,California,91324,All,18.0,2017-08-01,2016-11-01,273.0,1.0,91324
NCT03005067,10.06811409,To Evaluate the Efficacy and Safety of 1146A Nasal Spray in Adult Participants With Symptoms of Common Cold,Completed,Phase 2,Randomized,"December 29, 2016","June 7, 2017",Treatment,Birmingham,Alabama,35211,All,18.0,2017-06-01,2016-12-01,182.0,1.0,35211
NCT03021304,0.0,Study of Mepolizumab Safety Syringe in Asthmatics,Completed,Phase 3,,"February 1, 2017","August 8, 2017",Treatment,Birmingham,Alabama,35243,All,12.0,2017-08-01,2017-02-01,181.0,1.0,35243
NCT03099096,0.6289308176,Study of Mepolizumab Autoinjector in Asthmatics,Completed,Phase 3,,"May 4, 2017","November 30, 2017",Treatment,Birmingham,Alabama,35243,All,12.0,2017-11-01,2017-05-01,184.0,1.0,35243
